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Abstract 
In March 2013, NHS England extended its national bowel cancer screening programme to include 
once-only flexible sigmoidoscopy (‘bowel scope’) screening for men and women aged 55. Since 
roll-out of the programme began, uptake has been low and inequitable, with people living in the 
most deprived areas being the least likely to take part in screening. This thesis examines uptake 
at St Mark’s Hospital, a centre which serves a socioeconomically diverse population with below 
average uptake, and goes on to describe the development and evaluation of an intervention 
targeted at those who do not participate. Study 1 identifies and describes possible targets for 
intervention. The results of the study informed the design of a self-referral reminder letter and 
theory-based information leaflet to be sent to individuals who did not attend bowel scope 
screening (BSS) within one year of their original invitation. Study 2 describes a test of the 
intervention’s feasibility, with results demonstrating its potential to increase BSS uptake. Study 3 
examines the effectiveness of the reminder letter and theory-based leaflet by comparing uptake 
against appropriate controls, namely: no reminder or the designed reminder letter sent with the 
standard information booklet used by the National Health Service. The results of the randomised 
controlled trial (RCT) demonstrate that uptake was significantly higher among the two groups 
receiving the reminder, with the group receiving the theory-based leaflet showing the highest rate 
of uptake. In Study 4, the materials were re-sent to those who had not attended BSS within 24 
months of their initial invitation. The results of this extension to the RCT corroborate the outcome 
of the first reminder. This series of studies demonstrates the usefulness of additional reminders 
in the BSS programme, which is discussed alongside other implications for policy in the 
discussion of this thesis.  
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Thesis aims and overview 
Aims 
The overall aim of this thesis was to design and evaluate an intervention to improve uptake in the 
National Health Service (NHS) Bowel Scope Screening Programme (BSSP) at St Mark’s Hospital 
in London.  
The specific aims were to: 
1. Analyse uptake and response to the screening invite at St Mark’s Hospital for the first 
fourteen months of the NHS BSSP’s initial implementation. 
2. Systematically develop an intervention to improve participation at St Mark’s Hospital 
using the Behaviour Change Wheel (BCW) as a theoretical framework for the 
intervention’s design. 
3. Evaluate the feasibility and effectiveness of implementing the devised intervention in 
studies informed by the Medical Research Council’s (MRC’s) Guidelines for Developing 
and Evaluating Complex Interventions. 
Overview 
The first four chapters of this thesis present the background literature.  
Chapter 1 presents bowel cancer as a significant public health problem characterised by high 
mortality and an advanced stage at diagnosis. It makes the case for screening as a public health 
strategy to improve outcomes from the disease and provides an overview of the modalities which 
have the best evidence to support their use to date. 
Chapter 2 describes the organisation and delivery of bowel cancer screening in the United 
Kingdom. It highlights the importance of uptake to the clinical effectiveness of organised screening 
programmes and documents the known sources of inequality described in the previous literature.  
Chapter 3 provides an overview of the theoretical perspectives that have most frequently been 
applied in research examining bowel cancer screening uptake and discusses the evidence in 
relation to each theory. It summarises that a number of models have been examined, but that no 
one model is currently recognised as being best. 
Chapter 4 reviews the evidence for the intervention strategies that have previously been used to 
improve bowel cancer screening participation and provides the concluding background literature 
to this thesis.  
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Chapters 5 – 9 comprise the empirical chapters.  
Chapter 5 examines uptake and response to the screening invite at St Mark’s Hospital during the 
first fourteen months of the NHS BSSP’s initial implementation (March 2013 to May 2014).  
Chapter 6 reports the development of a self-referral reminder and theory-based leaflet designed 
to improve uptake at St Mark’s Hospital using behaviour change techniques (BCTs) selected 
using the BCW.  
Chapter 7 assesses the feasibility of sending non-participants the self-referral reminder and 
theory-based leaflet 12 months after their initial invitation.  
Chapter 8 tests the effectiveness of sending non-participants the self-referral reminder, with and 
without the theory-based leaflet, 12 months after their initial invitation in a formal RCT. 
Chapter 9 extends the evaluation of the self-referral reminder and theory-based leaflet by 
examining their effectiveness when sent a second time (24 months after the initial invitation) in 
an extension of the RCT. 
Chapter 10 concludes the thesis by drawing together the findings from the studies. It discusses 
the limitations of the work as well as its implications for the BSSP and future research.  
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Chapter 1. Colorectal cancer and screening 
1.1 Colorectal cancer incidence and mortality 
1.1.1 Global burden 
Colorectal cancer (CRC, also referred to as bowel cancer) is a leading cause of morbidity and 
mortality throughout the world (Ferlay et al., 2015). In 2012, CRC accounted for nearly 10% of all 
newly diagnosed cancer cases (1.36 million of 14 million), and more than 8% of all newly 
registered cancer deaths (690,000 of 8.2 million), making it the third most frequently diagnosed 
cancer and the fourth leading cause of cancer-related deaths that year (Cancer Research UK., 
2015a; Cancer Research UK., 2015b).  
CRC incidence rates are highest in developed countries, where the majority of cases (55%) are 
diagnosed. Globally, there is nearly a tenfold difference in CRC incidence rates between regions 
with the highest and lowest rates of CRC, with CRC incidence rates ranging from over 40 cases 
per 100,000 people in the United States of America (USA), Australia, New Zealand and Western 
Europe, to less than five per 100,000 in parts of Africa, Asia and South America (Cancer Research 
UK, 2015a; Figure 1-1).  
Figure 1-1. Worldwide CRC incidence: age standardised CRC rates by world region (Cancer 
Research UK., 2015a) 
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1.1.2 UK burden 
In the United Kingdom (UK) specifically, CRC is the fourth most frequently diagnosed cancer 
(Cancer Research UK., 2016a) and the second leading cause of cancer-related deaths (Cancer 
Research UK., 2016b; Figure 1-2), accounting for more than 9.8% of all newly diagnosed cancer 
cases and over 8.7% of all newly registered cancer deaths (Cancer Research UK., 2015c; Cancer 
Research UK., 2015d).  
Figure 1-2. The top 20 most common causes of cancer death in the UK by gender, 2014 (Cancer 
Research UK., 2016a) 
 
 
Incidence rates in the UK are higher among men than women. In 2012, the incidence rate of CRC 
was 58 new cases per 100,000 men and 38 new cases per 100,000 women. This was the highest 
incidence rates had been since 1971, when the Office for National Statistics (ONS) started 
collecting data on the incidence of CRC (see Figure 1-3; ONS., 2013).  
As with incidence rates, CRC mortality rates in the UK are higher among men than women. 
However, unlike CRC incidence rates, which have steadily increased over the past forty years, 
CRC mortality rates have steadily declined (Figure 1-3; ONS,. 2013). In 2012, the mortality rate 
of CRC in the UK was 21 deaths per 100,000 men, and 13 deaths per 100,000 women; nearly 
half of what they had been in 1971 (Figure 1-3; ONS., 2013). 
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Figure 1-3.  CRC incidence and mortality rates for men and women living in the UK between 
1971 and 2010 (ONS., 2013) 
 
1.2 Aetiology 
1.2.1 Risk factors for the development of CRC 
1.2.1.1 Environmental and lifestyle factors 
The aetiology of CRC is influenced by a number of environmental and lifestyle factors, including: 
fruit and vegetable intake (van Duijnhoven et al., 2009), drinking alcohol (Cho et al., 2004), 
smoking cigarettes (Botteri et al., 2008; Liang et al., 2009), eating red and processed meat (Chan 
et al., 2011), being overweight or obese (Moghaddam et al., 2007; Ning et al., 2010) and not 
exercising regularly (Slattery et al., 2004; Wei et al., 2004; Wolin et al., 2009; Boyle et al., 2011). 
In addition to being affected by multiple environmental and lifestyle factors, the aetiology of CRC 
is greatly influenced by a person’s age and previous medical history. As shown in Figure 1-4 
(Cancer Research UK., 2016e), the likelihood of being diagnosed with CRC rapidly increases with 
age, so much so that men aged 60-64 are nearly fourteen times more likely to be diagnosed with 
CRC than men aged 20 years younger (i.e. aged 40-44). The effect of age is less pronounced in 
women, although older women (e.g. over the age of 80-84) are also much more likely to develop 
CRC than younger women (e.g. under the age of 69).  
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Figure 1-4. Age-specific incidence rates per 100,000 of the UK population: 2012 – 2014 (Cancer 
Research UK., 2016e) 
 
1.2.1.2 Previous medical history 
In terms of medical history, a previous history of bowel polyps (Winawer., 2007), severe ulcerative 
colitis and Crohn’s disease are all associated with an increased risk of developing CRC (Canavan 
et al., 2006; Jess et al., 2012). There are also two known genetic syndromes linked to the 
malignancy, namely: ‘hereditary non-polyposis colon cancer’ (HPNCC) and ‘familial adenomatous 
polyposis’ (FAP). These syndromes with known genetic defects (i.e. HPNCC and FAP) only 
account for one to five percent of all CRCs (Winawer., 2007), so that, at present, genetic 
screening can only make a limited contribution to risk reduction in the general population.  
1.2.2 The adenoma-carcinoma pathway 
The majority of CRCs (over 90%) develop from adenomas (also referred to as ‘adenomatous 
polyps’): benign growths that develop from gland cells which line the bowel wall (Winawer and 
Zauber., 2002; Stryker et al., 1987; Risio., 2010). An estimated 33% to 50% of all adults will 
develop one or more adenomas during their lifetime (Bond., 2000; Schatzkin et al., 1994) and, 
while all have the potential to become malignant, fewer than 10% ever develop into invasive 
cancer (Levine and Ahnen., 2006; Risio., 2010)1.  
                                                     
1 The likelihood that an adenoma will ever develop into invasive cancer is highly dependent on a number of factors, 
including the size and histological type of the adenoma, the degree of epithelial dysplasia (i.e. the extent to which cells 
appear to be abnormal), and the involvement of specific tumour suppressor genes (Vogelstein and Kinzler., 2004).  
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1.3 Survival by stage at diagnosis 
Chances for survival are strongly contingent on the stage at diagnosis (Cancer Research UK., 
2014a). Patients with localised disease (Stage I) have the best chances for survival, with 95% 
surviving for at least five years (Cancer Research UK., 2014a; Table 1-1). In patients with CRC 
that has infiltrated the colon wall (Stage II), the chances of surviving five or more years are 
reduced to 80%, and for patients where the cancer has spread to one or more lymph nodes (Stage 
III), the chances of survival are reduced further still (66%). Patients with distant metastases (Stage 
IV) have the poorest chances of survival, with as few as 10% surviving for five or more years 
(Cancer Research UK., 2014a). Unfortunately, due to the extensive pre-clinical phase of CRC 
(Komuta et al., 1999), most patients are diagnosed when the cancer has spread to the 
surrounding tissues or lymph nodes (stages III and IV), and the prognosis for survival is generally 
poor (Verdecchia et al., 2009; Table 1-1). 
 
Table 1-1. Five-Year relative survival of colorectal cancer patients in England (2002-2006) by 
stage at diagnosis  
Stage at 
diagnosis 
Staging criteria 
% of 
diagnoses 
5-year relative 
survival (%) 
Stage I 
(Early) 
Cancer is limited to inner lining of the 
colon or rectal (submucosa), but has 
not spread fully into the muscle. 
9 95 
Stage II 
Cancer has infiltrated the submucosa to 
the surrounding muscle, but no lymph 
nodes are implicated. 
25 80 
Stage III 
At least one Lymph node has been 
affected in the area close to the bowel. 
25 66 
Stage IV 
(Late) 
The cancer has metastasised to other 
organs. 
10 25-40 
Unknown N/A 31 35.4 
Sources: Edge et al., 2010; Cancer Research UK., 2014a 
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1.4 Treatment 
As well as being associated with a poorer prognosis for survival, late stage CRC is generally 
associated with more expensive and more invasive treatment regimens. For most early stage 
CRCs, surgery is the main treatment (Cancer Research UK., 2016c), whereas for late stage 
CRCs, a combination of surgery and chemotherapy or radiotherapy is recommended (Cancer 
Research UK, 2016d). The lifetime cost per head to treat a CRC can consequently range from 
£3,337 for a stage I CRC, to £12,519 for a stage IV CRC (Cancer Research UK., 2014b). Impetus 
to improve the early diagnosis of CRC is therefore high not only because doing so will have 
improved outcomes for the patient, but reduced treatment costs for the NHS as well. 
1.5 Strategies to improve CRC outcomes 
1.5.1 Awareness of the symptoms of CRC 
As mentioned above, the majority of CRCs are asymptomatic in the initial stages of development2 
(Risio., 2010). As such, raising awareness of the symptoms of CRC is unlikely to help detect 
cases early. Researchers have instead focused mostly on alternative strategies to improve 
outcomes from CRC, such as those which prevent disease (e.g. through lifestyle changes and 
screening for adenomas which can be removed before they develop into cancer), and those which 
test for disease before symptoms develop (i.e. through screening for cancer in the early stages 
of development). 
1.5.2 Lifestyle changes 
It is estimated that over half (54.4%) of all CRC cases diagnosed in the UK are associated with 
lifestyle and environmental factors (Parkin., 2011). However, while these factors are associated 
with an increased risk of developing CRC, there is little evidence demonstrating whether lifestyle 
approaches to reducing CRC risk are effective (Whitlock et al., 2008). In addition, many of the 
risk factors associated with CRC development (such as smoking and being overweight or obese) 
are also associated with an increased risk of developing multiple other chronic illnesses (such as 
heart disease and type 2 diabetes, etc.). As such, awareness of these behaviours as risk factors 
for disease form part of a broader approach to improving public health, and not a targeted one 
specific to CRC (Mason and McGinnis., 1990).  
  
                                                     
2 Symptoms include a persistent change in bowel habit, bleeding from the back passage, a lump in the abdomen, blood 
in the stool, anaemia, unexplained tiredness or weight loss and abdominal pain (Cancer Research UK., 2015e). 
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1.5.3 Screening for CRC 
Unlike lifestyle changes, screening offers a targeted approach to improving health outcomes by 
identifying apparently healthy individuals who might be at an increased risk of a disease or 
condition and then offering them information, further tests and appropriate treatment to reduce 
their risk or any complications arising from the condition (Public Health England., 2013b). 
However, not all conditions are suitable for screening, and so criteria for appraising the viability, 
effectiveness and appropriateness of screening are recommended by the World Health 
Organisation (WHO; see Appendix 1-1 for an overview of the criteria used by the UK National 
Screening Committee). Based on various iterations of the WHO criteria, screening for CRC has 
been recommended by a number of government and health organisations, including the United 
States Preventive Services Task Force (Levin et al., 2008), the Asia Pacific Colorectal Cancer 
Working Group (Sung et al., 2008; Sung et al., 2015), and the Council of the European Union 
(The Council of the European Union., 2003). As a result, there are now CRC screening 
programmes in over 60 countries spanning five continents (Schreuders et al., 2015).  
1.6 CRC screening tests 
Several investigations are capable of testing for CRC and the pre-cancerous growths from which 
they develop (Whitlock et al., 2008). They can be broadly categorised into two groups: early 
detection screening tests and preventive screening tests. The following provides a brief overview 
of the methods which are most frequently used and have the strongest evidence-base to support 
their use to date. 
1.6.1 Early detection screening tests 
Early detection screening tests improve outcomes from CRC by detecting cases early (i.e. Stages 
I and II), when chances for survival are highest. The most widely used early detection tests are 
faecal occult blood tests (FOBts; Benson et al., 2012; Schreuders et al., 2015). FOBts test for 
CRC by detecting occult blood in the stool, which is often detectable in the early (as well as late), 
asymptomatic stages of disease (Greegor., 1967).  
There are two primary ways of testing for faecal occult blood, both of which use reagents that 
react with one of the two functional moieties of haemoglobin (the oxygen-binding metalloprotein 
of red blood cells; Perutz., 1976). These two methods are the guaiac faecal occult blood test 
(gFOBt), which reacts with haem (the non-protein, oxygen-binding, portion of haemoglobin), and 
the faecal immunochemical test (FIT), which reacts with globin (the structural protein portion of 
haemoglobin; Sanford and McPherson, 2009).  
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1.6.1.1 Guaiac faecal occult blood test screening 
1.6.1.1.1 Procedure 
Individuals complete the gFOBt by applying a small amount of stool sample onto a test card 
impregnated with guaiac (a resin that acts as phenolic redox indicator) using a cardboard 
applicator (see Figure 1-5 for an example of the gFOBt kit used in the English Bowel Cancer 
Screening Programme). Two samples are usually taken from each bowel motion, so as to reduce 
the chances of obtaining a false negative result (i.e. a negative result for a sample that is positive 
for faecal occult blood). As tumours and adenomas can bleed intermittently, and the test may not 
be sensitive enough to detect particularly low concentrations of faecal haemoglobin (Van Rossum 
et al., 2008), the stool sampling process is repeated so that sample is taken from up to six 
separate motions (the number of samples taken varies from programme to programme; 
Schreduers et al., 2015). The test kit is usually completed at the individual’s home and then 
returned by post to a screening centre for analysis (Halloran., 2009), where a solution of hydrogen 
peroxide is applied to the reverse of each of the sample panels by a medical laboratory assistant 
or equivalent member of staff. A change in colour from white to blue in most of the panels usually 
indicates an abnormal result (as with the number of samples taken, the algorithm for a positive 
result varies between screening programmes) and a referral for follow-up investigation by a 
gastroenterologist is made (Benson et al., 2008; Halloran., 2009).  
Figure 1-5. Guaiac faecal occult blood test kit used by the NHS Bowel Cancer Screening 
Programme (Royal Devon and Exeter NHS Foundation Trust., 2017) 
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1.6.1.1.2 Evidence  
A meta-analysis of four large RCTs examining the effectiveness of biennial gFOBt screening to 
reduce CRC mortality found a cancer-specific mortality reduction of 13% at the population level 
and of 18% for individuals who completed the first round of screening (Scholefield et al., 2011). 
In addition, findings from the first one million completed gFOBt kits in England showed that, 
among individuals with staging data, 71.3% of screen-detected cancers were diagnosed at stage 
I or II (Logan et al., 2012), suggesting that biennial screening with the gFOBt does indeed reduce 
cancer-specific mortality through early detection.  
With regards to the prevention of CRC, there is mixed evidence to support gFOBt screening. For 
example, one large RCT conducted in Minnesota (USA) found that screening with the gFOBt 
reduced CRC incidence over an 18-year follow-up (Mandel et al., 2000), while more recent data 
from a large pilot in England indicated no change in incidence over a 20-year follow-up period 
(Scholefield et al., 2011). As a result, there is good evidence to support the use of biennial gFOBt 
screening in terms of preventing CRC deaths, but weak evidence to support its use in terms of 
preventing CRC incidences. 
1.6.1.2 Faecal immunochemical test screening 
1.6.1.2.1 Procedure 
Individuals completing the FIT are typically required to collect a single sample of their stool (in 
some programmes two samples are collected; Schreuders et al., 2015) in a bottle containing 
buffer solution (i.e. a solution that resists pH change) using a plastic applicator (Levi et al., 2007). 
As with the gFOBt, the FIT is completed in the individual’s home and then returned to a screening 
centre where it is analysed by a medical laboratory assistant (see Figure 1-6 for an example of 
the FIT kit piloted in the English Bowel Cancer Screening Programme). Unlike the gFOBt, the FIT 
provides a quantitative test result which allows the cut-off for a positive result to be manipulated 
depending on whether the screening programme being set up wants to use a higher level of 
sensitivity, and thereby increase the number of pre-cancerous lesions detected (these are 
associated with lower concentrations of faecal haemoglobin), or decrease the sensitivity of the 
test to reduce the number of colonoscopy referrals being made (i.e. due to limited endoscopy 
capacity; Moss et al., 2016).  
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Figure 1-6. Faecal immunochemical test kit piloted by the NHS Bowel Cancer Screening 
Programme (Moss et al., 2016) 
 
1.6.1.2.2 Evidence 
There are currently no published RCTs demonstrating that screening with the FIT is more or less 
superior to screening with the gFOBt or no screening in terms of reducing CRC-related mortality 
in average risk adults (Tinmouth et al., 2015a). Two studies, including an ecological study 
conducted in Italy (Zorzi et al., 2015) and a large prospective cohort study conducted in Taiwan 
(Chiu et al., 2015) have, however, found that CRC-related mortality was reduced (10% and 22% 
respectively) in regions where screening with FIT was implemented compared with regions where 
screening had not been implemented. Despite a lack of definitive evidence demonstrating that 
FIT is as effective, or more effective, than gFOBt screening, or no screening, many countries have 
implemented FIT-based CRC screening programmes (Schreuders et al., 2015). Data collected 
by these programmes, as well as large RCTs with extensive follow-up periods, are likely to 
contribute evidence to support the use of FIT screening, on the basis that the test is analytically 
superior to the gFOBt, which itself has been shown to be effective (Scholefield et al., 2011).  
1.6.2 Preventive screening tests 
Preventive screening tests help to prevent CRC by identifying and removing colorectal adenomas 
before they develop into cancer. Much like early detection tests, preventive screening tests also 
offer the potential to identify CRC early, but this is not the primary mechanism by which they help 
prevent deaths from CRC. 
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1.6.2.1 Flexible sigmoidoscopy screening 
1.6.2.1.1 Procedure 
Flexible sigmoidoscopy (FS) is the endoscopic examination of the rectum and sigmoid colon (the 
most distal third of the large bowel) with a thin flexible tube equipped with a charged coupled 
device (CCD) or fibre-optic camera (see Figure 1-7; Atkin et al., 2001). The test is performed at a 
clinic or hospital by a trained nurse or physician and takes between five and ten minutes to 
complete, depending on the need for polypectomy (the removal of polyps) and biopsy (the 
sampling of tissue; Eddy., 1990). Individuals undergoing the test are typically given an enema to 
prepare the distal bowel (the rectum and sigmoid colon) for examination. The enema can be self-
administered by the person in their own home or by a nurse at the hospital on the day of the test. 
If the bowel is not adequately prepared for examination, it may be necessary for the patient to 
receive a second enema to ensure a satisfactory test can be performed. The person does not 
need to be sedated during the procedure, although FS can be uncomfortable, particularly when 
the bowel needs to be inflated (this is done to aid the endoscope through the bowel and is 
achieved by pumping small amounts of air or carbon dioxide into the bowel). Most people (87%), 
however, report no pain or only mild pain (Robb et al., 2012), and almost all (98%) find the test to 
be highly acceptable (Taylor et al., 2000).  
Figure 1-7. Illustration demonstrating patient positioning and room set-up for flexible 
sigmoidoscopy examination (Johns Hopkins Cancer Center., 2017) 
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While in absolute terms only a relatively small portion of the large bowel can be examined using 
FS (approximately one third), the sites which can be observed represent those most frequently 
affected by cancer (Figure 1-8; Cancer Research UK., 2015c). Around two thirds (58% to 75%) 
of all CRCs and 80% of all colorectal adenomas (72% to 86%) develop in the rectum and sigmoid 
colon (Cancer Research UK., 2015c; Corley et al., 2013; Whitlock et al., 2008), meaning that the 
majority of cases can be detected without examining the whole bowel. In addition, the detection 
of one or more distal adenomas during FS can be used as an indicator for lesions occurring in 
the proximal colon, with approximately one third (31%) of all people with a distal adenoma 
detected at FS also having one or more proximal adenomas detected at colonoscopy (Imperiale 
et al., 2000; Lieberman et al., 2000). Follow-up colonoscopy can thereby be used in conjunction 
with FS to enable the subsequent detection of most adenomas and CRCs (Whitlock et al., 2008). 
As with other screening modalities, the extent to which follow-up colonoscopy increases the 
number of adenomas and CRCs detected is highly susceptible to dropout, with only those who 
attend colonoscopy benefitting from the advantages of having the test (Plumb et al., 2016). 
Figure 1-8. Distribution of CRC cases within the large bowel, Great Britain, 2007-2009 (Cancer 
Research UK., 2015c) 
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1.6.2.1.2 Evidence 
The evidence to support the effectiveness of FS screening (versus no screening) is highly 
compelling. Findings from a recent meta-analysis of five large RCTs revealed that, when 
examined on an intention-to-treat basis (i.e. all invitees), once-only FS screening was associated 
with a cancer-specific mortality reduction of 28%, and a cancer-specific incidence reduction of 
18% (Elmunzer et al., 2012). When examined on a per-protocol basis, (i.e. on the basis that a 
person was screened), the results from the meta-analysis are even more convincing, with once-
only FS screening being associated with a cancer-specific mortality reduction of 50% and a 
cancer-specific incidence reduction of 32% (Elmunzer et al., 2012).  
In the longest-running RCT, the benefits of once-only FS screening were shown to be sustained 
over a 17 year follow-up period (Atkin et al., 2017). In that specific study, once-only FS screening 
was associated with a cancer-specific incidence reduction of 26%, and a cancer-specific mortality 
reduction of 31% in the intention-to-treat analysis (CRC incidence and mortality were reduced by 
35% and 40% respectively in the per-protocol analysis). Results were similar at eleven years 
(Atkin et al., 2010), where once-only FS screening was associated with a cancer-specific 
incidence reduction of 23%, and a cancer-specific mortality reduction of 30% in the intention-to-
treat analysis (33% and 43% respectively in the per-protocol-analysis). 
As well as there being compelling evidence to suggest that once-only FS screening is more 
effective than no screening, there is evidence to support the effectiveness of once-only FS 
screening to detect colorectal adenomas and cancers over stool-based tests. In a recent meta-
analysis of data collected from 13 RCTs, FS was found to be over seven times more effective at 
detecting advanced adenomas than gFOBt, and more than three times more effective than FIT 
(Littlejohn et al., 2012). One study comparing attendance and adenoma detection rates (ADRs) 
between gFOBt, FIT and FS confirmed that, per 100 invitees, FS had a higher diagnostic yield 
than both FIT and gFOBt (diagnostic yield per 100 invitees was 2.6 for FS, 0.55 for gFOBt and 
1.5 for FIT – diagnostic yield was defined as proportion of invitees with advanced neoplasia; Hol 
et al., 2010), despite having considerably lower uptake (uptake was 32.4% for FS, 49.5% for 
gFOBt and 61.5% for FIT). 
1.6.2.2 Colonoscopy 
1.6.2.2.1 Procedure 
Colonoscopy is the endoscopic examination of the large bowel with a flexible tube equipped with 
a CCD or fibre-optic camera (Figure 1-9; Atkin et al., 2001). It is different from FS in that it enables 
the examination of the whole bowel and not just the rectum and sigmoid colon. The test is usually 
performed at a hospital by a trained physician and takes around thirty to forty-five minutes to 
complete, depending on the need for biopsy and polypectomy (Overholt., 1975).  
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Prior to colonoscopy, patients are required to prepare for the test at home using a ‘full-laxative’ 
preparation. This involves drinking a purgative medicinal solution and adhering to a strict set of 
dietary instructions. A common form of dietary advice is to eat only non-solid food and drink plenty 
of fluids for two days before the test, and to then forego solid food for the final day before the test. 
If the bowel preparation is not sufficient, the patient may be invited to come back for another 
appointment. 
The test is performed using sedation. After the examination, patients are monitored for at least 
one hour (while the sedative wears off) before being discharged by a nurse if there are no 
complications. However, the sedative can take up to 24 hours to wear off, and so patients are 
advised to make transport arrangements which do not involve driving during this time.  
Figure 1-9. Illustration demonstrating patient positioning and room set-up for colonoscopy 
examination (Cancer Research UK 2016f) 
 
1.6.2.2.2 Evidence 
There are currently no RCTs demonstrating the effectiveness of colonoscopy screening to 
improve CRC outcomes compared with no screening or screening with other tests. Several RCTs 
are currently underway, but will not be completed for another five to ten years (Department of 
Veteran Affairs, 2012; Quintero et al., 2012; Kaminski et al., 2012). As a result, the current 
evidence to support the use of screening colonoscopy is limited to case-control studies conducted 
in regions where colonoscopy screening has already been implemented (Baxter et al., 2009; 
Doubeni et al., 2016). 
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Results from a case-control study conducted in Canada found that case patients (i.e. patients 
who had died of CRC) were less likely to have undergone colonoscopy than control patients (i.e. 
patients who had not died of CRC, but were similar in terms of their age, sex, socioeconomic 
status and Charlson Comorbidity Index Scores; Baxter et al., 2009). In addition, colonoscopy was 
strongly associated with fewer deaths from left-sided CRC, but not right-sided CRC, suggesting 
that colonoscopy prevents deaths from left-sided CRC, but not right-sided CRC. Findings were 
similar for a recent case-control study conducted in the USA, with case patients (i.e. patients who 
died of CRC) being less likely to have previously undergone colonoscopy than control patients 
(Doubeni et al., 2016). However, the results were different with regards to the effects of 
colonoscopy on left and right-sided CRC, with colonoscopy being associated with a reduction in 
CRC deaths for both left and right-sided CRCs and not just CRCs occurring on the left-side of the 
bowel. As a result, there is consistent evidence to suggest that colonoscopy prevents deaths from 
left-sided cancers, but inconsistent evidence to suggest that colonoscopy prevents deaths from 
right-sided cancers. 
On-going RCTs may provide more robust evidence to support the use of colonoscopy screening 
when they are completed (Department of Veteran Affairs., 2012; Quintero et al., 2012; Kaminski 
et al., 2012). Preliminary results from one RCT (the Nordic-European Initiative on Colorectal 
Cancer - NordICC) already suggest that colonoscopy will be effective at reducing the incidence, 
and thereby the mortality, of both left and right-sided CRC, with high-risk adenomas being 
detected and removed from the left side of the colon in 5.8% of screened adults, and from the 
right side of the colon in a further 4.5% (Bretthauer et al., 2016).  
1.7 Summary 
CRC is a leading cause of morbidity and mortality throughout the world. Screening can help 
prevent cases through the timely detection and removal of adenomas in asymptomatic adults. 
The following chapter describes the organisation and uptake of CRC screening in the UK – the 
country where the studies comprising this thesis were carried out.  
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Chapter 2. Colorectal cancer screening in the United Kingdom: 
organisation and uptake 
2.1 The NHS Bowel Cancer Screening Programme 
2.1.1 Introduction 
The English NHS Bowel Cancer Screening Programme (BCSP) is a population-based screening 
programme for CRC that invites men and women, aged 60-74, to complete a gFOBt once every 
two years (Halloran., 2009). It was initiated in October 2006, following the results of a large UK 
RCT, which demonstrated that biennial screening with the gFOBt reduced CRC-specific mortality 
on an intention-to-treat basis (Hardcastle et al., 1996). The programme was fully implemented 
across the country in 2010. At that time, screening was only available to men and women aged 
60-69 (the original age range for the programme), however, and it was not until 2014 that full 
coverage of the programme, with the age extension (i.e. 70-74 year olds), was ultimately 
achieved. Similar programmes are offered in Scotland, Wales and Northern Ireland; with some 
slight regional variations in delivery between these countries. For example, in Scotland, screening 
is offered to men and women from the age of 50, rather than 60 (Halloran., 2009). 
2.1.2 Organisation and delivery 
To organise and record all screening episode actions, the English NHS BCSP uses web-based 
software managed by NHS Digital. The software is populated with information from the NHS 
database of General Practice-registered patients, which is updated on a daily basis and contains 
the basic patient-identifiable data needed to fulfil the requirements for invitation (i.e., Name, 
Address, Date of Birth and NHS Number; Halloran., 2009). Call and recall (i.e. invitation and re-
invitation) of the eligible population, issue and analysis of test kits and a Freephone helpline for 
the public are provided by five regional hubs based in Guildford, London, Rugby, Nottingham and 
Gateshead (Figure 2-1; Logan et al., 2012). Each Hub serves approximately 15 JAG (Joint 
Accreditation Group) accredited screening centres, each of which receives patients referred by 
the Hub following a positive test result (Halloran., 2009). 
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Figure 2-1. Areas of England covered by five regional programme hubs (Logan et al., 2012) 
 
2.2 The NHS BSSP 
2.2.1 Introduction 
A once-only FS screening programme for men and women aged 55 – 59 (i.e. the NHS BSSP) is 
also offered in England and was introduced in March 2013. 
2.2.2 Organisation and delivery 
As with the NHS BCSP, the NHS BSSP uses software managed by NHS Digital to organise and 
record all screening episode actions. Invitation to screening and a Freephone helpline for the 
public are similarly managed by the five regional bowel cancer screening Hubs (see Chapter 
2.1.2). Appointments, however, are managed by the screening centres, which generate the clinic 
lists each week. The Hub then invites eligible men and women to attend3 (Figure 2-2).  
                                                     
3 The Screening Centre uses age to identify adults for invitation. However, not everyone aged 55 years is eligible to have 
the test. For example, individuals are not eligible for screening if they have had all of their large bowel removed, use a 
stoma bag to collect their stool, are being treated for inflammatory bowel disease (e.g. ulcerative colitis of Chron’s 
disease), have had heart surgery in the last three months, or cannot walk more than 100 yards without resting because 
of a lung or heart problem. These exclusions are highlighted in the information booklet sent with the invitee’s pre-invitation 
letter (see: 2.3.2 The NHS BSSP Invitation Pathway). 
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Figure 2-2. The NHS BSSP Pathway 
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2.2.3 The NHS BSSP invitation pathway 
Appointments are offered to men and women aged 55 (the optimal age for the greatest quality 
adjusted life year gain; Whyte et al., 2012). Invitees receive a pre-invitation letter notifying them 
that they will be invited for a BSS appointment two months after their 55th birthday (i.e. eight weeks 
prior to their actual appointment; Figure 2-2). The pre-invitation letter explains that BSS helps 
prevent CRC by removing small growths that have the potential to become malignant, and that 
the test is offered to all adults aged 55 (see Appendix 2-1). An invitation letter is then sent two 
weeks after the pre-invitation letter. The invitation letter offers the recipient a timed appointment 
for the test at their local screening centre. It also reiterates that FS helps prevent CRC by removing 
small pre-cancerous growths in the bowel and emphasises that participation is an individual 
choice (see Appendix 2-2). A booklet, called: ‘the NHS Bowel Scope Screening informed choices 
booklet’, is sent with the invitation letter and is designed to provide the individual with the 
information required to make an informed choice about whether to take part in the programme 
(see Appendix 2-3). Individuals can confirm their appointment by returning their appointment slip 
to their local Hub using the Freepost envelope provided. Alternatively, they can confirm, cancel 
or change their appointment by calling. Anyone who does not respond to their appointment offer 
within two weeks is sent a reminder letter (see Appendix 2-4). If there is no response within an 
additional two weeks, the individual’s appointment is cancelled and a non-response letter is 
mailed (see Appendix 2-5). The non-response letter explains that the individual’s appointment 
has been cancelled and states that they can self-refer for an appointment up until the age of 60, 
should they later decide that they want to take part in screening. A copy of the letter is also sent 
to the individual’s general practitioner (GP; Appendix 2-6). 
2.2.3.1 Bowel preparation 
For individuals who confirm that they will be attending their appointment, a confirmation letter is 
sent two weeks in advance to verify the date, time and location of the appointment (see Appendix 
2-7). The confirmation letter also explains that to have the test, the individual will receive a bowel 
preparation kit (an enema and instruction booklet), which they will need to self-administer on the 
day of their appointment (approximately one hour before starting their journey to the screening 
centre). The enema is sent with a letter and instructions for use approximately one week before 
the appointment (see Appendices 3-8 and 3-9 respectively). If the recipient is not confident about 
self-administering the test, or they have any disability preventing them from doing so, they can 
contact the screening centre to request to have it done by one of the screening practitioners. 
Other assistance, such as the need for an interpreter to be present at the appointment, can also 
be requested in the same way.  
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2.2.3.2 Pre-appointment consultation 
On the day of the appointment, there is a pre-appointment consultation between the screening 
practitioner and the attending adult. The screening practitioner explains what will happen during 
the appointment and reiterates the risks and benefits of the procedure to ensure that an informed 
decision to be screened (or not) is made. The pre-appointment consultation also provides an 
opportunity for the screening practitioner to address any questions or concerns that the individual 
may have. Should the attending adult wish to proceed with the examination, they are required to 
sign a consent form (Appendix 2-10), indicating that the risks of the test have been explained to 
them.  
2.2.3.3 The procedure  
The procedure itself takes approximately five to ten minutes, depending on the need for 
polypectomy and biopsy. The attending adult is given a hospital gown or shorts (referred to as 
‘dignity shorts’) to wear in place of their clothes during the procedure (should they prefer to). Once 
they have changed into their gown or shorts in a private changing area, they are ready to proceed 
with the investigation, which is performed in an endoscopy suite. The individual lies on their side 
on a bed which is slightly elevated so that the endoscope can be inserted into the person’s back 
passage (anus). Once the endoscope has been inserted, the screening practitioner examines the 
rectum and sigmoid colon for any polyps, which can be removed during the procedure using a 
snare. To help manoeuvre the endoscope through the lower bowel, a small amount of carbon 
dioxide gas is usually pumped into the bowel to inflate it slightly. This is achieved via one of the 
endoscopes internal channels, of which there are several. Another channel can be used to clean 
parts of the bowel where the preparation has not been effective. This is usually done by squirting 
a small amount of saline solution to the site(s) where faecal matter has not been cleared. Once 
the practitioner has examined the rectum and sigmoid colon (i.e. up to, but not beyond, the 
traverse colon), they begin the process of withdrawing the endoscope. As the practitioner 
withdraws the endoscope, they continue to examine the bowel for any polyps to remove. The 
procedure is narrated to the attendee, who is able to watch the examination (if they choose) on a 
monitor used by the screening practitioner.  
2.2.3.4 After the test 
After the test the screened adult is taken to a recovery area, where they are monitored for 
approximately 15 minutes before being discharged from the hospital with some additional 
information regarding what to do if they experience any adverse effects from the procedure (e.g. 
severe pain, bleeding from their back passage, etc.). The person is informed of the results of their 
test several weeks later (or on the day if nothing is found).  
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If the person has a normal result (i.e. no abnormalities detected), their episode is closed and they 
are not contacted again until the time of their 60th birthday (except to inform them in writing that 
they have a normal result), when they are invited to take part in the NHS BCSP. If they have an 
abnormal result (e.g. three or more adenomas <1cm, one adenoma >1cm, etc.), they are referred 
for a colonoscopy to examine the whole bowel. Individuals with intermediate and high-risk 
pathology are referred for surveillance, where they are offered a colonoscopy every one or three 
years, depending on their pathology results (see Figure 2-2). 
2.3 Uptake of CRC screening in England 
2.3.1 Uptake of gFOBt  
The benefits of screening are limited to those who take up the screening test offer (Parkin et al., 
2008; Geurts et al., 2015). Thus, in terms of improving population outcomes, uptake is highly 
important. In an early analysis of the first 2.6 million gFOBt invitations administered in England 
(October 2006 – January 2009), the uptake of biennial gFOBt screening was 54% (von Wagner 
et al., 2011). While this was high compared with other countries (e.g. Australia and the 
Netherlands, where initial uptake was 46% and 49% respectively; Australian Government, 
Department of Health and Ageing, Monitoring and Evaluation Steering Committee., 2005; 
Deutekom et al., 2009), it was far from optimal and contained considerable ethnic and 
socioeconomic variation.  
More recent research examining uptake in England suggests that participation has steadily 
increased since it was first introduced, with uptake rising from 50.9% during the first fiscal year 
(2006 / 2007), to 58.2% in the most recently examined (2014 / 2015; Moss et al., 2016). Despite 
this gradual improvement in uptake, participation in England remains considerably lower than 
other countries (such as Spain, Sweden and Finland, where uptake is 64%, 65% and 67% 
respectively; Klabunde et al., 2015), and remains below the Council of the EU’s target of 65% 
(von Karsa et al., 2013).  
As well as being low compared with other European countries, the uptake of gFOBt screening in 
England is low compared with that of the more established Cervical and Breast Cancer Screening 
Programmes, both of which routinely achieve uptake of over 70% (Health and Social Care 
Information Centre., 2016a; Health and Social Care Information Centre., 2016b). Recent evidence 
suggests that when the gFOBt is replaced with the FIT (Summer, 2018), uptake will be higher 
than the European target of 65% (uptake of FIT in a recent English pilot study was 66.4%; Moss 
et al., 2016). Further improvements in uptake will still be required if the English BCSP is to achieve 
the target of 75% uptake in all clinical commissioning groups (CCGs) by 2020 (the Independent 
Cancer Taskforce., 2015). This will be an even bigger challenge for the NHS BSSP, for which the 
uptake of screening is much lower. 
Chapter 2. Colorectal cancer screening in the United Kingdom: organisation and uptake 
 
45 
 
2.3.2 Uptake of FS 
The uptake of once-only FS screening has been examined in the early stages of the NHS BSSP 
(McGegor et al., 2015a), as well as a number of pre-programme trials and pilot settings (Atkin et 
al., 2002; Brotherstone et al., 2007; Robb et al., 2010a; Bevan et al., 2014). The largest trial of 
FS screening conducted in the UK (i.e. the UK FS trial; Atkin et al., 2010) was designed in such 
a way that extrapolation of uptake was very difficult. It used a design which was intended to reduce 
non-adherence and thereby increase the statistical power of the trial. Potential participants were 
sent a pre-screening interest questionnaire, which asked: ‘if you were invited for the bowel 
screening test, would you attend?’, with response options: ‘yes definitely’, ‘yes probably’, ‘no 
probably’ and ‘no definitely’ (Atkin et al., 2001). Only those who returned the questionnaire and 
indicated that they ‘probably would’ or ‘definitely would’ attend were subsequently included in the 
trial (Atkin et al., 2002). In the NHS BSSP, no such pre-screening interest questionnaire is used 
to select invitees, and all eligible adults are invited for BSS irrespective of their screening interest. 
However, as the aim of the study was to determine the effectiveness of once-only FS screening 
to reduce the incidence and mortality of CRC, and not the acceptability of the screening test to 
the public, the design used was appropriate.  
Knowing that any such design (i.e. one involving a pre-screening interest questionnaire) would 
not likely be used in any future screening programme, the researchers conducted two additional 
studies: one to test the feasibility of offering FS screening at a single centre in London 
(Brotherstone et al., 2007) and another to test the acceptability of the test using a conventional 
screening invitation (i.e. one that did not involve using a pre-screening interest questionnaire to 
preferentially select invitees; Robb et al., 2010a). Both studies were conducted at St Mark’s 
Hospital – the centre where the studies described in this thesis were carried out (see Chapters 5-
9). In the first study, Brotherstone colleagues (2007) measured uptake to be 55%, which was 
higher than the second study, in which Robb and colleagues (2010a) found uptake to be 45%. In 
both studies, uptake was high compared with similar trials conducted (at the same time) in the 
Netherlands and Italy, where uptake was 32.5% and 26.5%, respectively (Segnan et al., 2007; 
Hol et al., 2010b).  
More recent research conducted after the NHS BSSP was confirmed has produced less positive 
results. In a pathfinder study conducted in 2011, uptake of screening was only 29% (Bevan et al., 
2014), although in this study there was no reminder to non-responders (i.e. people who did not 
confirm whether they would be attending their appointment within a given timeframe), something 
which was believed (but not proved) to be important for increasing uptake in the previous 
feasibility and pilot studies (Brotherstone et al., 2007; Robb et al., 2010a).  
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In the first and only study to examine uptake since the NHS BSSP’s official launch in 2013, my 
colleagues and I found uptake to be 43% (McGregor et al., 2015a). This was 22 percentage points 
below the Council of the EU’s target for acceptable participation (65%; von Karsa et al., 2013), 
and 32 percentage points below the Intendent Cancer Taskforce target for 2020 (i.e. 75% in all 
CCGs; The Independent Cancer Taskforce,. 2015). With no publicity or marketing strategies 
currently in place, achieving uptake of 75% in all CCGs by 2020 will require a concerted effort, 
particularly in the most socioeconomically deprived areas, where uptake is considerably lower 
(i.e. 20 percentage points lower) than the least deprived areas (see 2.5.1 Socioeconomic status).  
2.4 Demographic variation in uptake  
The identification of population subgroups who have particularly low uptake is an important quality 
assurance process in the delivery of screening. It helps to evaluate whether the introduction of a 
new programme is likely to exacerbate existing inequalities in health, and thereby enables 
strategies to promote uptake to be implemented in ways which help to achieve equality in 
healthcare delivery (Marmot et al., 2010).  
2.4.1 Socioeconomic status 
Organised screening programmes are designed to minimise inequalities in uptake through the 
use of direct invitations to the target population. In England, all screening and treatment is 
provided free of charge, thereby minimising financial barriers to participation. However, although 
there is no cost to patients, several studies have found that there are important socioeconomic 
inequalities in uptake that need to be addressed to ensure equality in screening. For example, in 
their study (mentioned above), von Wagner and colleagues (2011) reported that uptake of the 
first 2.6 million gFOBt invitations in England ranged from 35% in the most deprived quintile of 
areas4, to 61% in the least deprived quintile of areas. This socioeconomic gradient in participation 
was observed not only across the whole population, but within each individual regional screening 
hub as well (von Wagner et al., 2011). 
The uptake of FS screening has been found to be similarly graded in England’s National BSSP 
(McGregor et al., 2015a), with only 33% of the invited population participating in the most deprived 
quintile of areas in England, compared with 53% in the least deprived quintile of areas. The same 
observation was reported in the pathfinder study (Bevan et al., 2014); however, in that study, 
uptake ranged from 19.4% in the most deprived quartile of areas, to 36.5% in the least deprived 
quartile (Bevan et al., 2014). 
                                                     
4 In their study, von Wagner and colleagues (2011) assessed area-level deprivation using the Index of Multiple Deprivation, 
which is the government’s official measure of relative deprivation for small areas / neighbourhoods in England (Department 
for Communities and Local Government., 2011). 
Chapter 2. Colorectal cancer screening in the United Kingdom: organisation and uptake 
 
47 
 
Individual-level data on socioeconomic status (SES) collected through prospective questionnaires 
sent to individuals who were due to be invited for screening have confirmed the findings of studies 
using area-level data for deprivation (Sutton et al., 2000; Power et al., 2008). These studies show 
that higher SES is associated with an increased likelihood of attending FS screening. For 
example, in one study, Power and colleagues (2008) used education, housing tenure and car 
ownership to generate a socioeconomic scale ranging from 0 (most deprived) to 3 (least 
deprived), and found that this was highly predictive of attendance at screening (Power et al., 
2008). The same study found that ‘employment status’, which did not form part of the scale, was 
independently associated with uptake (Power et al., 2008). 
2.4.2 Ethnicity 
Similar, but slightly less graded variations in uptake have been observed for area-level ethnic 
diversity. In von Wagner and colleagues 2011 analysis (described above), the most ethnically 
diverse areas in England had lower uptake than the least ethnically diverse areas, with uptake 
rates ranging from 38% in the most ethnically diverse quintile of areas, to 58% in the least 
ethnically diverse quintile (von Wagner et al., 2011).  
Neither of the London-based FS pilot studies, nor the English pathfinder study, examined 
variations in uptake by area-level ethnic diversity (Brotherstone et al., 2007; Robb et al., 2010a; 
Bevan et al., 2014). Only the early uptake analysis has consequently ever examined the 
association between area-level diversity and uptake in England (McGregor et al., 2015a). Unlike 
studies for gFOBt screening, my colleagues and I (McGregor et al., 2015a) found a non-significant 
difference in uptake between the most and least ethnically diverse areas (uptake was 37.8% and 
44.9% in the most and least ethnically diverse areas respectively).  
The association between ethnicity and uptake using individual-level data has been reported in 
two questionnaire studies conducted as part of the UK FS trial (Sutton et al., 2000; Robb et al., 
2008a). In one study, Sutton and colleagues (2000) examined the association between ethnicity 
(dichotomised as ‘White’ and ‘non-White’) and uptake by asking participants about their ethnicity 
in a prospective questionnaire (attendance at screening was assessed on the day of the 
appointment). They found no association between ethnicity and uptake (Sutton et al., 2000). In a 
second study also conducted within the UK FS trial, Robb and colleagues (2008a) examined the 
association between ethnicity and uptake using a different code for ethnicity. When individuals 
were categorised as being of either a ‘White’, ‘Black’, or ‘Asian’ ethnicity, there was no difference 
in uptake between Black and White men and women, but there was a significantly lower uptake 
for Asian adults (Robb et al., 2008a). 
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2.4.3 Age and Gender 
Uptake of the gFOBt in England’s national BCSP has been shown to vary by age and gender, as 
well as by area-level deprivation and area-level ethnic diversity, with men being less likely to take 
up the test than women (50.96% vs. 56.35% respectively), and adults aged 60-64 being less likely 
to take up the test than adults aged 65-69 (52.78% vs. 54.54% respectively; von Wagner et al., 
2011). However, while men have been shown to be less likely to participate in gFOBt screening 
than women, their uptake increases with age, whereas for women uptake remains relatively stable 
(von Wagner et al., 2011). This increase in uptake with age by male adults somewhat diminishes 
gender differences in uptake, so that older men and women have somewhat similar participation 
(von Wagner et al., 2011).  
While men are less likely to participate in gFOBt screening (von Wagner et al., 2011; Moss et al., 
2012; Lo et al., 2014), there is uncertainty with regards to whether or not they are also less likely 
to participate in FS screening. For example, in the two feasibility studies conducted in London, 
women were either as likely (Robb et al., 2010a) or more likely (Brotherstone et al., 2007) to take 
part in screening, whereas in the UK FS trial (Sutton et al., 2000) and early uptake analysis 
(McGregor et al., 2015a), women were less likely to take part.  
Age, which ranged from 55 to 64 years, was not a predictor of uptake in the UK FS trial (Sutton 
et al., 2000). As FS screening invitations are only sent to adults aged 55 in the NHS BSSP, uptake 
of FS screening by age was not examined in the early uptake analysis (McGregor et al., 2015a) 
or preceding pathfinder study (Bevan et al., 2014). Despite being offered to a range of adults, 
neither the London-based feasibility study nor the pre-programme pilot study included age as a 
variable in their uptake analyses (Brotherstone et al., 2007; Robb et al., 2010a). 
2.5 Geographic variation 
As well as there being much variation in the uptake of screening by demographic characteristics, 
such as age and gender, there is also considerable variation in uptake by geographic location. 
Such variations in uptake are independent of neighbourhood characteristics in which, as I have 
described previously, uptake varies based on the socioeconomic deprivation and ethnic diversity 
of people living in each area. For example, in an evaluation of the first one million tests issued by 
the English BCSP, Logan and colleagues (2012) found that uptake was highest in areas covered 
by the North-Eastern hub and lowest in areas covered by the London Hub. The overall uptake of 
screening in the North-Eastern Hub was subsequently 20 percentage points higher than the 
London Hub (uptake was 60% and 40% in the North-Eastern and London Hubs respectively; 
Logan et al., 2012).   
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Similar variations in uptake have been observed for FS screening. In the London-based pilot study 
conducted by Robb and colleagues (2010a), uptake varied between CCGs and was nearly 15 
percentage points lower in the London borough of Brent than the London borough of Harrow 
(uptake was 44.4% and 58.8% respectively). More recently, in the early analysis of uptake data 
in the NHS BSSP, my colleagues and I found that there was considerable geographic variation in 
uptake between screening centres (McGregor et al., 2015a). Here too, differences in uptake were 
independent of area-level deprivation and area-level ethnic diversity. Uptake ranged from 36.8% 
in the centre with the lowest uptake (South of Tyne), to 52.0% in the centre with the highest 
(Surrey).  
2.6 Summary 
In England, the NHS offers once-only FS screening to all men and women aged 55-59 and 
biennial gFOBt screening to all men and women aged 60-74. Although offered automatically and 
for free, the uptake of these screening tests is low and contains a strong social gradient. In the 
following chapter, I consider the theoretical perspectives that have most frequently been applied 
in research examining bowel cancer screening participation and discuss the evidence to support 
their use.   
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Chapter 3. Psychological perspectives of uptake in colorectal 
cancer screening: theory and evidence 
3.1 Social Cognition Models 
The theoretical models that have most commonly been applied to understanding CRC screening 
behaviour are the Health Belief Model (HBM; Becker., 1974), the Theory of Planned Behaviour 
(TPB; Ajzen., 1991) and Social Cognitive Theory (SCT; Bandura., 2004; Kiviniemi et al., 2011). 
All three are social cognition models: models which propose that cognitions (such as attitudes 
and beliefs) are the most proximal determinants of behaviour and can be used to explain the 
relationship between distal factors (such as SES and gender) and inequalities in health (Michie 
et al., 2014).  
3.1.1 The Health Belief Model 
The HBM was developed specifically to understand the uptake of health screening and has been 
used to identify factors associated with health behaviours for many years since its introduction to 
the literature (Becker., 1974). The HBM proposes that behaviour is regulated by four central 
constructs, which, in turn, are modified by sociodemographic factors, personality and social 
influence (Figure 3-1). The model hypothesises that behaviour is regulated by a person’s 
perceived chances of getting the health condition (perceived risk), how serious getting the health 
condition would be (perceived severity), how effective the advised action to reduce the risk of 
getting the condition is (perceived benefits), and what the tangible and psychological costs of the 
advised health action are (‘perceived barriers’). Cues to action are also included in the model and 
are thought to be directly and independently associated with behaviour. Cues are essentially 
factors that promote action and can either be internal (such as the presence of symptoms), or 
external (such as exposure to a mass media campaign). They (cues to action) are thought to be 
more likely to change behaviour if an individual is already motivated to maintain good health 
(Conner and Norman., 1996). The following section discusses the evidence for these constructs 
as they relate to CRC screening behaviours. 
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Figure 3-1. The Health Belief Model (Adapted from Becker., 1974) 
 
 
3.1.1.1 The HBM and CRC screening 
Studies examining the association between HBM constructs and CRC screening behaviour have 
mostly found that high perceived benefits and low perceived barriers are independently 
associated with participation (Hoogewerf et al., 1990; Kelly and Shank., 1992; Myers et al., 1994; 
Lewis and Jensen., 1996; Wardle et al., 2000; James et al., 2002; Harewood et al., 2002; Manne 
et al., 2002; Rawl et al., 2005). High levels of perceived susceptibility have also been shown to 
be associated with CRC screening participation. The association between high perceived severity 
and uptake, however, is less certain (Blalock et al., 1990; Burack and Liang, 1987; Janz et al., 
2003; Price., 1993; Weller et al., 1995).  
In a review of the literature exploring the relation of individual health behaviour constructs with 
CRC screening behaviour, Kviniemi and colleagues (2011) reported the proportion of articles in 
which each of the HBM constructs was associated with compliance. They found that high 
perceived benefits and low perceived barriers were associated with uptake in 73% and 68% of 
studies respectively (Kiviniemi et al., 2011). In addition, they found that perceived susceptibility 
was associated with uptake in the majority of studies (64%), but that, by contrast, perceived 
severity was only rarely associated with uptake (16%). These findings are consistent with a 
number of meta-analyses examining the associations between perceived risk and perceived 
severity in relation to other health behaviours (e.g. Floyd et al., 2000; Harrison et al., 1992; 
McCaul et al., 1996; Milne et al., 2000), all of which concluded that perceived risk was associated 
with behaviour, while perceived severity was not. 
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3.1.2 The Theory of Planned Behaviour 
The TPB proposes that intentions, which represent a person’s willingness to act (and how much 
effort they are willing to exert in order to perform the health behaviour), are the proximal cause of 
behaviour (Figure 3-2; Ajzen., 1991). In formulating intentions, the TPB theorises that people take 
into account their attitudes towards the behaviour (attitudes), the perceived social pressure to 
perform it (subjective norms), and the amount of control they believe they have over the behaviour 
(perceived behavioural control). According to the theory, attitudes are thought to be the function 
of beliefs about the likely consequences of the action (similar to perceived benefits and barriers 
in the HBM), while subjective norms are thought to be derived from the perceived normative 
expectations of relevant referent groups and the motivation to comply with significant others 
wishes. Perceptions about behavioural control, meanwhile, are thought to be influenced by beliefs 
concerning whether one has the necessary resources and opportunities to perform the behaviour. 
These can be internal (e.g. personal skills), or external (e.g. the opportunities available), and are 
proposed to have a direct influence on behaviour; Figure 3-2). 
Figure 3-2. The Theory of Planned Behaviour (Adapted from Ajzen., 1991) 
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3.1.2.1 TPB and CRC screening 
The TPB has been applied to a range of health behaviours and there are meta-analytic reviews 
to support the theory’s capacity to predict behaviour (and intentions of behaviour) across a variety 
of contexts (Godin and Kok., 1996; Armitage and Conner., 2001). In one meta-analytic review, 
Godin and Kok (1996) reviewed studies applying the TPB to screening behaviours specifically. 
They found that attitudes were strongly correlated with intentions to take part in screening (r = 
0.51), and that correlations between subjective norms and intentions (r = 0.33), and perceived 
behavioural control and intentions (r = 0.46), were lower, suggesting that attitudes are more 
strongly correlated with screening intentions than subjective norms and perceived behavioural 
control. The strength of the correlations between intentions and behaviour (r = 0.35), and 
perceived behavioural control and behaviour, were average (r = 0.29). 
In a prospective study of FS screening intentions and behaviour, Power and colleagues (2008) 
found that, in the univariable analyses, social cognition variables were strongly associated with 
intentions and were also significant predictors of screening attendance. In the multivariable 
analysis, however, associations with behaviour became non-significant when intention was added 
to the model (Power et al., 2008). These findings, along with those cited in other studies (Godin 
and Kok., 1996; Armitage and Conner., 2001), suggest that screening behaviour is mediated by 
intention, which in turn is mediated by social cognition variables, subjective norms and perceived 
behavioural control. In their study, Power and colleagues (2008) also found that social cognition 
variables and factors related to life difficulties (e.g. socioeconomic deprivation, poor health status, 
etc.) were able to discriminate between non-intenders, intenders, and people who attended 
screening from those who had positive intentions, but did not attend. Furthermore, mean 
differences between groups were large, suggesting that life difficulty factors may play an important 
role in translating intentions into behaviour (Power et al., 2008). 
3.1.3 Social Cognitive Theory 
SCT describes behaviour as an interaction of personal factors with the environment (Figure 3-3; 
Bandura., 1980). According to the theory, four factors affect the likelihood that someone will 
perform a behaviour. Specifically, SCT proposes that behaviour is mediated by self-efficacy, 
goals, environmental impediments and facilitators (i.e. sociocultural factors) and outcome 
expectancies (Bandura., 2004). Self-efficacy refers to people’s beliefs that they can exert control 
over their motivation and behaviour over their social environment. Self-efficacy is thought to help 
people regulate their behaviour by determining how high people set their goals and how much 
effort they exert in attempting to achieve them. Outcome expectancies, meanwhile, refer to 
people’s beliefs about the possible consequences of their actions and are thought to be directly 
affected by self-efficacy. Outcome expectancies are thought to help people regulate their 
behaviour by influencing goal-setting and, similarly, how much effort they are willing to exert in 
order to achieve their goals.  
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SCT distinguishes between predictors of intention and action by proposing that, while outcome 
expectancies are important determinants of goals, self-efficacy is more important in predicting 
action and regulates the translation of intentions into action. As such, SCT recognises that goal-
setting is necessary, but not always sufficient, to regulating behaviour. 
Figure 3-3. Social Cognitive Theory (Adapted from Bandura., 1980) 
 
3.1.3.1 SCT and CRC screening 
Since its initial introduction to the research literature, SCT has been used to explain a wide variety 
of health behaviours (Godin et al., 2008; Kiviniemi et al., 2011; Young et al., 2014). The majority 
of research studies using SCT have focussed on the two more dominant constructs: self-efficacy 
and outcome expectancies (Godin et al., 2008; Kiviniemi et al., 2011; Young et al., 2014). Findings 
from studies using SCT in the context of CRC screening specifically have shown that people who 
believe participating in screening will have positive consequences (outcome expectancies) and 
have more confidence in their ability to attend screening (self-efficacy) are more likely to take part 
(Myers et al., 1998; Kremers et al., 2000; Watts et al., 2003; Sun et al., 2004). Self-efficacy 
specifically has been associated with positive intentions (goals) to attend CRC screening 
(Friedman et al., 2004), lending further evidence to support this model.  
3.2 Stage models 
Stage models use similar concepts to social cognition models, but organise them in a different 
way (Sutton., 2000). According to this approach, people move through a sequence of discrete, 
qualitatively distinct stages prior to changing their behaviour (or adopting a new behaviour; 
Weinstein et al., 1998b). Different factors are thought to be important for different stage 
transitions. Hence, people in different stages are assumed to require different interventions to 
help them move to the next stage in the sequence (such interventions are commonly referred to 
as ‘stage-matched’ interventions).  
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There are a number of stage-based models, the most relevant for CRC screening being the 
transtheoretical model (TTM; Prochaska et al., 1992) and the precaution adoption process model 
(PAPM; Weinstein and Sandman., 1992). The following discusses the evidence for these models 
as they relate to CRC screening behaviours. 
3.2.1 The Transtheoretical Model 
Although it is often referred to simply as the ‘stages of change’ model of behaviour, the TTM 
contains theoretical constructs from many different models of behaviour (hence the name: the 
transtheoretical model of behaviour). Constructs within the model include the stages of change 
(which form the basic organising principle of the model; see Figure 3-4), the processes of change 
(which facilitate movement from one stage to the next), self-efficacy (taken from Bandura’s Social 
Cognitive Theory; Bandura., 1980), temptation (which is the opposite of self-efficacy; DiClemente 
et al., 1991) and the perceived pros and cons of changing (which represent the perceived barriers 
and benefits of behaviour change, as described by the HBM; Prochaska and DiClemente., 1982; 
Prochaska et al., 1992).  
The main organising principle is that behaviour change occurs in five sequential stages: pre-
contemplation (not planning to change behaviour within the next six months), contemplation 
(thinking about changing behaviour within the next six months, but not planning to change 
behaviour within the next month), preparation (taking steps towards changing behaviour within 
the next month), action (attempting to change behaviour) and maintenance (having changed 
behaviour for at least six months). The first three stages (pre-contemplation, contemplation and 
preparation) are all defined in terms of a person’s intentions and past behaviour (Prochaska and 
DiClemente., 1982). By contrast, the last two stages (action and maintenance) are defined purely 
in terms of behaviour (intentions are not taken into consideration). Progression through the stages 
is assumed to be sequential, although it may not necessarily be linear (indeed, most people tend 
to relapse and do not achieve their aims on the first attempt; Michie et al., 2014). For example, in 
the case of smoking cessation (the behaviour for which the model was initially developed; 
Prochaska and DiClemente., 1982), someone might quit for more than six months (maintenance), 
but then start smoking again, thereby regressing to a previous stage (e.g. pre-contemplation, 
contemplation, etc.). As a result, the stages of change are presented as a spiral in which people 
start at the top (pre-contemplation) and then move through the stages in order (contemplation, 
preparation, action, maintenance). This gives the model the flexibility to account for people who 
relapse to a previous stage and the way in which some people cycle and recycle through the 
stages several times before achieving long-term behaviour change.  
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Figure 3-4. The Transtheoretical Model of Health Behaviour Change (Adapted from: Prochaska 
et al., 1992) 
 
 
3.2.1.1 The TTM and CRC screening 
The TTM has been applied to a wide range of health behaviours (Bridle et al., 2005), including 
condom use (Prochaska et al., 1994a), sunscreen use (Prochaska et al., 1994b), healthy eating 
(Kasila et al., 2003), cancer screening (Spencer et al., 2005) and exercise (Marcus and Simkin., 
1994). The model has been particularly popular among clinicians and practitioners and there is a 
large body of evidence which is interpreted by its proponents as supporting the model (Sutton et 
al., 2002). With regards to cancer screening specifically, the TTM has been applied many times 
with varying degrees of success (Spencer et al., 2005). For example, in a review of the literature, 
Spencer and colleagues (2005) found that there was good evidence to suggest that the TTM 
applies well to mammography screening, but mixed evidence to support its application to cervical 
and CRC screening (Spencer et al., 2005). Several studies conducted since the review have 
provided evidence to support some of the assumptions of the TTM, but not all (Cole et al., 2007; 
Tung et al., 2008; Zajac et al., 2016). For example, in a study conducted in Australia, Cole and 
colleagues (2007) found that the uptake of CRC screening was increased when people received 
an advanced notification letter, which increased uptake by transitioning people from a stage of 
pre-contemplation, to a stage of contemplation (and subsequently preparation and action; Cole 
et al., 2007).  
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3.2.2 The precaution adoption process model 
Increasing attention on the criticisms of the TTM5 has diverted attention away from its application 
to research (Armitage., 2009). Instead, more recent studies have focussed on the PAPM, which 
was developed in response to the limitations of the TTM (Weinstein., 1988). Unlike its 
predecessor, the PAPM aims to explain the deliberative processes involved in turning decisions 
into action (e.g. whether to have a newly available vaccine). It does not aim to explain the gradual 
development of behaviour patterns (e.g. diet, exercise, etc.), or the adoption of risk behaviours 
(e.g. smoking, drug use, etc.), and it does not define stages based on time (one of the major 
criticisms of the TTM; Armitage., 2009). Instead, the PAPM consistently defines stages based on 
psychological criteria (Figure 3-5; Weinstein., 1988). 
The PAPM proposes that behaviour change occurs in seven distinct stages (see Figure 3-5). In 
the first stage (Stage 1), people are unaware of the health issue and have formed no opinion 
about it. When they first learn something about the hazard, they start to form opinions of the 
precautionary behaviour (Stage 2). At this point, they are thought to be unengaged and think that 
the health danger or hazard does not apply to them. At the point when people make a personal 
conception (e.g. through personal experience, including reading about the topic in more detail 
and drawing parallels to their own situation), they are thought to become engaged and move to 
the decision-making stage (Stage 3). The decision-making process can result in one of three 
possible outcomes. First, the individual may choose to suspend judgement, remaining in Stage 3 
temporarily or permanently. Second, they may decide not to act (Stage 4). Third, they may decide 
to adopt the target behaviour, and thus move to Stage 5 (i.e. ‘Decided to act’). Those who decide 
to adopt should then begin to initiate the behaviour (Stage 6). A seventh stage, if relevant, 
indicates that the behaviour has been maintained over time (people in this stage are successfully 
repeating the protective action).   
As with the TTM, the PAPM suggests that there are specific factors associated with movement 
from one stage to the next. However, unlike the TTM, the PAPM does not specify what these 
factors are (Weinstein., 1988). As such, the model is not directly testable, and only serves as an 
assessment framework for determining what stage of adopting a precautious behaviour people 
are situated (Weinstein and Sandman., 1992). What is assumed, however, is that factors 
influencing transitions through the stages are likely to differ across populations and behaviours.  
 
                                                     
5 Problems with the TTM include a lack of standardisation of measures, particularly for the stages of change, logical flaws 
in current staging algorithms, inadequate specification of the causal relationships among the different constructs, 
misinterpretation of cross-sectional data on the stages of change and confusion concerning the nature of stage models 
and how they should be tested (Armitage., 2009). 
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On this basis, Weistein and Sandman (1992) suggest that the population and behaviour specific 
factors should be identified and thus used to inform the design and or tailoring of interventions. 
Example factors include media messages about the protective behaviour, which may stimulate 
progression from stage 1 (unaware) to stage 2 (unengaged), and beliefs about personal 
susceptibility to the health threat, which may stimulate progression from either stage 3 
(undecided) to stage 4 (decided not to act), or from stage 3 to stage 5 (decided to act).  
Figure 3-5. The Precaution Adoption Process Model (Adapted from: Weinstein and Sandman., 
1992) 
 
 
 
 
 
 
 
 
 
3.2.2.1 PAPM and CRC screening 
Since its introduction to the research literature, the PAPM has been applied to a wide range of 
protective health behaviours, including: home radon testing (Weinstein and Sandman., 1992), 
mammography screening (Clemow et al., 2000), fruit and vegetable intake (De Vet et al., 2008), 
cervical screening (Marlow et al., 2017), CRC screening (Costanza et al., 2005; Ferrer et al., 
2011) and calcium intake and exercise in patients with epilepsy (Elliott et al., 2007). With regards 
to CRC screening specifically, several studies have applied the PAPM to describe which stage of 
adopting the behaviour people are currently in (Costanza et al., 2005; Ferrer et al., 2011).  
  
Unaware of issue 
(Stage 1) 
Unengaged by issue 
(Stage 2) 
Deciding about whether to act 
(Stage 3) 
Decided to act 
(Stage 5) 
Acting 
(Stage 6) 
Maintenance 
(Stage 7) 
Decided not to act 
(Stage 4) 
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In one study, Ferrer and colleagues (2011) used a modified version of the PAPM to categorise 
people into one of eight behaviour change stages (ranging from ‘unaware’, to ‘initial’, 
‘maintenance’ and ‘relapse’). In their study, they collected staging data on 2470 respondents (men 
and women aged 50-75 years) via the National Cancer Institute’s 2003 Health Informatics Trends 
Survey (a US-based national telephone survey; Nelson et al., 2004). Participants were asked: 
“Have you ever heard of a stool blood test/ sigmoidoscopy / colonoscopy?”. Anyone who 
answered “no” was classed as being “unaware” of screening (stage 1), while anyone who 
answered “yes” was asked further questions about their readiness to screen and previous 
screening history (see Figure 3-6). Responses to these questions were used to stage individuals 
accordingly. Additional questions were then asked to assess participants perceived risk of cancer, 
worry about cancer, fatalism, and beliefs about ambiguity of cancer prevention recommendations 
(e.g. worry about CRC was assessed by asking: “How often do you worry about getting colon 
cancer?” with four response options ranging from ‘rarely or never’ to ‘all the time’). The study 
found that there were significant differences in health perceptions by stage, with individuals in the 
‘not engaged’ stage reporting significantly lower levels of worry than those in any other stage, and 
those in the ‘decided to act’, ‘initial’ and ‘maintenance’ stages reporting significantly less 
prevention ambiguity than individuals in any of the other stages. Similar findings were made by 
Costanza and colleagues (2005), who found that provider recommendation, a family history of 
CRC and higher decisional balance scores were all associated with higher PAPM stages.  
Figure 3-6. CRC screening readiness staging algorithm (Ferrer et al., 2011).  
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3.3 Summary 
A range of theoretical models have been applied in research examining CRC screening 
participation. No single model is recognised as being best and the topic of whether participation 
in CRC screening is a continuous or staged process is an ongoing debate. In the following 
chapter, I provide an overview of the different strategies that have been used to modify CRC 
screening behaviour and the evidence to support their use to date.  
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Chapter 4. Strategies to improve participation in colorectal 
cancer screening 
4.1 Overview 
Strategies to improve participation in organised screening programmes, such as those offered in 
the UK, can be broadly categorised according to six intervention types (i.e. reminders in addition 
to usual invitation, primary care endorsement, additional interventions in non-participants, 
enhanced invitation materials, direct contact and varying the screening test) and six intervention 
time points during which they can be delivered (i.e. before the invitation, at the time of the 
invitation, between invitation and screening, during screening [e.g. once a home-based kit has 
been delivered], before the next invitation and at the time of the next invitation; Figure 4-1). Using 
these concepts as the basis for a conceptual framework, Duffy and colleagues (2016) performed 
a rapid review to assess the effectiveness of each intervention type to increase uptake across a 
wide range of cancer screening studies. Reminders, primary care endorsement, offering more 
acceptable screening tests and interventions which target non-participants were all consistently 
found to improve uptake. The magnitude of their effects, however, varied greatly within the 
intervention categories (e.g. studies exploring the use of primary care endorsement to increase 
screening uptake ranged from a two percent increase in uptake, to a 20% increase in uptake). 
The authors suggested that this was most likely due to the oversimplification of studies into broad 
categories (e.g. interventions which target non-participants), which may have overlooked some 
of the important distinctions between studies in terms of their design and the ways in which 
interventions were implemented (in the NHS, screening is organised differently for each of the 
major screening programmes). In this chapter, I discuss the evidence for each intervention 
category as it relates to CRC screening specifically. 
Figure 4-1. Intervention types and time points (Duffy et al., 2016) 
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4.2  Reminders in addition to usual invitation 
Broadly speaking, reminders are short messages which prompt individuals to use a health service 
(Stone et al., 2002). These messages can be delivered in a number of ways and at a number of 
different time-points, depending on the set-up and delivery of the service (Baron et al., 2008; Duffy 
et al., 2016). For example, reminders can be delivered physically by post, verbally over the phone, 
or digitally by text-message and email. Each method has its own unique set of advantages and 
limitations. For example, while text-message reminders (also referred to as short messaging 
service reminders, or SMS reminders) provide a relatively inexpensive method for delivering 
reminders (i.e. relative to postal and telephone-based reminders; von Karsa et al., 2013), they 
allow only a limited number of characters to be sent at any one time and are limited to those 
individuals who have a mobile telephone number registered with their healthcare provider (recent 
English studies have found that coverage ranges from 40-50%; Kerrison et al., 2015; Hirst et al., 
2017). By contrast, telephone reminders are relatively expensive, as they involve direct contact 
with a healthcare professional (Halloran et al., 2012). At the same time, telephone reminders allow 
more information to be communicated and provide an opportunity for the patient to ask questions 
about the test (Saywell et al., 2003).  
In a systematic review of patient-directed reminders to increase community demand for breast, 
cervical and CRC screening, Baron and colleagues (2008) found that, according to Community 
Guide methods (Briss et al., 2000; Zaza et al., 2000), there was strong evidence to suggest that 
patient reminders increase demand for gFOBt screening, Papanicolaou test screening and 
mammography screening, but no evidence to assess whether patient reminders were effective 
for FS screening (i.e. no qualifying studies addressed these procedures at that time; Baron et al., 
2008). Within their review, Baron and colleagues (2008) identified seven studies examining the 
use of reminders for individuals who were overdue for gFOBt screening specifically. They found 
that, on average, reminders increased median uptake by 11.5 percentage points, and that, 
irrespective of the method used (e.g. telephone, postal, etc.), the results were consistently positive 
(Baron et al., 2008).  
A recent review of strategies to promote CRC screening identified one study in which participation 
rates were examined before and after the delivery of a non-responder reminder for FS screening 
(Senore et al., 2015b). The study randomly allocated people to one of three groups: Group 1 (n 
= 5220) received a standard invitation letter, Group 2 (n = 5212) received an advanced notification 
letter before the standard invitation letter, and Group 3 (n = 5223) received a modified version of 
the advanced notification letter that included the offer to discuss screening with the individual’s 
own GP. A reminder letter was sent in all three groups if there was no response to the invitation 
within three months (Senore et al., 2015a). The results showed that uptake was significantly 
higher in all three groups six months after the reminder was sent. Uptake increased from 22%, to 
26%, in Group 1; from 26%, to 31%, in Group 2; and from 26%, to 31%, in Group 3.  
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Across all three groups combined, the total proportion attending an appointment increased from 
25%, to 29% (Senore et al., 2015a). Unfortunately, as there was no control group in which 
individuals did not receive a reminder, the extent to which the changes in uptake could attributed 
to the reminder was not determinable.  
4.3 Interventions in non-participants 
4.3.1 Repeated invitations  
Another established means of improving CRC screening uptake is to offer repeated invitations 
(Steele et al., 2010; Lo et al., 2014; Pisera et al., 2016). Repeated invitations are additional rounds 
of invitation that follow an initial screening invite, usually on an annual, biennial or triennial basis. 
Unlike reminders, which tend to prompt people about an existing opportunity to take part in 
screening, repeated invitations offer people a new opportunity to take part in screening, either by 
offering them a new appointment, or by sending them another kit to complete. In the English 
BCSP, the proportion of people completing at least one round of gFOBt screening (i.e. prevalence 
screening) increases with each round of repeated invitation, i.e. from 54% in the first instance, to 
60% in the second, and 63% in the third (Steele et al., 2010). The same is true for incidence 
screening (i.e. the proportion of people completing a second, third or fourth round of screening), 
with first incidence (gFOBt) screening increasing from 87% following a single round of repeated 
invitation, to 94% after a second (Lo et al., 2014).  
The use of such a strategy to promote the uptake of once-only FS screening has not previously 
been examined (Senore et al., 2015a; Duffy et al., 2016). One previous study conducted as part 
of the Nordic-European initiative on Colorectal Cancer (NordICC) trial did, however, examine the 
use of a second invitation to facilitate the uptake of once-only colonoscopy screening in previous 
non-participants (Pisera et al., 2016). In that study, one thousand individuals aged 55 to 64 years 
who did not respond to an invitation and reminder were randomly assigned in a 1:1 ratio to receive 
either: 1) a second invitation and reminder six and three weeks (respectively) before a new 
colonoscopy appointment date, or 2) an invitation six weeks before an educational meeting. 
Uptake was significantly higher in the repeated invitation group compared with the educational 
session group (uptake was 16.5% and 4.3% in the repeated invitation and educational group 
respectively). As the study did not include a control group, however, it was not possible to say 
whether either intervention was more effective than usual care (i.e. no repeated invitation or 
educational meeting). Furthermore there was no information about the interval between 
invitations (Pisera et al., 2016). 
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4.3.2 Modified repeated invitations 
Several studies have shown that, when used in conjunction with other interventions, such as 
primary care endorsement, the effectiveness of repeated invitations can be enhanced (Duffy et 
al., 2016). For example, one study showed that gFOBt uptake was more than twice as high among 
previous non-participants who received a second invitation with a gFOBt kit than it was for 
previous non-participants who received a second invitation by itself (uptake was 20.1% and 9.6% 
respectively; Tinmouth et al., 2015b). Similar results have been observed for other screening 
programmes (e.g. breast screening), where modified repeated invitations have also been shown 
to be effective (Vernon et al., 2010). 
4.4 Primary Care endorsement 
In England, the NHS Cancer Screening Programmes are carried out with very little primary care 
involvement (Halloran., 2009). GPs are notified which individuals take part in screening, as well 
as the outcomes of the screening test, but are not actively involved in the delivery or coordination 
of the screening programmes, which are managed centrally by Public Health England (PHE). For 
some screening (e.g. cervical screening), GPs receive monetary benefits (i.e. Quality and 
Outcomes Framework points) for achieving national targets at their practice, and so are 
incentivised to promote uptake (NHS Employers., 2016). However, the NHS BSSP is not one of 
these.  
When embedded within the invitation letter, a primary care endorsement (i.e. an endorsement 
from primary care, such as the invitee’s own GP or GP practice) can be an effective and low-cost 
intervention that is easy to implement (Wardle et al., 2016; Raine et al., 2016a). Indeed, primary 
care endorsement has been shown to improve the uptake of gFOBt screening by as much as 14 
percentage points (Segnan et al., 1997; Cole et al., 2002; Richardson et al., 1994; Camilloni et 
al., 2013). The extent to which primary care endorsement can improve uptake is highly dependent 
on the way in which it is delivered. For example, one study demonstrated that, while the 
endorsement of the individual’s primary care practice can be effective, it is less effective than 
when the endorsement comes from the individual’s primary care practitioner (Cole et al., 2002). 
Another study showed that the effectiveness of the endorsement is modified by the inclusion of 
the GPs signature (Hewitson et al., 2011). The same study also demonstrated that the inclusion 
of an enhanced leaflet designed to address barriers to screening had an additional effect 
(Hewitson et al., 2011).  
Primary care endorsement has also been shown to consistently improve uptake across multiple 
rounds of invitation (Zajac et al., 2010) and when added to a second non-responder reminder 
letter (Benton et al., 2017). Its potential to improve FS screening participation, however, has not 
been examined (Senore et al., 2015B).  
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4.5 Varying invitation materials or strategy 
As discussed in Chapter 3, participation in screening is mediated by personal factors, such as 
worry, perceived risk, and the perceived barriers and benefits of screening (O'Sullivan and Orbell, 
2004; Champion et al., 2007). By modifying invitation materials to target these constructs, 
behavioural scientists have attempted to influence behaviour, and thereby promote uptake and 
improve population health.  
4.5.1 Targeted and tailored invitation materials  
Targeting, as defined by Kreuter and Skinner (2000), is the development of a single intervention 
approach for a defined population subgroup which takes into consideration characteristics shared 
by the subgroup’s members (Kreuter and Skinner., 2000). The practice of targeting is one that 
has been widely applied in the health education and health communication literature (Kreuter and 
Wray, 2003; Rimal and Adkins., 2003) and is an age-old practice of social marketing, where 
consumers are divided into market segments, towards which communications are then targeted 
(Campo et al., 2012).  
To fully capture the idea of targeting, it is important to understand a second concept, called 
tailoring. Tailoring is a process in which communications are personalised using individual-level 
data gathered through questionnaires. The technique was originally developed to match 
communications to the stages of change described in the TTM (see 3.2.1 The Transtheoretical 
Model), but has since been used to tailor messages to many more individual characteristics, such 
as attitudes and beliefs (Stroebe., 2011). A meta-analytic review of tailored print health behaviour 
change interventions demonstrated that tailored messages were more effective than a no-
intervention control and a non-tailored comparison group, and were most effective when tailored 
to a number of factors, including theoretical concepts, a person’s behaviour and individual 
demographics (Noar et al., 2007; Revere and Dunbar, 2001).  
One RCT examining the impact of tailored and targeted interventions on CRC screening 
participation found that, while screening was found to be significantly higher in all three 
intervention groups (i.e. targeted intervention, tailored intervention, and tailored intervention plus 
telephone reminder) compared with standard invitation (i.e. non-tailored, non-targeted, and with 
no telephone call), it did not vary significantly between intervention groups (Myers et al., 2007). 
In a second study examining the cost-effectiveness of these interventions, the authors reported 
that the tailored interventions were more expensive per additional person screened (both with and 
without the telephone reminder) compared with the targeted intervention (Lairson et al., 2008), 
and thereby offered no financial or operational benefit over an intervention targeting fewer 
characteristics.  
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In another RCT examining the effectiveness of a culturally tailored navigator programme to 
improve the uptake of CRC screening, culturally tailored navigation was more effective than usual 
care (Percac-Lima et al., 2009). However, no group receiving non-tailored navigation was 
included, making it difficult to assess the added benefit of tailoring the intervention. Further 
research is therefore needed to justify the use of tailoring, which, as noted above, is generally 
more expensive. The current evidence suggests that tailoring could be useful for improving uptake 
of specific groups, such as ethnic minority groups, where materials written in English are not 
always suitable.  
4.5.2 Stage-matched interventions 
Stage-matched interventions are designed to address the psychological factors associated with 
specific stage movements (e.g. progression from one stage, such as pre-contemplation, to 
another, more advanced stage, such as contemplation – see 3.2 Stage models) and, as such, 
are thought to be more effective at facilitating stage transitions than non-stage-matched 
interventions. The strongest evidence to support their use comes from match–mismatch studies, 
in which people who are at different stages of a behavioural process are offered either stage-
matched or mismatched information (i.e. information which is matched to a different stage to that 
of the individual; Weinstein et al., 1998a). Forward stage movement is then compared between 
individuals of the same stage in the different groups. To date, however, only a handful of match-
mismatch studies have been conducted.  
Four previous studies were unable to confirm that matched interventions were more effective than 
mismatched interventions (Blissmer and McAuley., 2002; Allen et al., 1997; Kadden et al., 1998; 
Quinlan and McCaul., 2000). Two other studies using different stage-based models of behaviour, 
however, did find evidence for matching effects (Weinstein et al., 1998a; Dijkstra et al., 1998). In 
one study, Weinstein and colleagues (1998) offered people stage-matched or stage-mismatched 
materials to stimulate radon testing in their homes (Weinstein et al., 1998a). They found that the 
information on the reasons and background of testing was more effective for people in the 
‘undecided’ stage (i.e. stage 3 of the PAPM; Figure 3-5), while information on selecting and using 
a test kit was more effective for people in the ‘decided-to-act’ stage (i.e. stage 5 of the PAPM; 
Figure 3-5).  
In another study, Dijkstra and colleagues (1998) offered information on the outcomes of quitting, 
information on quitting strategies, or a combination of both types of information to smokers in 
three qualitatively distinct stages of smoking cessation (Dijkstra et al., 1998). For smokers in the 
pre-contemplation stage (i.e. not motivated to quit – taken from the TTM), no matching effects 
were found. For smokers in the contemplation stage (i.e. thinking about quitting), however, a 
combination of both types of information was most effective, and smokers in the preparation stage 
(i.e. planning to quit on the short-term) benefited most from information on quitting strategies only.  
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In a more recent study, Dijkstra and colleagues (2006) examined the effectiveness of stage-
matched interventions using a complete stage model, which included smokers, ex-smokers, and 
three theoretically defined information conditions to stimulate the process of behaviour change 
(Dijkstra et al., 2006). They found that, at two months follow-up, the matched interventions were 
significantly more effective at stimulating forward-stage transition than the mismatched 
interventions. No long-term data on the effectiveness of these interventions currently exists. 
Very little research examining the effectiveness of stage-matched interventions to facilitate 
forward stage transitions in CRC screening uptake has been reported (Senore et al., 2015A, Duffy 
et al., 2016). One recent study conducted in Australia demonstrated that a modified advance 
notification letter designed to facilitate forward-stage movement in people who were in the pre-
contemplation stage improved overall uptake (Zajac et al., 2016). The same study also found that, 
while the advanced notification letter was effective, an enhanced invitation letter designed to 
facilitate forward stage movement in people who were thought to be in a stage of contemplation 
(i.e. had received the advance notification letter) did not improve uptake. 
4.5.3 Advance notification letters 
Advance notification letters, also referred to as ‘teaser letters’, are letters that are sent to 
screening eligible adults prior to an invitation for screening. They are intended to ‘prime’ people 
for their invitation by moving them from a stage of pre-contemplation to a stage of contemplation 
or readiness (Cole et al., 2007; Zajac et al., 2016). Evidence for their effectiveness originates from 
a Cochrane review, which documented that previous studies in which this technique was used to 
increase the return rate of postal questionnaires had reported highly positive results (Edwards et 
al., 2007). Four RCTs examining the effectiveness of advance notification letters to improve CRC 
screening uptake have been conducted since the publication of this review (Senore et al., 2015B). 
All four found that the receipt of an advance notification letter was associated with an increased 
uptake of CRC screening (Cole et al., 2007; Libby et al., 2011; van Roon et al., 2011; Senore et 
al,. 2015A). Three found that advance notification was associated with an increased participation 
in gFOBt- and FIT-based screening (van Roon et al., 2011; Libby et al., 2011; Cole et al., 2007) 
and one found an association for FS-based screening (Senore et al., 2015A).  
In one study, Libby and colleagues (2011) found that advance notification letters were an effective 
method for increasing uptake in CRC screening for men and women, younger and older adults, 
and people living in the most and least deprived areas (Libby et al., 2011). A follow-up economic 
analysis found that the inclusion of the letter within the Australian programme was associated 
with an incremental ratio of $6796 (approximately £5200) per quality adjusted life-year (QALY) 
gained (Cronin et al., 2013), which was well within the £20,000 threshold set by the National 
Institute for Health and Care Excellence (NICE; McCabe et al., 2008). Many organised CRC 
screening programmes now include an advanced notification letter based on the results of these 
studies (Schreuders et al., 2015). 
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4.5.4 Educational interventions 
Several studies examining the barriers to CRC screening have suggested that better education 
and low-literacy information materials might improve uptake (Olynyk et al., 1996; Sutton et al., 
2000; Brotherstone et al., 2006; von Wagner et al., 2009; Kobayashi et al., 2014; Kobayashi et 
al., 2016; Ghanouni et al., 2017). However, previous research testing these strategies has 
reported mixed results (Vernon., 1997). In one study conducted in the UK, gFOBt compliance 
was increased when a health education intervention was included with the invitation letter 
(Hardcastle et al., 1983), and similar observations were made in the US for the inclusion of an 
educational leaflet and follow-up telephone call (Tilley et al., 1999). In the UK FS trial, Wardle and 
colleagues (2003) found that the inclusion of a leaflet designed to modify negative attitudes 
towards FS screening was also associated with a modest increase in uptake. Other studies have 
produced less positive results (Kelly and Shank., 1992; Nichols et al., 1986), including one study 
which found that including a health education leaflet unexpectedly reduced compliance (Pye et 
al., 1988). In a recent study reporting the outcomes of four large RCTs conducted within the NHS 
BCSP, neither a narrative-based leaflet nor a GIST-based leaflet improved uptake when sent in 
conjunction with the standard invitation materials (Wardle et al., 2016; McGregor et al., 2016b; 
Smith et al., 2017), despite pilot studies demonstrating their face validity (McGregor et al., 2015b; 
Smith et al., 2015).  
4.6 Direct contact interventions 
4.6.1 Patient navigation 
In the USA, Harold Freeman pioneered a concept, called Patient Navigation (PN), in which the 
healthcare provider actively seeks out and removes barriers to cancer-related care, including 
cancer screening (Freeman., 2012). PN involves a trained individual giving tailored support to 
patients to help them overcome the barriers preventing them from optimising their healthcare 
along the cancer pathway. It can take on many different communication formats, including face-
to-face and over the phone.  
PN has been used to increase participation for various screening, including breast, cervical and 
CRC screening (Percac-Lima et al., 2009; Battaglia et al., 2011; Percac-Lima et al., 2013; Phillips 
et al., 2011; Donaldson et al., 2012; Green et al., 2013; Honeycutt et al., 2013). It has been found 
to be particularly effective among hard-to-reach groups (Muliira and D’Souza., 2015). In a review 
of the PN literature, Muliira and D’Souza (2015) identified 15 studies examining the effectiveness 
of PN to improve the uptake of CRC screening in primary care settings, six of which were RCTs. 
Only three of the RCTs reported that PN was associated with a statistically significant increase in 
participation; the remaining three all reported statistically non-significant improvements in uptake 
(Muliira and D’Souza., 2015).  
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In the UK, PN has been used to lesser extent. No studies examining the effectiveness of PN to 
promote the uptake of CRC screening were identified in three recent reviews of the research 
literature (Senore et al., 2015b; Muliira and D’Souza, 2015; Duffy et al., 2016). Several telephone 
interventions identified in the rapid review by Duffy et al (2016) did involve detailed scripts and 
briefing of the staff so that they were able to answer patient questions. One such study in CRC 
screening showed positive results (Shankleman et al., 2014). However, results from a more recent 
RCT suggest that a telephone reminder with support to address barriers to screening is no more 
effective than a telephone reminder without support (Chambers et al., 2016). Research exploring 
the effectiveness of PN in the context of the English BSSP is currently underway and will add 
significantly to the research literature in this area (McGregor et al., 2016a). 
4.7 Alternative screening tests 
Alternative screening tests can increase uptake if they are more acceptable to the screening 
eligible population than the current modality. A recent rapid review of the literature identified ten 
studies evaluating the effectiveness of offering alternative screening tests to improve uptake 
(Duffy et al., 2016), including three for CRC screening and seven for cervical screening (no 
studies were identified for breast screening). In two studies, FIT was associated with a higher 
participation rate than both colonoscopy and gFOBt screening, with differences in the order of 15 
and 20 percentage points (Gupta et al., 2013; Santare et al., 2015). In another study, capsule 
colonoscopy (a procedure in which the patient swallows a small, wireless camera that takes 
pictures of the colon and rectum as it passes through the digestive system) was associated with 
a small increase in uptake over conventional colonoscopy screening (Groth et al., 2012). In the 
seven cervical screening studies (predominantly conducted with women who had a history of non-
participation), Human Papilloma Virus self-sampling was associated with higher uptake than 
smear testing, with differences in the order of about 10 percentage points.  
In a meta-analysis of 13 RCTs comparing the acceptability of FS, gFOBt and FIT screening, 
uptake was significantly lower for FS compared with gFOBt and FIT (Littlejohn et al., 2012). Only 
one study included within the analysis reported similar uptake for FS screening with FOBt- and 
FIT-based screening (Segnan et al., 2007). The remaining 12 all found uptake for FS to be lower. 
In another meta-analysis, Vart and colleagues (2012) included studies comparing uptake between 
gFOBt screening with FIT (Vart et al., 2012). They found that, in all but one study included in the 
analysis, uptake was significantly higher among individuals offered FIT. In the other study, uptake 
was significantly higher among people offered the gFOBt (Levi et al., 2011). The results from this 
review were recently corroborated by the English BCSP FIT pilot (Moss et al., 2016). Moss and 
colleagues (2016) found that, of those who did not complete the gFOBt in the first round, 23.9% 
took part in the second round when they were offered the FIT, which compared favourably with 
those re-offered the gFOBt (only 12.5% of which took part).  
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4.8 Other intervention strategies 
4.8.1 Incentives  
Incentives are a group of interventions in which people are rewarded for their behaviour (Bech., 
2005). They differ from disincentives, which motivate people to change their behaviour using 
penalties (e.g. through fines, higher taxation and increased insurance renewal), and can be 
broadly split into two categories: those which offer a monetary incentive (these are frequently 
referred to as ‘economic incentives’ or ‘financial incentives’) and those which offer a non-monetary 
incentive (such as a voucher or coupon). They have been shown to be effective for a range of 
health behaviours, including smoking, drug abuse and screening for Tuberculosis (Lussier et al., 
2006; Prendergast et al., 2006; Giles et al., 2014), but are considered coercive, and so have rarely 
been tested in organised programmes, such as the English BCSP, which promotes informed 
decision making.  
In a systematic review of the literature, Giles and colleagues (2014) identified three studies 
examining the effectiveness of incentives to promote screening uptake: one examining the 
effectiveness of incentives to promote the uptake of breast and cervical screening (Debari et al., 
2007) and two examining the effectiveness of incentives to promote the uptake of Tuberculosis 
screening (Malotte et al., 1998; Malotte et al., 1999). In the study examining the effectiveness of 
incentives to promote the uptake of breast and cervical screening, Debari and colleagues (2007) 
found that the offer of a five-dollar gift voucher was not effective. In the first of their two studies 
examining the effectiveness of incentives to increase Tuberculosis screening compliance among 
active drug users, Malotte and colleagues (1998) found that both a five-dollar incentive and a ten-
dollar incentive were more effective than no incentive, and that a ten-dollar incentive was more 
effective than a five-dollar incentive (Malotte et al., 1998). In the second study, Malotte and 
colleagues (1999) found that drug users who received ten-dollars in cash were more likely to 
attend screening than those who received ten-dollars in grocery store vouchers, bus tokens or 
fast food coupons, and that individuals receiving coupons were more likely to attend screening 
than individuals who did not receive any incentive. They also found that there was no difference 
in uptake between the type of non-monetary incentive used (e.g. between people offered store 
coupons, bus tokens or fast food vouchers) and uptake of screening. 
Several other studies examining the effectiveness of incentives to promote the uptake of cancer 
screening have been published since the systematic review by Giles and colleagues (2014) took 
place (Kiran et al., 2014; Gupta et al., 2016; Forster et al., 2017; Mehta et al., 2017). One 
examined the effectiveness of patient-directed incentives to promote the uptake of CRC screening 
in Fortworth, Texas (Gupta et al., 2016). Another examined the effectiveness of a primary care 
‘pay-for-performance’ scheme to promote the uptake of breast, cervical and CRC screening in 
Ontario, Canada (Kiran et al., 2014). These studies mostly yielded only small increases in uptake. 
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4.9 Summary 
A number of strategies to improve participation in CRC screening have been examined. Some of 
the most researched strategies include: ‘reminders in addition to usual invitation’, ‘primary care 
endorsement’, ‘interventions which target non-participants’ and ‘offering alternative screening 
tests’. Evidence demonstrating the effectiveness of intervention strategies to promote the uptake 
of FS screening specifically, however, is currently lacking for all intervention types. No RCTs 
demonstrating the effectiveness of non-participant reminders, primary care endorsement or 
repeated invitations were identified within this review, or others conduct before it. These findings, 
combined with the low uptake of the English BSSP, formed the basis for this thesis, the aims of 
which were to design and evaluate an intervention strategy to promote BSS participation at St 
Mark’s Hospital (see Thesis aims and overview). The following chapter presents the first empirical 
chapter of this thesis.  
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Chapter 5. Examining uptake at St Mark’s Hospital (Study 1)6 
5.1 My contributions to the work presented in this chapter 
I conceived the idea for the study and wrote the study protocol. The data used were extracted 
from the Bowel Cancer Screening System (BCSS) by Dave Vernon (Interim Data Analyst, Eastern 
Bowel Cancer Screening Hub). The data were pseudonymised by Shaila Kumar (Health 
Improvement Specialist at St Mark’s Hospital), who transferred the data to me for analysis. I coded 
the data and derived the values for area-level deprivation, ethnic diversity and distance to the 
screening centre using pseudonymised postcode sectors that were later matched to individuals 
within the dataset by Shaila. I analysed the data after receiving statistical advice on the 
appropriateness of my proposed analysis plans from Dr Gianluca Baio (Reader in Statistics and 
Health Economics, UCL). I interpreted the results with input from my supervisors Dr Lesley 
McGregor, Dr Christian von Wagner and Professor Jane Wardle. Lesley led on the publication of 
the manuscript (McGregor et al., 2015a), which examined uptake across all six pilot centres 
(mentioned in the background literature – see Chapter 2). I contributed to the analysis and 
interpretation of the results of the published manuscript, as did the other co-authors.  
  
                                                     
6 A version of this Chapter has been published in the Journal of Medical Screening (Appendix 5-1) 
 
Reference: McGregor LM, Bonello B, Kerrison RS, Nickerson C, Baio G, Berkman L, Rees CJ, Atkin W, Wardle J, von 
Wagner C (2016) Uptake of Bowel scope (flexible sigmoidoscopy) screening in the English National Programme: the first 
14 months. J Med Screen. 23(2): 77-82 
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5.2 Introduction 
Evidence presented in Chapter 2 highlighted that there were important inequalities in BSS 
participation between men and women and people living within the most and least deprived areas 
of England (McGregor et al., 2015a). The aim of this study was to examine variation in uptake at 
St Mark’s Hospital specifically, with the wider aim of informing the development of the 
interventions to be developed and evaluated in the latter chapters of this thesis (see Chapters 6, 
7, 8 and 9). 
5.2.1 Aims 
The specific aims of this study were to: 1) examine the association between demographic and 
service-related variables with invitees’ response to the screening invite and attendance at 
screening and, 2) examine variation in attendance among those who confirm their appointment.  
5.3 Methods  
5.3.1 Study design 
I performed a retrospective analysis of uptake data collected for St Mark’s Hospital during the first 
fourteen months of the NHS BSSP’s initial implementation. 
5.3.2 Study population and setting 
5.3.2.1 Study setting 
St Mark’s Hospital is a specialist hospital located within the Northwest London Borough of Brent. 
It played an important role in the UK FS trial (Atkin et al., 2010), leading on the delivery of several 
pre-programme feasibility and pilot studies that were influential in the decision to implement the 
NHS BSSP (Brotherstone et al., 2007; Robb et al., 2010a). In addition, it was one of six centres 
to begin piloting BSS invitations as part of the national BSSP after its official introduction in March 
2013 (McGregor et al., 2015a). It commissioned this PhD as part of its 2013 health improvement 
strategy. 
5.3.2.2 Study population 
St Mark’s Hospital serves the socioeconomically and ethnically diverse London boroughs of Brent 
and Harrow (ONS., 2015). The following provides a brief overview of the areas. A comprehensive 
overview of the population is provided in the appendix (see Appendix 5-2). 
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5.3.2.2.1 Ethnic diversity 
The London Boroughs of Brent and Harrow are among the most ethnically diverse boroughs in 
all of England (ONS., 2015). Of the two, Brent is the more diverse, with almost two thirds (63.6%) 
of its residents being of a non-white ethnic background, compared with just over half (57.7%) in 
Harrow. Ethnically, the two boroughs are very different. Harrow has a greater proportion of Asian 
residents (42.7% in Harrow vs. 34% in Brent), and in this borough, Asian is the single most 
common ethnic group (in Brent it is the second most common ethnic group after White). Black 
and Chinese / any other ethnicity comprise the remaining non-White populations in Brent and 
Harrow. Collectively, these ethnicities account for 28.8% and 15.0% of people in Brent and 
Harrow respectively. The somewhat higher proportion of these minority groups in Brent is 
reflective of the overall higher diversity of this region (see Appendix 5-2).  
Compared with the broader population of London, both Boroughs have a higher proportion of 
Asian residents (ONS., 2015). Brent also has a higher proportion of Black, Chinese and other 
ethnic group residents also. Compared with England, both boroughs have fewer White residents 
and more Asian, Black and Chinese / any other ethnic group residents, which is consistent with 
the overall higher diversity of London (see Appendix 5-2). 
5.3.2.2.2 Household language 
English is not the main language in 22.5% and 15.9% of households in Brent and Harrow 
respectively (ONS., 2015). As such, English is not spoken as the main language in a larger 
proportion of households in Brent and Harrow than the broader populations of London and 
England, where 12.9% and 4.4% of households (respectively) do not speak English as the main 
language (see Appendix 5-2).  
5.3.2.2.3 Economic activity 
In terms of economic activity, Brent and Harrow are very similar (ONS., 2015). In Brent, 70.1% of 
people are economically active, compared with 70.7% of people in Harrow. Economic activity in 
these areas is also comparable to that of the broader populations of London and England, where 
71.7% and 69.9% of people (respectively) are economically active (see Appendix 5-2). 
5.3.2.2.4 Car or van availability 
With regards to household car or van availability, Brent and Harrow are very different (ONS., 
2015). In Harrow, household car or van availability is similar to that of the broader population of 
England, where over 75% of residents live in a household which has access to one or more cars 
or vans. In Brent, household car or van availability is closer to that of London, where over 40% of 
residents live in households which have no access to a car or van (see Appendix 5-2).  
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5.3.2.2.5 Education 
The level of education of people living in Brent and Harrow is comparable; 70.4% of people in 
Brent and 72.3% of people in Harrow have at least one level 2 qualification or above (e.g. GCSE, 
A-level, etc. ONS., 2015). Proportions are also similar for those who have no qualifications (19.2% 
in Brent compared with 16.8% in Harrow; see Appendix 5-2).  
5.3.2.2.6 Housing tenure 
Home ownership is lower in Brent than Harrow. Only 42.9% of residents in Brent either own their 
home outright or with a mortgage or loan, whereas in Harrow, home ownership is 65.2% (ONS., 
2015). Compared with the broader populations of London and England, where nearly two thirds 
(48.2% and 63.2% respectively) of people either own their home outright or with a mortgage or 
loan, home ownership is low in Brent but high in Harrow (see Appendix 5-2). 
5.3.3 Analytic sample 
The analytic sample for this study was all men and women invited for BSS at St Mark’s Hospital 
between March 2013 and May 2014. 
5.3.4 Data extraction  
The data used for this study were extracted from the BCSS by a data analyst at the Eastern Bowel 
Cancer Screening Hub (see Table 5-1 for an overview of the data specification submitted to the 
Eastern Bowel Cancer Screening Hub by the clinical programme manager at St Mark’s Bowel 
Cancer Screening Centre, BCSC). The data were transferred to St Mark’s BCSC via a secure 
NHS.net connection, and any identifiable information removed by a member of the direct care 
team, prior to being transferred to myself at UCL for analysis (see Appendix 5-3 for an overview 
of the flow of data through the study).  
Table 5-1. Data specification 
Variables Reason for request 
NHS Number Required for extraction 
Gender Required for analysis  
CCG Required for analysis  
Postcode Required for analysis  
Confirmed an appointment Required for analysis  
Attended an appointment Required for analysis 
Date and time of appointment offered Required for analysis  
Date and time of appointment attended Required for analysis  
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5.3.5 Measures 
To examine possible associations between demographic and service-related variables with odds 
for ‘confirming an appointment’ and ‘attendance at screening’, a range of data available on the 
BCSS were extracted and added to the study database (see Table 5-1). Several of these, 
including gender and area-level deprivation, were shown to predict participation in the early 
uptake study (McGregor et al., 2015a) and were included to examine their associations with 
uptake at St Mark’s Hospital specifically. Others, such as appointment type and area-level ethnic 
diversity, were not found to be significant predictors of uptake in the early uptake study (McGregor 
et al., 2015a), and were included to assess whether they were associated with uptake at St Mark’s 
Hospital in particular. Two additional variables, distance to the screening centre and CCG, which 
were not included in the early uptake study, were also included in the analysis to assess their 
associations with uptake. Difficulty in getting to the screening centre has previously been reported 
as a barrier to uptake (Cole et al., 2012), and so distance to the screening centre was added as 
a proxy for this potential practical barrier to uptake. CCG has been identified as a predictor of 
uptake in other studies (Robb et al., 2010a), and so was included as a variable in this study for 
this reason. 
5.3.5.1 Gender and CCG 
The gender and CCG of each person was added to the study database as part of the initial 
extraction.  
5.3.5.2 Area-level deprivation 
I converted the postcode of each person’s home address into a score on the 2010 Index of 
Multiple Deprivation7 (IMD) using Geoconvert: an online tool that enables users to convert 
geographies into Census-derived statistics (UK Data Service Census Support., 2017). I then 
categorised the scores into quintiles of the national distribution to compare uptake between 
individuals living in the most and least deprived areas. To ensure people were not identifiable 
during the conversion, postcodes were pseudonymised by a member of the direct care team at 
St Mark’s BCSC, who merged the converted data with the study database using a unique 
participant identification (ID) number contained within both datasets (this was deleted once the 
data had been merged, so that postcodes could not be retrospectively identified).  
                                                     
7 The index of multiple deprivation is the government’s official measure of relative deprivation for small areas in England 
(Department for Communities and Local Government., 2011). It uses administrative data and census-derived indicators 
of income, education, employment, living environment, health and disability, barriers to housing and services, and crime 
at small-area level to generate a scale ranging from 0 (least deprived) to 80 (most deprived). 
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5.3.5.3 Area-level ethnic diversity 
The process of obtaining and converting each person’s home postcode address into an area-level 
ethnic diversity score (i.e. ‘percent non-White’) was similar to that described for area-level 
deprivation (see 5.3.5.2 Area-level deprivation). I received a pseudonymised list of home 
postcode addresses and unique study IDs from St Mark’s BCSC, converted them into area-level 
ethnic diversity scores using Census data on the proportion of non-White residents within each 
postcode (ONS., 2011), categorised them into quintiles of their national distribution, and returned 
them to a member of the direct care team at St Mark’s BCSC, who merged the data with the study 
database. Again, a unique study ID was used to facilitate the process of merging the data and 
was deleted after the data had been merged so that postcodes could not be identified 
retrospectively. 
5.3.5.4 Appointment type 
The date and time of the appointment offered in the initial invitation was extracted for each person 
from the BCSS as part of the initial extraction. Appointments offered on weekday afternoons (i.e. 
between 1pm and 3:30pm) were coded as ‘routine appointments’, and appointments offered on 
weekday evenings (i.e. between 4:45pm and 7pm) and Saturdays as ‘out-of-hours appointments’. 
The process of converting the day and time of the appointment into the type of appointment 
offered was facilitated by myself using the anonymised study database. 
5.3.5.5 Distance to the screening centre 
The process of obtaining and converting each person’s home postcode address into distance to 
the screening centre (in miles) was similar to that described for area-level deprivation and area-
level ethnic diversity. I received a pseudonymised list of home postcode addresses and unique 
study IDs from St Mark’s BCSC, converted them into distances from the screening centre using 
the ‘Google Maps Distance Function’ in Microsoft Excel and returned them to the direct care team 
at St Mark’s BCSC, who merged the data with the study database. Again, a unique study ID was 
used to facilitate the process of merging the data and was deleted after the data had been merged, 
so that postcodes could not be identified retrospectively. 
5.3.5.6 Changed appointment 
To assess the proportion of individuals who rescheduled their appointment, the time and date of 
the appointment offered and the time and date of the appointment attended were extracted from 
the BCSS as part of the initial extraction. These data were then compared to determine whether 
people attended the appointment they were initially offered, or whether the appointment attended 
was a different day / time. As with appointment type, I converted the data myself within the 
anonymised study database. 
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5.3.5.7 Confirmed an appointment and attendance at screening 
Response to the screening invite (i.e. confirmed an appointment yes / no) and attendance at 
screening (i.e. attended an appointment yes / no) were extracted from the BCSS as part of the 
initial extraction.  
5.3.6 Analysis 
Descriptive statistics were used to describe the sample population. Univariable and multivariable 
binary logistic regression were used to investigate possible associations between baseline 
characteristics and confirming and attending an appointment (Engel., 1988). A subgroup analysis 
was performed on individuals who confirmed an appointment to examine whether variables were 
associated with odds of attending a confirmed appointment specifically. The amount of variance 
explained by each model was reported using the Nagelkerke R square statistic (Nagelkerke., 
1991). The data were assessed using SPSS (version 24). 
5.3.7 Ethical approval, research governance and trial sponsorship 
Ethical approval and trial sponsorship were not required for this study. 
5.4 Results  
5.4.1 Sample characteristics 
Over the first 14 months of the NHS BSS programme’s initial implementation, 4933 men (n = 
2449, 49.6%) and women (n = 2848, 50.4%) were invited for screening at St Mark’s BCSC (Table 
5-2). The majority were registered with an address within the London Borough of Brent (n = 3134, 
63.5%) and were offered an out-of-hours appointment (n = 3023, 61.3%). More than 70% were 
registered with an address within the most ethnically diverse quintile of areas (n = 3644, 73.9%) 
and only a small portion were registered with an address within the least ethnically diverse quintile 
of areas (n = 337, 6.8%). The majority were also registered with an address in either the most 
deprived (n = 903, 18.3%) or second most deprived (n = 1848, 37.4%) quintile of areas in England. 
The proportion of invitees from the most diverse quintile of areas varied by CCG and was higher 
in Brent (n = 2557, 81.6%) than Harrow (n = 1087, 60.4%), as was the proportion of invitees from 
the most socioeconomically deprived areas (n = 857, 27.3% and n = 46, 2.6% for Brent and 
Harrow respectively; Table 5-2).  
The mean distance between each person’s home address and the screening centre was 2.9 miles 
(Standard Deviation, SD = 1.4). On average, invitees from Brent lived slightly further from the 
screening centre than invitees from Harrow (mean distance to the screening centre was 2.2 miles 
and 3.3 miles, respectively). These findings were consistent with data reported by the ONS (ONS., 
2015). 
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Table 5-2. Description of the study population 
 
Brent 
(n = 3134) 
Harrow 
(n = 1799) 
Total 
(n = 4993) 
Gender, n (%) 
     Women 1552 
(49.5) 
932 
(51.8) 
2484 
(50.4) 
     Men  1582 
(50.5) 
867 
(48.2) 
2449 
(49.6) 
Quintile of deprivation (IMD score), n (%) 
     Most deprived 
     (33.50 – 80.00) 
857 
(27.3) 
46 
(2.6) 
903 
(18.3) 
     Quintile 2 
     (21.62 – 33.49) 
1560 
(49.8) 
283 
(15.7) 
1848 
(37.4) 
     Quintile 3  
     (14.61 – 21.61) 
647 
(20.6) 
591 
(32.9) 
1238 
(25.1) 
     Quintile 4  
     (9.88 – 14.60) 
55 
(1.8) 
552 
(30.7) 
607 
(12.3) 
     Least deprived  
     (0.01 – 9.87) 
11 
(0.4) 
326 
(18.1) 
337 
(6.8) 
     Missing 4 
(0.1) 
1 
(0.1) 
5 
(0.1) 
Quintile of ethnic diversity (% of non-white residents within a postcode sector), n (%) 
     Most diverse 
     (0.00-28.17) 
2557 
(81.6) 
1087 
(60.4) 
3644 
(73.9) 
     Quintile 2  
     (28.18 – 36.94) 
318 
(10.1) 
325 
(18.1) 
643 
(13.0) 
     Quintile 3   
     (14.61 – 21.61) 
80 
(2.6) 
112 
(6.2) 
192 
(3.9) 
     Quintile 4   
     (46.89 – 62.92) 
64 
(2.0) 
127 
(7.1) 
191 
(3.9) 
     Least diverse  
     (62.93 – 100.00) 
111 
(3.5) 
147 
(8.2) 
258 
(5.2) 
     Missing 4 
(0.1) 
1 
(0.1) 
5 
(0.1) 
Appointment type, n (%) 
     Out-of-hours 1909 
(60.9) 
1114 
(61.9) 
3023 
(61.3) 
     Routine  1225 
(39.1) 
685 
(38.1) 
1910 
(38.7) 
Distance to the screening centre, Miles (SD) 
     Distance, Mean (SD) 
     (0 – 13 miles) 
3.27 
(1.45) 
2.18 
(0.91) 
2.87 
(1.38) 
Abbreviations: IMD, Index of Multiple Deprivation; SD, Standard Deviation 
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5.4.2 Confirmed an appointment  
Of the 4933 men and women invited for screening at St Mark’s BCSC, 2480 (50.3%) confirmed 
their appointment. Differences in the proportion confirming an appointment by gender, CCG, area-
level deprivation, area-level ethnic diversity, appointment type and distance to the screening 
centre are reported in Table 5-3. 
In the univariable analyses, the proportion of individuals confirming an appointment did not vary 
by gender or the type of appointment offered (both Ps > 0.05), but did vary by CCG, area-level 
deprivation, area-level ethnic diversity and distance to the screening centre (all Ps < 0.05). 
Confirmation of an appointment was highest in the least deprived areas and lowest in the most 
deprived (57.9% vs. 43.7%; Odds Ration [OR] = 1.8, 95% Confidence Interval [CI] = 1.4 – 2.3, P 
< 0.001), with an almost linear trend across deprivation quintiles (Table 5-3). Confirmation of an 
appointment was also higher in the least ethnically diverse areas compared with the most 
ethnically diverse areas (58.5% vs. 48.6%; OR = 1.5, 95% CI = 1.2 – 1.9, P < 0.01). As with area-
level deprivation, there was an almost linear trend across diversity quintiles (Table 5-3). The 
proportion of invitees confirming an appointment decreased as distance to the screening centre 
increased (OR = 0.9, 95% CI = 0.9 – 1.0, P < 0.001) and was higher in Harrow than Brent (uptake 
was 55.3% and 47.4% in Harrow and Brent respectively; OR = 1.4, 95% CI = 1.2 – 1.5, P < 0.001).  
Results were similar in the multivariable analysis (Table 5-3), with strong evidence of significant 
differences between the most and least deprived areas (adjusted OR [aOR] = 1.4, 95% CI = 1.0 
– 1.92, P < 0.05), as well as the most and least ethnically diverse (aOR = 1.3, 95% CI = 1.0 – 1.7; 
P < 0.05). After adjusting for covariates, there was no longer evidence for a difference in 
confirming an appointment by CCG (aOR = 1.1, 95% CI = 0.9 – 1.3, P > 0.05) or distance to the 
screening centre (aOR = 1.0, 95% CI = 0.9 – 1.0, P > 0.05).  
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Table 5-3. Sample variation in response to the screening invite at St Mark’s BCSC 
 
Responded 
n (%) 
Unadjusted OR 
(95% CI) 
Adjusted OR1 
(95% CI) 
Overall response (n = 4933) 
2480  
(50.3) 
- - 
Gender 
     Womena (n = 2484) 1240  
(49.9) 
- - 
     Men (n = 2449) 1240  
(50.6) 
1.03  
(0.92 - 1.15) 
1.04  
(0.93 - 1.16) 
CCG 
   Brenta (n = 3134) 1486 
(47.4) 
- - 
   Harrow (n = 1799) 994 
(55.3) 
1.37*** 
(1.22 - 1.54) 
1.08  
(0.92 - 1.27) 
Quintile of deprivation (IMD score) 
     Most depriveda (n = 903) 
(33.50 – 80.00) 
395  
(43.7) 
- - 
     Quintile 2 (n = 1843) 
(21.62 – 33.49) 
879  
(47.7) 
1.17* 
(1.00 - 1.38) 
1.10  
(0.93 - 1.30) 
     Quintile 3  (n = 1238) 
(14.61 – 21.61) 
661  
(53.4) 
1.47*** 
(1.24 - 175) 
1.29** 
(1.06 - 1.58) 
     Quintile 4  (n = 607) 
(9.88 – 14.60) 
347  
(57.2) 
1.72*** 
(1.40 - 2.11) 
1.42** 
(1.10 - 1.83) 
     Least deprived (n = 337) 
(0.01 – 9.87) 
195  
(57.9) 
1.77*** 
(1.37 - 2.28) 
1.42 * 
(1.05 - 1.92) 
Quintile of ethnic diversity (% of non-white residents within a postcode sector) 
     Most diversea (n = 3644) 
(0.00-28.17) 
1770  
(48.6) 
- - 
     Quintile 2 (n = 643) 
(28.18 – 36.94) 
336  
(52.3) 
1.16  
(0.98 - 1.37) 
1.12  
(0.93 - 1.35) 
     Quintile 3  (n = 192) 
(14.61 – 21.61) 
107  
(55.7) 
1.33* 
(1.00 - 1.79) 
1.22  
(0.91 - 1.64) 
     Quintile 4  (n = 191) 
(46.89 – 62.92) 
113  
(59.2) 
1.53** 
(1.14 - 2.06) 
1.32  
(0.97 - 1.79) 
     Least diverse (n = 258) 
(62.93 – 100.00) 
151  
(58.5) 
1.49**  
(1.16 - 1.93) 
1.33* 
(1.02 - 1.72) 
Appointment type 
   Out-of-hoursa (n = 3,023) 1518  
(50.2) 
- - 
   Routine (n = 1,910) 962  
(50.4) 
1.01  
(0.90 - 1.13) 
1.02  
(0.91 -1.14) 
Distance to screening centre (Miles) 
   Distance (0 – 13 miles) - 0.93*** 
(0.89 - 0.97) 
0.96 
(0.92 - 1.01) 
Abbreviations: OR, Odds Ratio; CI, Confidence Interval; CCG, Clinical Commissioning Group; IMD, Index of Multiple 
Deprivation 
1Adjusted ORs and 95% CIs are adjusted for all other covariates in the table. 
aReference group 
*P < 0.05, **P < 0.01, ***P < 0.001 
Nagelkerke R Square = 0.015 
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5.4.3 Uptake (all invitees) 
Of the 4933 men and women invited for screening, 1997 (40.5%) attended an appointment. 
Differences in uptake by gender, CCG, area-level deprivation, area-level ethnic diversity, 
appointment type and distance to the screening centre are reported in Table 5-4.  
In the univariable analyses, uptake did not vary by gender or the type of appointment offered 
(both Ps > 0.05; Table 5-4), but did vary by CCG, area-level deprivation, area-level ethnic 
diversity, and distance to the screening centre (all Ps < 0.05). Uptake was highest in the least 
deprived areas and lowest in the most deprived areas (47.8% vs. 32.7%; OR = 1.7, 95% CI = 1.4 
– 2.0, P < 0.001), with an almost linear trend across intermediate quintiles of area-level deprivation 
(Table 5-4). Uptake was also higher in the least ethnically diverse quintile of areas compared with 
the most ethnically diverse quintile (47% vs. 38.7%; OR = 1.4, 95% CI = 1.2 – 1.7, P < 0.01). 
However, unlike area-level deprivation, there was no evidence of a linear trend across quintiles 
of area-level diversity (Table 5-4). As was the case for odds of confirming of an appointment, odds 
of attending an appointment decreased as distance to the screening centre increased (OR = 0.9, 
95% CI = 0.9 – 1.0, P < 0.01), and were higher in Harrow than Brent (OR = 1.3, 95% CI = 1.2 – 
1.5, P < 0.001; Table 5-4).  
Results were similar in the multivariable analysis (Table 5-4), with strong evidence of significant 
differences between the most and least deprived quintiles of areas (aOR = 1.5, 95% CI = 1.2 – 
1.9, P < 0.01), as well as the most and least ethnically diverse quintiles of areas (aOR = 1.3, 95% 
CI = 1.1 – 1.6, P < 0.01). After adjusting for covariates, there was no longer evidence for a 
significant difference in participation by CCG (aOR = 1.0, 95% CI = 0.9 – 1.2, P > 0.05) or distance 
to the screening centre (aOR = 1.0, 95% CI = 0.9 – 1.0, P > 0.05). 
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Table 5-4. Sample variation in screening uptake at St Mark’s BCSC  
 
Uptake  
n (%) 
Unadjusted OR 
(95% CI) 
Adjusted OR1 
(95% CI) 
Overall uptake (n = 4933) 
1997 
(40.5) 
- - 
Gender 
     Womena (n = 2848) 990 
(39.9) 
- - 
     Men (n = 2449) 1007 
(41.1) 
1.05 
(0.94 - 1.18) 
1.06 
(0.95 - 1.19) 
CCG 
   Brenta (n = 3134) 1190 
(38.0) 
- - 
   Harrow (n = 1799) 807 
(44.8) 
1.33*** 
(1.18 - 1.50) 
1.02 
(0.86 - 1.21) 
Quintile of deprivation (IMD score) 
     Most depriveda (n = 988) 
(33.50 – 80.00) 
345 
(34.9) 
- - 
     Quintile 2 (n = 999) 
(25.13 – 33.49) 
360 
(36.0) 
1.05 
(0.87 - 1.26) 
1.00 
(0.83 - 1.21) 
     Quintile 3  (n = 974) 
(20.81 – 25.12) 
397 
(40.8) 
1.28* 
(1.07 - 1.54) 
1.22* 
(1.01 - 1.48) 
     Quintile 4  (n = 982) 
(14.10 - 20.80) 
422 
(43.0) 
1.40** 
(1.17 - 1.69) 
1.27* 
(1.03 - 1.57) 
     Least deprived (n = 984) 
(0.01-14.09) 
470 
(47.8) 
1.70** 
(1.42 - 2.04) 
1.49** 
(1.17 - 1.89) 
Quintile of ethnic diversity (% of non-white residents within a postcode sector) 
     Most diversea (n = 1008) 
     (0.00-28.17) 
383 
(38.0) 
- - 
     Quintile 2 (n = 1017) 
     (28.18 – 36.94) 
391 
(38.4) 
1.02 
(0.85 - 1.22) 
1.03 
(0.85 - 1.23) 
     Quintile 3  (n = 933) 
     (36.95 – 46.86) 
359 
(38.5) 
1.02 
(0.85 - 1.23) 
1.01 
(0.83 - 1.23) 
     Quintile 4  (n = 986) 
     (46.89 – 62.92) 
407 
(41.3) 
1.15 
(0.96 - 1.37) 
1.15 
(0.93 - 1.41) 
     Least diverse (n = 984) 
     (62.93 – 100.00) 
454 
(46.1) 
1.40** 
(1.17 - 1.67) 
1.30** 
(1.06 - 1.59) 
Appointment type 
   Out-of-hoursa (n = 3023) 1225 
(40.5) 
- - 
   Routine (n = 1910) 772 
(40.4) 
1.00 
(0.89 - 1.12) 
1.01 
(0.90 - 1.13) 
Distance to the screening centre (Miles) 
   Distance (0 – 13 miles) - 0.94** 
(0.90 - 0.98) 
0.97 
(0.92 - 1.03) 
Abbreviations: OR, Odds ratio; CI, Confidence Interval; CCG, Clinical Commissioning Group; IMD, Index of Multiple 
Deprivation 
1Adjusted ORs and 95% CIs are adjusted for all other covariates in the table. 
aReference group 
*P < 0.05, **P < 0.01, ***P < 0.001; Nagelkerke R Square = 0.015 
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5.4.4 Attendance (invitees who confirmed an appointment only) 
Of the 2480 men and women who confirmed an appointment, 1997 (80.5%) attended. Differences 
in uptake among those who confirmed an appointment by gender, CCG, area-level deprivation, 
area-level ethnic diversity, appointment type and distance to the screening centre are reported in 
Table 5-5.  
In the univariable analyses, uptake among individuals who confirmed an appointment (n = 2480) 
did not vary by gender, CCG, area-level deprivation, appointment type or distance to the 
screening centre (all Ps > 0.05; Table 5-5), but did vary by area-level ethnic diversity, with people 
in the least ethnically diverse areas being significantly more likely to attend an appointment than 
individuals living in the most ethnically diverse quintile areas (80.1% vs. 87.4% respectively; aOR 
= 1.7, 95% CI = 1.1 – 2.8, P < 0.05).  
Results were similar in the multivariable analysis, with gender, CCG, appointment type and 
distance to the screening centre all remaining non-significant predictors of uptake among people 
who confirmed an appointment (all Ps > 0.05; Table 5-5). Area-level ethnic diversity, however, 
was no longer a significant predictor in the multivariable analysis (aOR = 1.6, 95% CI = 1.0 – 2.7, 
P > 0.05). Conversely, area-level deprivation, which was not a significant predictor in the 
univariable analysis, was a significant predictor in the multivariable analysis, with people living in 
the least deprived quintile of areas being significantly more likely to attend a confirmed 
appointment than individuals in the most deprived quintile of areas (86.7% vs. 80.8%; aOR = 1.8, 
95% CI = 1.0 – 3.1, P < 0.05).  
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Table 5-5. Sample variation in attendance among responders at St Mark’s BCSC 
 
Uptake 
n (%) 
Unadjusted OR 
(95% CI) 
Adjusted OR1 
 (95% CI) 
     Overall attendance (n = 2480) 
1997 
(80.5) 
- - 
Gender 
     Womena (n = 1240) 990 
(79.8) 
- - 
     Men (n = 1240) 1007 
(81.2) 
1.09 
(0.90 - 1.33) 
1.10 
(0.90 - 1.34) 
CCG 
   Brenta (n = 1486) 1190  
(80.1) 
- - 
   Harrow (n = 994) 807  
(81.2) 
1.07  
(0.88 - 1.32) 
0.92  
(0.70 - 1.22) 
Quintile of deprivation (IMD score 0-80) 
     Most depriveda (n = 395) 
(33.50 – 80.00) 
319 (80.8) - - 
 
     Quintile 2 (n = 879) 
(21.62 – 33.49) 
879 
(78.7) 
0.88 
(0.66 - 1.19) 
0.92 
(0.67 - 1.25) 
     Quintile 3  (n = 661) 
(14.61 – 21.61) 
529 
(80.0) 
0.96 
(0.70 - 1.31) 
1.03 
(0.72 - 1.48) 
     Quintile 4  (n = 347) 
(9.88 – 14.60) 
285 
(82.1) 
1.10 
(0.76 - 1.59) 
1.24 
(0.78 - 1.95) 
     Least deprived (n = 195) 
(0.01 – 9.87) 
169 
(86.7) 
1.55 
(0.96 - 2.51) 
1.80* 
(1.02 - 3.14) 
Quintile of ethnic diversity (% of non-white residents within a postcode sector) 
     Most diversea (n = 1770) 
(11.81 - 100) 
1418  
(80.1) 
- - 
     Quintile 2 (n = 336) 
(3.66 – 11.80) 
269  
(80.1) 
1.00  
(0.74 - 1.34) 
0.87  
(0.63 - 1.19) 
     Quintile 3  (n = 107) 
(1.78 – 3.65) 
84  
(78.5) 
0.91  
(0.56 - 1.46) 
0.86  
(0.53 - 1.39) 
     Quintile 4  (n = 113) 
(1.05 – 1.77) 
91  
(80.5) 
1.03  
(0.64 - 1.66) 
0.91  
(0.56 - 1.50) 
     Least diverse (n = 151) 
(0 – 1.04) 
132  
(87.4) 
1.73  
(1.05 - 2.83)* 
1.61  
(0.97 - 2.66) 
Type of appointment offered 
   Out-of-hoursa (n = 1518) 1225 
 (80.7) 
- - 
   Routine (n = 962) 772  
(80.2) 
0.97  
(0.79 - 1.19) 
0.98  
(0.80  - 1.20) 
Distance to the screening centre (Miles) 
   Distance (0 – 13 miles) - 1.00  
(1.00 - 10.1) 
1.03  
(0.94 - 1.13) 
Abbreviations: OR, Odds Ratio; CI, Confidence Interval; CCG, Clinical Commissioning Group; IMD, Index of Multiple 
Deprivation 
1Adjusted ORs and 95% CIs are adjusted for all other covariates in the table. 
aReference group 
*P < 0.05, **P < 0.01, ***P < 0.001; Nagelkerke R Square = 0.010 
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5.4.5 Proportion of appointment times offered, attended and rescheduled 
Of the 4933 men and women invited for screening, 1910 (38.7%) were offered a routine (weekday 
afternoon) appointment and 3023 (61.3%) were offered an out-of-hours (weekday evening or 
weekend) appointment (Table 5-6). Of those who attended an appointment (n = 1997), only 39.9% 
(n = 797) attended the appointment they were originally offered, and the level of attendance was 
similar for both types of appointment offered (39.1% vs. 41.1%; Table 5-6). A further 34.5% (n = 
689) attended an appointment within their original appointment slot (i.e. same day, different time). 
The remaining 25.6% (n = 511) attended an appointment within a different appointment slot (i.e. 
different day and / or different time of day). The proportion attending an appointment within the 
same appointment slot was higher for people who were offered an out-of-hours appointment than 
those offered a routine appointment (uptake was 38.4% and 28.4% respectively; Table 5-6).  
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Table 5-6. Proportion of appointment times offered, attended and re-scheduled at St Mark’s BCSC. 
 Same appointment Changed appointment 
Appointment 
slot offered 
Offered n (%) Overall 
attendance n (%) 
Attendance at appointment 
offered n (%) 
Attended appointment within 
appointment slot n (%) 
Attended a different 
appointment slot n (%) 
     Out-of-hours 3023 (61.3) 1225 (40.5) 479 (39.1) 470 (38.4) 276 (22.5) 
     Routine 1910 (38.7) 772 (40.4) 318 (41.1) 219 (28.4) 235 (30.4) 
     Total 4933 1997 (40.5) 797 (39.9)  689 (34.5) 511 (25.6) 
8
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5.5 Discussion 
This study examined uptake at St Mark’s Hospital during the first fourteen months of the NHS 
BSSP’s initial implementation. The results demonstrate that half (50.3%) of all people invited for 
screening confirmed their appointment, and that most (80.5%) went on to attend. These findings 
were consistent with previous research conducted within the UK FS trial (Atkin et al., 2010), which 
also found that most people who confirmed an appointment attended, and that only a minority do 
not attend or cancel (Brotherstone et al., 2007; Robb et al., 2010a). 
While most people who confirmed an appointment went on to attend, there were almost 500 
missed appointments at the centre during the study period, and many more that had to be 
rescheduled. Such inefficiencies in healthcare delivery are associated with considerable 
monetary costs to the healthcare provider and adverse clinical implications for the non-attending 
adult (Moore et al., 2001; Guttman et al., 2011). Each year, the direct cost of missed appointments 
to the NHS are thought to equate to approximately £34 million for practice nurse appointments, 
£185 million for GP appointments, and over £700 million for hospital appointments (Developing 
Patient Partnerships., 2004). As non-attendance has not previously been examined within the 
NHS BSS programme, the exact cost of missed appointments to the NHS are currently unknown. 
Estimates from the most recent appraisal of the options for CRC screening, however, suggest 
that the cost of a single missed appointment is at least £5.00 (Whyte et al., 2012). At this rate (i.e. 
£5.00 per missed appointment), the cost of the 483 missed appointments observed in this study 
would equate to approximately £2,5008; although the actual cost may be much greater than this. 
Consideration should, therefore, be given to strategies which are designed to prevent missed 
appointments, as well as those which promote uptake by other means (e.g. improving response 
to the initial invitation, etc.). Such interventions would not only improve the overall uptake of BSS 
(by up to ten percentage points), but reduce the total cost of missed appointments as well. 
Perhaps the greatest opportunity to improve uptake (highlighted by these data) lies in targeting 
individuals who do not respond to the initial invitation (i.e. ‘non-responders’). The present study 
finds that these individuals comprise almost half of the total eligible population at St Mark’s 
Hospital, making them the single largest group of individuals invited for screening at the centre. 
Given their higher socioeconomic deprivation and ethnic diversity, interventions targeting these 
individuals would be most effective if they focused on issues which are particularly pertinent to 
lower socioeconomic and ethnic minority groups (Robb et al., 2008b; Robb et al., 2010b). 
Targeting barriers which are specific to these groups may have the added benefit of reducing 
socioeconomic and ethnic disparities in uptake at the centre, as have been observed in this study 
and several others before it (Brotherstone et al., 2007; Robb et al., 2008a; Robb et al., 2010a). 
                                                     
8 Estimated by multiplying the cost of a single missed appointment by the number of missed appointments observed 
during the study period. 
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5.5.1 Strengths  
This study had several strengths. First, it used objective measures of confirming and attending 
an appointment, both of which have previously been shown to be more reliable than self-reported 
measures (Baier et al., 2000; Rauscher et al., 2008; Lo et al., 2016). Second, it used a large 
sample that contained a high proportion of individuals from the most ethnically diverse and 
socioeconomically deprived parts of England, meaning that it was possible to examine response 
to the screening invite and uptake in a hard-to-reach population, which is of particular importance 
with regards to developing strategies to reduce inequalities in health (PHE., 2013a; McGregor et 
al., 2015a). Lastly this study was not reliant on the return of study questionnaires, and so it was 
not vulnerable to the inherent risks of these methods of data collection (e.g. missing data, low 
response rates, etc.; Baruch et al., 2008; Sterne et al., 2009). 
5.5.2 Limitations 
As well as several strengths, this study had a number of important limitations. First, this study 
was limited to routine data stored on the BCSS. As such, it was not possible to include other 
potential predictors of responding to the screening invite and attendance at screening (e.g. 
previous bowel symptoms, ethnicity, etc. Wardle et al., 2000; Power et al., 2008; Robb et al., 
2008a). Second, the analytic sample was more deprived than the rest of England (average 2010 
IMD score in analytic sample and England was 24.7 and 21.7 respectively), and a higher 
proportion were from the most ethnically diverse areas (73.9% in the analytic sample compared 
with 20% in the general population). As a result, the findings may not be generalisable to other 
parts of the country, particularly those where the eligible population is less diverse and more 
affluent than the national average (e.g. Surrey; ONS., 2011). Lastly, the census data used to 
assess area-level deprivation and area-level diversity was collected in 2001 (Department for 
Communities and Local Government., 2011). As a result, the measure used may have been 
outdated and become less reliable. 
5.6 Conclusion 
This study found that half of all people invited for screening confirmed their appointment, and that 
a little over 40% attended. The results indicate that there is considerable room for improvement, 
particularly to improve uptake among non-responders, who constitute the largest group of non-
participants at St Mark’s Hospital.   
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Chapter 6. Development of a self-referral reminder and leaflet for 
bowel scope screening non-participants  
6.1 My contributions to the work presented in this chapter 
I conceived the idea for the interventions, planned their development and applied for UCL ethics 
with advice from my supervisors. The self-referral reminder letter and theory-based leaflet were 
co-developed by Resonant: a social marketing company that specialises in health behaviour 
(Resonant., 2015). Initial designs were tested in a co-production workshop led by John Isitt 
(Director of insight, Resonant). I helped conduct the workshop and took notes on the responses 
of participants, which were used to inform future iterations of the study materials. I also carried 
out one-to-one interviews and focus groups with members of the public in the London Boroughs 
of Brent and Harrow to get their views on the revised materials. Resonant were responsible for 
incorporating the advised changes into the intervention materials and produced the final versions 
based on my recommendations. I planned the interviews with input from my supervisors, who 
also gave advice on how to develop the intervention materials from beginning to end.   
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6.2 Introduction 
In the previous chapter, I found that nearly half of all people invited for BSS at St Mark’s Hospital 
did not confirm their appointment, and thereby constituted the largest group of non-participants. 
The aim of this chapter was to develop an intervention strategy to improve BSS uptake among 
this group at St Mark’s Hospital. 
6.2.1 Aims 
The specific aims were to: 1) develop an intervention strategy to promote uptake using the BCW, 
2) obtain feedback on initial intervention materials from residents in Brent and Harrow and, 3) 
revise the content of the intervention materials for assessment in follow-up studies informed by 
the MRC’s guidelines for developing and evaluating complex interventions (see Chapters 7, 8 and 
9). 
6.2.2 Introduction to the Behaviour Change Wheel 
In Chapter 3, I provided a brief overview of the theoretical models that have most frequently been 
applied in research examining bowel cancer screening participation. None stood out as being 
superior, and many suffered from rigid structures that prohibited the inclusion of other known 
correlates of behaviour. In considering which framework for developing interventions to use in this 
thesis then, it made sense to use a framework that had an integrative model of behaviour at its 
core, one that incorporated constructs (if possible) from a range of models, ideally including the 
HBM, TPB and SCT (i.e. the models that had the best evidence to support their use in the context 
of CRC screening behaviours – see Chapter 3). The BCW is one such framework which does 
this.. It was developed by reviewing all of the theoretical frameworks for behaviour change 
identified in a systematic search, and then linking together the relevant components in a way that 
allowed for a comprehensive and systematic approach to intervention design (Michie et al., 2011). 
At its core, the BCW contains the COM-B model (Figure 6-1): an integrative model of behaviour 
that theorises that behaviour is part of an interacting system made up of three components (which 
can be divided into 14 theoretical domains; Michie et al., 2014), which include a person’s 
capability, opportunity and motivation to change (Figure 6-1; Michie et al., 2014). Surrounding this 
is a layer of nine intervention functions to choose from, depending on the COM-B analysis one 
arrives at (i.e. whether it is capability, opportunity, motivation, or a combination of all three which 
need to change in order to achieve the desired behaviour). These nine intervention functions are 
described only in very general terms (e.g. ‘education’, ‘persuasion’, ‘enablement’, etc.), with a 
more specific description of the 93 BCTs having been published separately (Michie et al., 2013). 
The outer layer identifies seven types of policy that one can use to deliver the intervention 
functions (e.g. regulation, legislation, service provision, etc.).  
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Figure 6-1. The Behaviour Change Wheel (Michie et al., 2014). 
 
The key benefit of using the BCW is that it encourages intervention designers to consider the full 
range of intervention options and choose those that are most likely to be successful through a 
systematic evaluation of theory and evidence. It provides a system for making the best use of the 
understanding and resources available to arrive at an intervention strategy (Michie et al., 2014). 
Other frameworks for developing interventions are also available (e.g. MINDSPACE, Intervention 
Mapping, etc. Bartholomew et al., 1998; Dolan et al., 2010), but the BCW is the only framework 
which covers the full range of intervention options available for behavioural interventions (Michie 
et al., 2014). 
6.3 Intervention development  
6.3.1 Step 1: Using the BCW to identify the intervention strategy 
The BCW intervention design process is comprised of eight steps (summarised in Figure 6-2), 
which cover: (1) understanding the behaviour, (2) identifying intervention options and (3) 
identifying implementation options. Collectively, they address the key questions: (1) what is the 
behavioural problem you are trying to solve? (2) what behaviour(s) are you trying to change and 
in what way? (3) what will it take to bring about the desired behaviour change? (4) what types of 
intervention are likely to bring about the desired change? and (5) what should be the specific 
intervention content and how should this be implemented? (Michie et al., 2014).  
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Figure 6-2. The BCW Intervention Design Process (Michie et al., 2011) 
 
As per the BCW intervention design process guidelines (Figure 6-2), I began by defining the 
problem in behavioural terms (i.e. ‘uptake among eligible men and women invited for BSS at St 
Mark’s Hospital is low’ – see Chapter 5; Appendix 6-1), before selecting and specifying the target 
behaviour (i.e. ‘self-referral’; Appendix 6-2 and 6-3 respectively) and identifying what needs to 
change for the target behaviour to occur (i.e. self-referral may be brought about by targeting the 
COM-B constructs: ‘psychological capability’, ‘physical opportunity’, ‘social opportunity’ and 
‘reflective motivation’; Appendix 6-4). Once I arrived at the behavioural diagnosis (i.e. that, to 
facilitate self-referral, psychological capability, physical opportunity, social opportunity and 
reflective motivation needed to change), I was able to identify the intervention functions (i.e. 
‘modelling’, ‘environmental restructuring’, ‘persuasion’, ‘education’ and ‘enablement’; Appendix 6-
5) and policy categories (i.e. ‘marketing and communication’; Appendix 6-6) that would be most 
likely to bring about that change (these were identified using the APEASE criteria, the initials 
stand for ‘Affordability’, ‘Practicability’, ‘Effectiveness and cost-effectiveness’, ‘Acceptability’, 
‘Safety’ and ‘Equity’). A meeting with the London BCSP Hub and St Mark’s Hospital was arranged 
to discuss the practicability of intervention options found to be effective in a review of the literature 
(Chapter 4). Several were dismissed for ethical reasons. For example, the offer of a financial 
incentive to self-refer was dismissed on the basis that it was unfair and went was contra to the 
principles of informed decision making. Others were rejected due to logistical restraints within the 
programme. For example, it was not possible to vary invitation materials, such as the cancellation 
letter, to include interventions that might reduce barriers to self-referral for St Mark’s Hospital 
specifically (i.e. due to the centralised nature of the mailing system). Finally, after identifying the 
relevant and practicable intervention functions and policy categories, I was able to identify 
possible BCTs (i.e. ‘demonstration of the behaviour’, ‘adding objects to the environment’, ‘prompts 
/ cues’, ‘credible source’, ‘information about health consequences’, ‘pros and cons’ and 
‘instruction on how to perform the behaviour’; Appendix 6-7) and modes of delivery (i.e. ‘leaflets’; 
Appendix 6-8) that could be used to achieve the desired behaviour. An overview of the 
intervention design is provided in Table 6-1. The completed worksheets used to arrive at the 
intervention design are provided in the appendix (see appendices 6-1 to 6-8).  
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Table 6-1. Summary of the intervention strategy 
Intervention functions COM-B components served 
by the intervention functions 
Selected BCTs Policy categories through 
which BCTs can be delivered 
Mode of delivery  
Modelling Social opportunity Demonstration of the behaviour 
Adding objects to the 
environment 
Prompts / cues 
Credible source  
Information about health 
consequences  
Instruction on how to perform 
behaviour 
Pros and Cons 
 
Communication / marketing Leaflets 
Environmental restructuring Physical opportunity 
Social opportunity 
Persuasion Reflective motivation 
Education. Psychological capability 
Reflective motivation 
Enablement Psychological capability 
Physical opportunity 
Social opportunity 
9
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6.3.2 Step 2: Establishing the leaflet content 
Having identified the intervention strategy (i.e. using the BCTs ‘demonstration of behaviour’, 
‘adding objects to the environment’, ‘prompts / cues’, ‘credible source’, ‘information about health 
consequences’, ‘instructions on how to perform the behaviour’ and ‘pros and cons’ to modify 
‘social opportunity’, ‘reflective motivation’, ‘psychological capability’, and ‘physical opportunity’; 
see Table 6-1) and the mode of delivery (i.e. leaflets; see Table 6-1), the next step was to develop 
the content for the intervention materials. This was done by: 1) literature review of the barriers 
and benefits of BSS (i.e. ‘pros and cons’), 2) interviewing previously screened adults to obtain 
testimonials ‘demonstrating the behaviour’ and, 3) contacting local GP Cancer Leads to provide 
a primary care endorsement (i.e. ‘credible source’). The following provides a brief overview of 
these activities and the way in which they were performed. 
6.3.2.1 Identifying the perceived barriers and benefits of BSS 
Studies were selected for review on the basis that they examined the barriers and benefits to BSS 
(as opposed to other modalities or CRC screening generally) and were published after 1997 
(findings from prior to this were obtained from Vernon’s 1997 review of the literature on barriers 
to CRC screening, which included a breakdown of the barriers to screening by test). Appendix 6-
9 provides an overview of the reviewed papers. 
6.3.2.2 Obtaining testimonials from BSS participants 
Testimonials were obtained from previous BSS participants (see Appendices 6-10 and 6-11). 
These individuals had been recruited via St Mark’s BCSC (see Appendix 6-12). Permission to 
use their quotes for the purposes of the leaflet were obtained accordingly (see Appendix 6-13 for 
a copy of the interview schedule and Appendix 6-14 for a copy of the consent form). The quotes 
used are given below. 
“I must admit I was nervous, but the specialist nurse explained everything very clearly. It wasn’t 
painful at all. I was told I had no polyps and given the all clear, which was a huge relief. My 
friend died from bowel cancer five years ago, so I was determined this wouldn’t happen to me!” 
“The staff at St Mark’s Hospital were great. The doctor found a polyp, which he removed. I didn’t 
feel a thing. The doctor explained that polyps often don’t have any symptoms, so people don’t 
always know if they have them. I’m glad they found the polyp before it had a chance to become 
something more serious” 
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6.3.2.3 Obtaining a primary care endorsement 
The GP Cancer Lead for the Northwest London Borough of Hillingdon agreed to endorse the 
BSSP (see Appendix 6-15). The quote used within the leaflet is given below. 
“I would urge anyone aged 55 to 59 to take this quick, potentially lifesaving, one-off test that 
significantly reduces your risk of getting bowel cancer.” 
6.3.3 Step 3: Incorporating a prompt / cue 
A prompt / cue was added to the intervention strategy by developing a ‘self-referral’ reminder 
letter alongside which the leaflet could be delivered to non-responders. The specification for the 
reminder letter was such that it encompassed the remaining three BCTs recommended by the 
BCW (see 6.3.1 Using the BCW to identify the intervention strategy), namely: ‘instructions on how 
to perform the behaviour’ (see 6.3.3.1 Instruction on how to perform the behaviour), ‘adding 
objects to the environment’ (see 6.3.3.2 Adding objects to the environment), and ‘information 
about health consequences’ (see 6.3.3.3 Information about health consequences).  
On the basis that the timing of interventions can have a positive effect if they coincide with annual 
milestones (e.g. birthdays; Hoff and Bretthauer, 2008), the self-referral reminder was designed to 
be sent one year after the initial invitation. A ‘follow-up’ reminder letter was also developed to 
supplement the self-referral reminder letter (previous research has shown that additional 
reminders can have benefits over and above reminders used in isolation; see Chapter 4).  
The specification for the follow-up reminder letter was the same as the self-referral reminder letter 
(see above). It was to be designed to be sent four weeks after the self-referral reminder. This was 
a pragmatic decision, one intended to give people enough time to respond to the self-referral 
reminder without feeling harassed. 
6.3.3.1 Instructions on how to perform the behaviour 
Instructions on how to self-refer for BSS were provided by the clinical programme manager at St 
Mark’s BCSC (see Appendix 6-16 for an excerpt from the final reminder letter).  
6.3.3.2 Adding ‘objects’ to the environment 
Several ‘objects’ or facilitators were added to the reminder letters to help initiate self-referral. First, 
an ‘appointment-request slip’ was added to the reminder letter (see Appendix 6-17). The slip 
included options for the preferred time and day of the appointment and the gender of the 
practitioner performing the test (both of which [i.e. the day and time of the appointment and gender 
of the practitioner performing the test] have previously been cited as barriers to uptake;  
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see Appendix 6-9 for an overview of the perceived barriers and benefits of BSS). Second, I added 
a Freepost return envelope addressed to St Mark’s BCSC to the intervention package. Lastly, a 
map with instructions on how to get to the centre was also included (this was contained with the 
information leaflet as opposed to the reminder letter; see Appendix 6-18 for an excerpt from the 
final leaflet). This was added to help people plan their journey to the hospital (to overcome a 
commonly endorsed barrier to attendance; see Appendix 6-9 for an overview of the perceived 
barriers and benefits of BSS). 
6.3.3.3 Information about health consequences 
Information about the health consequences of attending BSS (i.e. reduced risk of CRC incidence 
and reduced risk of CRC death) was obtained from the most recent evidence available at the time 
(i.e. Elmunzer et al., 2012; see Appendix 6-19 for an excerpt from the drafted reminder letter). 
See Table 6-2 for an overview of the intervention strategy, descriptions of the BCTs used and 
examples of their use in the draft intervention materials developed.
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Table 6-2. Overview of the intervention strategy 
BCT Definition Examples of use  
Pros and Cons Advise the person to identify reasons for wanting (pros) 
or not wanting (cons) to change behaviour 
A list of the benefits of BSS was added to the leaflet (see 
Appendices 6-20).  
Demonstration of the 
behaviour 
Provide an observable sample of the performance of 
the behaviour, directly in person or indirectly (e.g. via 
film, pictures) for the person to aspire to or imitate. 
Testimonials of people who had performed the behaviour were 
added to the leaflet (see Appendices 6-10 and 6-11). 
Credible source Present verbal or visual communication from a credible 
source in favour or against the behaviour 
A primary care endorsement from the GP Cancer Lead endorsing 
the NHS BSSP was added to the leaflet (see Appendix 6-15). 
Prompts / cues 
 
Introduce or define environmental or social stimulus 
with the purpose of prompting or cueing the behaviour. 
The prompt or cue would normally occur at the time or 
place of performance. 
A prompt was added to the intervention strategy by developing a 
‘self-referral’ reminder letter and a ‘follow-up’ reminder letter (see 
Templates 1 and 3 at the end of this chapter). 
Instruction on how to perform 
a behaviour 
Advise or agree on how the to perform behaviour. Instructions on how to self-refer for BSS were added the reminder 
letter (see Appendix 6-16 for an excerpt from the self-referral 
reminder letter). 
Adding objects to the 
environment 
Add objects to the environment in order to facilitate 
performance of the behaviour 
Several ‘objects’ or facilitators were added to the s reminder 
letters, including an ‘appointment-request slip’ and Freepost 
return envelope (see Appendix 6-17). 
Information about health 
consequences  
Provide information (e.g. written, verbal, visual) about 
health consequences of performing the behaviour 
Information about the health consequences of BSS (e.g. reduced 
risk of CRC incidence and death) was added to the reminder 
letters (see Appendix 6-19). 
9
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6.3.4 Step 4: Development of initial versions 
6.3.4.1 First drafts in collaboration with a social marketing team 
Initial versions of the intervention materials were developed by the behavioural insights team of a 
social marketing company (Resonant). I sent them a briefing document outlining the intervention 
strategy described above (see Appendix 6-21), alongside draft content to be used for the reminder 
letters. They prepared draft versions of the materials based on the specified criteria for which 
they: 
1) Based the colour scheme and typography around St Mark’s Hospital’s branding. 
 
2) Chose images representative of a diverse population, so as to reflect and engage 
respective members of the audience. 
 
3) Used a conversational tone to introduce a social presence to the information. 
 
4) Used formatting to divide the content of the leaflet into focussed sections (e.g. a ‘benefits 
of the bowel scope screening test’ section, a ‘polyps and cancer’ section), using sub-
headings to help people navigate the text. 
A meeting was held to review the materials. Adjustments were made to make the language: 1) 
less promotional and, 2) more accurate (e.g. saying that: ‘most people say they felt no pain or 
only mild pain’ as opposed to ‘no discomfort or only mild discomfort’). 
6.3.5 Step 5 – Review of draft materials 
6.3.5.1 Public engagement 
Initial designs of the reminder letter and leaflet were tested in a co-design workshop (facilitated 
by myself and Resonant) in which screening eligible adults from the London Boroughs of Brent 
and Harrow (n = 4; three male, one female; ages 55–58) gave feedback to inform future iterations 
of the materials (see Appendix 6-22 for a copy of the co-design workshop guide and Appendix 6-
23 for the workshop report). To collect feedback on the revised materials, I conducted a series of 
face-to-face interviews and focus groups with members of the public (n = 20). The purpose of 
these was to obtain an informal review of the intervention materials to ensure their acceptability 
and that there were no obvious problems with the materials. 
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Participants (n = 20) were representative of screening-eligible candidates (12 female, eight male, 
aged 50–59 years) and were from a range of ethnic backgrounds reflective of Brent and Harrow. 
Interviewees were encouraged to give their first impressions and interpretations and 
understanding of the information provided (see Appendix 6-24 for the interview schedule and 
Appendices 6-25 and 6-26 for the relevant approvals from UCL’s joint research office, JRO). They 
were also prompted to provide feedback on the: i) acceptability of the imagery and format, ii) 
readability and clarity of the wording, iii) communicative effectiveness, iv) amount of information 
provided and v) acceptability of different terminology (see Appendix 6-27 for a copy of the consent 
form).  
6.3.5.2 Revisions and development 
Intervention materials were edited and revised according to the feedback received from the 
members of the public interviewed. Examples of the feedback received include: 1) the preventive 
benefits of the test should be emphasised throughout the letter and leaflet, 2) images should 
better reflect the ethnicity of individuals living in Brent and Harrow, 3) the letter should be on NHS 
letter-headed paper, 4) materials should be written as simply as possible, 5) the layout, colour 
scheme and use of quotes was liked and, 6) that the leaflet should include details on public 
transport links to the screening centre. The final materials were revised by the social marketing 
company and approved by the UCL research team and clinical programme manager prior to 
evaluation in studies informed by the MRC guidelines for developing and evaluating complex 
interventions9 (see Figure 6-3; Craig et al., 2008). 
                                                     
9 The MRC framework for developing and evaluating complex interventions goes beyond the development of interventions 
(covered by the BCW) to provide guidance on their subsequent implementation and evaluation (Craig et al., 2008). The 
guidelines are often used in medicine for informing the development and evaluation of novel treatments. 
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Figure 6-3. Key elements of the development and evaluation process (Craig et al., 2008). 
 
 
 
 
 
 
 
 
 
6.3.6 Summary of the final intervention materials 
Self-referral reminder letter: The final version of the cover letter for the self-referral reminder 
was a personally addressed letter from St Mark’s Hospital which: 1) invited individuals to make a 
screening appointment by returning an ‘appointment-request-slip’ or by calling the Freephone 
telephone number for the centre; 2) reminded them that they had previously been invited for an 
appointment and were eligible to self-refer up until their 60th birthday; 3) gave participants the 
opportunity to select a preference for the day and time of the appointment and the gender of the 
practitioner performing the test and; 4) highlighted 3 key messages: i) that the risk of developing 
bowel cancer is highest in the recipient’s age group (55+ years), ii) screening is for people who 
do not have any signs or symptoms of bowel cancer and iii) screening can help prevent bowel 
cancer by removing polyps (Template 1).  
Theory-based leaflet: The leaflet re-iterated key points mentioned in the self-referral reminder 
letter and was tailored to the London areas served by St Mark’s Hospital (e.g. included a map 
with information about local transport links to the hospital, included photographs of individuals 
reflective of the London Boroughs of Brent and Harrow, etc.). The leaflet also included an 
educational / knowledge-building component to reinforce messages regarding the benefits of 
screening (effectiveness and rationale), a descriptive social norms message outlining uptake of 
BSS at St Marks’ Hospital (i.e. ‘270 people screened every month’), and several practical 
components designed to improve self-efficacy (e.g. instructions on how to book an appointment 
and directions to the hospital). 
Feasibility/piloting 
1 Testing procedures 
2 Estimating recruitment/retention 
3 Determining sample size 
Evaluation 
1 Assessing effectiveness 
2 Understanding change process 
3 Assessing cost-effectiveness 
Implementation 
1 Dissemination 
2 Surveillance and monitoring 
3 Long term and follow-up 
Development 
1 Identifying the evidence base 
2 Identifying the theory 
3 Modelling process and outcomes 
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Follow-up reminder: The follow-up reminder repeated key information included in the self-
referral reminder letter (see Template 3). 
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Template 1. Self-referral reminder letter (Page 1 of 2) 
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Template 1. Self-referral reminder letter (Page 2 of 2) 
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Template 2. Theory-based leaflet (a5, outer pages)  
  
1
0
5
 
C
h
a
p
te
r 6
. D
e
v
e
lo
p
m
e
n
t o
f a
 s
e
lf-re
fe
rra
l re
m
in
d
e
r a
n
d
 le
a
fle
t fo
r b
o
w
e
l s
c
o
p
e
 s
c
re
e
n
in
g
 n
o
n
-p
a
rtic
ip
a
n
ts
 
 
Chapter 6. Development of a self-referral reminder and leaflet for bowel scope screening non-participants 
 
106 
 
Template 2. Theory-based leaflet (a5, inner pages)  
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Template 3. Follow-up reminder letter (Page 1 of 2) 
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Template 3. Follow-up letter (Page 2 of 2) 
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6.4 Summary 
This chapter described the development of a ‘12-month’ self-referral reminder letter and theory-
based leaflet. The strategy was informed by the BCW, which was used to identify: 1) psychological 
capability, physical opportunity, social opportunity and reflective motivation as putative targets for 
change and; 2) the specific BCTs (i.e. Demonstration of the behaviour, adding objects to the 
environment, prompts / cues, credible source, information about health consequences, instruction 
on how perform behaviour and pros and cos) likely to be effective in promoting uptake. The 
development was further enhanced by a literature review and the presence of additional 
stakeholders, i.e. a social marketing company, the screening centre and members of the public, 
which allowed me to develop and refine iterations of the initial prototype. In the next chapter, I 
present a feasibility study exploring the practicality of delivering these reminders. The chapter 
comprises the next step in the MRC guidelines for developing and evaluating complex 
interventions.  
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Chapter 7. Evaluating the feasibility of the self-referral reminder 
and theory-based leaflet (Study 2)10 
7.1 My contributions to the work presented in this chapter 
I conceived the idea for the study and wrote the trial protocol with input from my supervisors 
(Christian, Jane and Lesley), Ms Sarah Marshall (Clinical Programme Manager, St Mark’s BCSC) 
and Ms Lorraine Gorman (Deputy Programme Manager, St Mark’s BCSC). I wrote the ethics 
application and calculated the sample size for the study after receiving statistical advice from Mr 
Nick Counsell (Medical Statistician, UCL) confirming the appropriateness of my proposed 
calculation plans. Mr Tark Elouihrani (Data Analyst, London Bowel Cancer Screening Hub) was 
responsible for identifying eligible adults from the BCSS. Shaila Kumar was responsible for 
maintaining the study database, delivering the reminders and anonymising and transferring the 
data at the end of the study. I coded the data and derived the values for area-level deprivation, 
which were later matched to individuals within the dataset (by Shaila Kumar) using unique 
participant study IDs. I analysed the data, after receiving statistical advice on the appropriateness 
of my proposed analysis plans from Nick Counsell. I also interpreted the results with input from 
my supervisors and led on the publication of the manuscript (Kerrison et al., 2016). All of the co-
authors contributed to the interpretation of the results.   
                                                     
10 A version of this Chapter, entitled: ‘Use of a 12 months’ self-referral reminder to facilitate uptake of bowel scope (flexible 
sigmoidoscopy screening) in previous non-responders: a London-based feasibility study’ has been published in the British 
Journal of Cancer (see Appendix 7-1 for the published manuscript) 
 
Reference: Kerrison RS, McGregor LM, Marshall S, Isitt J, Counsell N, Wardle J, von Wagner C (2016) Use of a 12 
months' self-referral reminder to facilitate uptake of bowel scope (flexible sigmoidoscopy) screening in previous non-
responders: a London-based feasibility study. Brit J Cancer. 114(7): 751-758 
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7.2 Introduction 
In the previous chapter, I developed a self-referral reminder, follow-up reminder and theory-based 
leaflet to improve uptake at St Mark’s Hospital in London. In this chapter, I examine the feasibility 
of sending these interventions to individuals who do not take part in screening within 12 months 
of receiving their initial invitation. 
7.2.1 Aims 
The primary aims of this study were to: 1) test the feasibility of sending previous non-responders 
a self-referral reminder letter and theory-based leaflet 12 months after their initial invitation and; 
2) assess whether the strategy met a basic level of efficacy that merited further investigation in a 
formal RCT (one of the possible next steps in the MRC guidelines for developing and evaluating 
complex interventions). The secondary aims were to: 1) explore gender preferences for a same-
sex practitioner among self-referrers; 2) explore variation in uptake by baseline characteristics 
and; 3) assess whether the follow-up reminder sent four weeks after the self-referral reminder 
added to this strategy. A review of the methods and process employed was included to help refine 
the strategy of any subsequent RCT.  
7.3 Methods 
7.3.1 Study design  
This study was a single-centre feasibility study with one trial arm. 
7.3.2 Study population and setting 
Eligible adults were men and women registered with a general practice within the London 
Boroughs of Brent and Harrow, who had not attended a BSS appointment within 12 months of 
their initial invitation. Individuals who originally confirmed their appointment, but did not attend, 
were excluded from the study to minimise confounding. 
7.3.3 Identification  
Eligible adults were identified on the BCSS by a member of the direct care team at the London 
Bowel Cancer Screening Hub (hereafter referred to as ‘the Hub’). The data were extracted one 
week prior to the beginning of the study (September 2014) following a formal data request from 
the clinical programme manager at St Mark’s BCSC, who asked the Hub to identify individuals 
invited for BSS at St Mark’s Hospital between September and November 2013 (i.e. 12 months 
before the study start date). The request specified that individuals should be excluded if they: (1) 
were no longer registered with a general practice within Brent and Harrow, (2) confirmed their 
initial appointment, but then did not attend, (3) currently had an appointment booked at the 
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screening centre, (4) were registered on the BCSS as ‘deceased’, or (5) had attended a BSS 
appointment since they were first invited one year ago. An overview of the data specification is 
presented in Table 7-1. 
Table 7-1. Data specification from St Mark’s BCSC to the Hub 
Variable Reason for request 
NHS Number Required for mail out 
Title Required for mail out 
First Name Required for mail out 
Middle Name(s) Required for mail out 
Last Name Required for mail out 
Address Required for mail out 
Postcode Required for mail out 
Initial invite date Required for mail out 
Gender Important baseline characteristic 
CCG Important baseline characteristic 
Initial episode status Important exclusion criteria 
Current episode status Important exclusion criteria 
Date of initial appointment Important exclusion criteria 
 
7.3.4 Enrolment 
Eligible adults were enrolled into the study over a 10 week period spanning from September to 
November 2014. On the basis that there was capacity to facilitate an additional five appointments 
each week, and the impact of the interventions on self-referral was unknown, the clinical 
programme manager at St Mark’s BCSC limited the number of eligible adults who could be 
enrolled into the study each week. As a result, not all eligible adults (i.e. previous non-responders) 
were included in the study, and individuals were randomly selected for inclusion from a variable 
weekly total of previous non-responders based on their initial invitation date. This was done using 
blocked pseudo-random selection methods, with non-participants blocked according to the week 
they received their initial invitation, and a subset (n = 16) randomly selected for inclusion in the 
study (Efird., 2010). 
7.3.5 Procedures  
Individuals included in the study were mailed a self-referral reminder letter, theory-based leaflet, 
appointment-request-slip and Freepost return envelope (addressed to St Mark’s BCSC) 12 
months after their initial invitation (Figure 7-1). Recipients were able to book an appointment either 
by returning the appointment-request-slip to the centre (thereby initiating a call from a member of 
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the administrative team), or by calling the centre directly on the Freephone telephone number 
provided. Responders were also able to indicate a preference for the gender of the practitioner 
performing the test, as well as the day and time of the appointment, either by selecting options 
on the appointment-request-slip, or when prompted during their call (administrative staff were 
given instructions to provide these options by the clinical programme manager).  
Anyone not responding to the self-referral reminder within four weeks was sent the follow-up 
reminder, which also included an appointment-request-slip, the theory-based leaflet and a 
Freepost return envelope. Individuals were then given a further eight weeks to respond. At this 
time, their attendance status was assessed by the health improvement specialist at the centre 
(using routine data stored on the BCSS) and added to the study database. Any self-referrals made 
after this time were not included in the study results, but were still fulfilled by St Mark’s BCSC. 
Individuals who self-referred for the test received a pre-appointment text-message reminder and 
telephone call, as per routine practice at St Mark’s BCSC. During the telephone call, the specialist 
screening practitioner: 1) confirms receipt of the bowel preparation (i.e. an enema with instructions 
for use), 2) elicits whether the individual would prefer to receive assistance with administering the 
enema at the hospital (i.e. rather than self-administering the enema in their own home) and, 3) 
reminds the individual that they should bring their consent form to the appointment. 
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Figure 7-1. BSS invitation flowchart with self-referral reminder added 
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7.3.6 Intervention details 
Detailed descriptions of the self-referral reminder, follow-up reminder and theory-based leaflet 
used in this study are provided in the previous chapter (i.e. Chapter 6). 
7.3.7 Consent procedures 
For those individuals who made an appointment, a confirmation letter and consent form were sent 
to their home address. The confirmation letter and consent form sent were the same as those 
used for routine appointments (see Appendices 2-7 and 2-10 respectively). Participants were 
asked (within the confirmation letter) to read the consent form (which contained important 
information regarding the risks of the procedure) before attending their appointment, and to call 
the screening centre if they had any questions. Participants were also asked (again, within the 
confirmation letter) to bring the consent form to their appointment, where a specialist screening 
practitioner would discuss the risks of the procedure before the appointment took place (see 
Chapter 2).  
7.3.8 Measures  
7.3.8.1 Gender and CCG 
Data on the gender and CCG of each person were extracted from the BCSS as part of the initial 
extraction performed by the Hub (see Table 7-1). 
7.3.8.2 Area-level deprivation 
I converted each person’s home postcode address into a score on the 2010 IMD using 
Geoconvert (see Chapter 5). I then categorised the scores into quintiles of the regional distribution 
to compare uptake between individuals living in the most and least deprived areas of Brent and 
Harrow. To ensure people were not identifiable during the conversion, postcodes were 
pseudonymised by a member of the direct care team at St Mark’s BCSC, who merged the 
converted data with the study database using a unique participant ID number contained within 
both datasets (this was deleted once the data had been merged, so that postcodes could not be 
retrospectively identified). 
7.3.8.3 Method of self-referral 
The method of self-referral (i.e. return of a slip or call to the centre) was added to the study 
database as the study progressed. Members of the administrative team at St Mark’s BCSC were 
informed of the study and were given instructions by the clinical programme manager to keep a 
record of any individuals who self-referred (and the method by which they did so) on the BCSS. 
As there was no entry field for the method of self-referral on the BCSS, the method of self-referral 
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was recorded in each individual’s ‘episode notes’ (on the BCSS), where details of patient-centre 
contact are routinely recorded using free-text (personal communication). These data were then 
extracted from the BCSS by the health improvement specialist responsible for maintaining the 
study database at St Mark’s BCSC. This was done on a weekly basis, four and 12 weeks after 
each person was sent their self-referral reminder (i.e. when the health improvement specialist 
checked the self-referral and attendance status of each person; see 7.3.8.6 Self-referral and 
attendance). 
7.3.8.4 Preferred gender of the practitioner and time and day of the appointment 
As with the method of self-referral (see 7.3.8.3 Method of self-referral), people’s preferences for 
the gender of the practitioner performing the test and the time and day of the appointment were 
added to the study database as the study progressed. Again, members of the administrative team 
at St Mark’s BCSC were asked by the clinical programme manager to record on the BCSS 
whether individuals who self-referred for an appointment expressed a preference for the gender 
of the practitioner and the time and day of the appointment. As with the method of self-referral, 
no entry field exists on the BCSS for the preferred gender of the practitioner, or the time and day 
of the appointment, and so this information was recorded within each individual’s episode notes 
(see 7.3.8.3 Method of self-referral). These data were then extracted from the BCSS by the health 
improvement specialist. This too was done on a weekly basis, four and 12 weeks after each 
person was sent a self-referral reminder (see 7.3.8.6 Self-referral and attendance). 
At the end of the study, when all of the data had been collected and pseudonymised, I converted 
the ‘preferred sex of the practitioner’ into ‘preference for a same-sex practitioner’, with outcomes 
‘yes’ and ‘no’ by comparing whether the preferred sex of the practitioner matched the gender of 
the person invited for screening. Differences between genders were then assessed using 
statistical methods (see 7.3.11 Analysis). 
7.3.8.5 Offered gender of the practitioner and time and day of the appointment 
The gender of the practitioner and the time and day of the appointment offered to each person 
who self-referred for screening were recorded on the BCSS and added to the study database in 
the same way as people’s preferences for these variables (see 7.4.8.4 Preferred gender of the 
practitioner and time and day of the appointment). The administrative staff at St Mark’s BCSC 
were instructed by the clinical programme manager to keep a record of these details in the BCSS 
episode notes, just as they had for people’s preferences. The health improvement specialist then 
added these details to the study database when checking the self-referral and attendance status 
of each person four and 12 weeks after they were sent a self-referral reminder (see 7.3.8.6 Self-
referral and attendance). 
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At the end of the study, when all of the data had been collected and pseudonymised, I converted 
the ‘preferred gender of the practitioner’ and the ‘gender of the practitioner offered’ into ‘received 
gender preference’, with outcomes ‘yes’ and ‘no’, by comparing whether each person’s preferred 
practitioner gender matched the gender of the practitioner offered. I did the same with the 
‘preferred day and time of the appointment’ and the ‘time and day of the appointment offered’ to 
derive ‘offered the preferred gender of the practitioner’ with response options ‘yes’ and ‘no’. The 
proportion of people who then received their preferences were then assessed using descriptive 
statistics (see 7.3.10 Analysis) as part of the review of the methods employed. 
7.3.8.6 Self-referral and attendance 
Self-referral and attendance were verified by the health improvement specialist at St Mark’s BCSC 
four weeks following the delivery of the self-referral reminder and eight weeks following the 
delivery of the follow-up reminder. The first assessment was carried out to establish which 
individuals had already self-referred / attended, and therefore were not eligible to receive a follow-
up reminder. The second assessment was carried out to determine the ‘end of study’ attendance 
status for each individual.  
7.3.9 Power calculation 
The power of the study to detect a minimum level of efficacy was calculated using exact methods 
based on the binomial distribution (A’Hern., 2001). Exact methods indicated that the sample size 
(n = 160) provided sufficient levels of statistical power (β = 0.015) and confidence (α = 0.018) to 
test for a five percentage point increase in uptake, with an unacceptable response rate of 0.35%, 
and a desired response rate of 5.35% (Table 7-2).  
Table 7-2. Power calculation overview 
P0 P1 Alpha Beta R+1 n 
0.0035 0.0535 0.018 0.015 3 160 
P0 = expected uptake for a poor intervention 
P1 = expected uptake for a good intervention 
R+1 = the minimum number of self-referred appointments required to merit further investigation in a RCT 
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7.3.9.1 Expected uptake 
The unacceptable response rate was based on the response rate of non-responders during the 
previous year (0.35%), and the desired response rate on a five percentage point improvement 
thereof. The decision to test for a five percentage point improvement in self-referral was made by 
the clinical programme manager, who indicated that a five percentage point improvement in 
uptake among non-responders would equate to a three percentage point increase in uptake11, 
which would be operationally significant. 
7.3.10 Analysis 
Descriptive statistics were used to describe the trial population, assess the proportion of 
individuals who received their appointment preferences, and determine whether the number of 
self-referred appointments exceeded the threshold for further investigation in a RCT (R+1 = 3). 
Univariable and multivariable binary logistic regression were used to investigate possible 
associations between baseline characteristics and uptake (Engel., 1988). Differences in people’s 
preferences for a same-sex practitioner were examined by gender using a standard test of 
difference between proportions (Pearson., 1900). The data were assessed on an intention-to-
treat basis using SPSS (version 24).  
7.3.11 Ethical approval, research governance and trial sponsorship 
The study was approved by the UCL JRO (reference: 14/0532) on the 1st of August 2014 
(Appendices 7-2 and 7-3), the North East Tyne and Wear South Research Ethics Service (Ref: 
14/SC/0088) on the 1st of September 2014 (Appendices 7-4 and 7-5), and the Northwest London 
Hospitals Research and Development (R and D) group (Ref: RD14 / 088) on the 22nd of 
September 2014 (Appendix 7-6).  
7.4 Results  
7.4.1 Sample characteristics 
This study took place between September and November 2014, with follow-up until January 2015. 
A total of 160 adults were randomly selected for inclusion in the study, the majority of which were 
female (n = 89, 55.6%) and registered with a general practice within Harrow (n = 83, 51.9%). 
Table 7-3 describes the basic attributes of the study participants. Figure 7-2 provides an overview 
of the flow participants through the study as it progressed. 
  
                                                     
11 Estimated by multiplying the proportion of people who do not take part in screening (i.e. 0.6) by the response rate for a 
good intervention (i.e. 0.05). 
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Table 7-3. Sample characteristics 
 n % 
Gender 
    Male 71 44.4 
    Female 89 55.6 
CCG 
    Brent 77 48.1 
    Harrow 83 51.9 
Tertile of deprivation (IMD Score) 
    Tertile 1 (Most deprived) 
    (27.51 – 80.00) 
68 42.5 
    Tertile 2 (Median deprived) 
    (17.69 – 27.50) 
42 26.3 
    Tertile 3 (Least deprived) 
    (0.00 – 17.68) 
50 31.3 
Abbreviations: CCG, Clinical Commissioning Group; IMD, Index of Multiple deprivation 
 
  
Chapter 7. Evaluating the feasibility of the self-referral reminder and theory-based leaflet (Study 2) 
 
120 
 
Figure 7-2. Flow of participants through the study  
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7.4.2 Uptake  
In total, 25 (15.6%) people attended a BSS appointment (Table 7-4). A further five (3.1%) self-
referred, but either did not attend (n = 3) or cancelled (n = 2), leaving 130 (81.3%) adult men and 
women who did not self-refer or attend an appointment.  
The results of the univariable and multivariable regression are presented in Table 7-4. There were 
no significant differences in uptake between men and women, CCGs, or tertiles of area-level 
deprivation (all Ps > 0.05; Table 7-4).  
 Table 7-4. Uptake by baseline characteristics (Univariable and multivariable regression) 
Comparisons 
Uptake  
n (%) 
Unadjusted OR  
(95% CI) 
Adjusted OR1 
(95% CI) 
Overall (n = 160) 
25 
(15.6) 
- - 
Gender 
Malea  
(n = 71) 
7 
(9.9) 
- - 
Female 
(n = 89) 
18 
(20.2) 
2.32 
(0.91 - 5.91) 
2.39 
(0.93 - 6.16) 
CCG 
Harrowa  
(n = 77) 
13 
(16.9) 
- - 
Brent  
(n = 83) 
12 
(14.5) 
0.83 
(0.35 - 1.96) 
0.86 
(0.28 - 2.58) 
Tertile of deprivation 
Tertile 1a  
Most deprived (n = 68) 
10 
(14.7) 
- - 
Tertile 2 
Median deprived (n = 42) 
7 
(16.7) 
0.91 
(0.33 - 2.49) 
0.96 
(0.27 - 3.49) 
Tertile 3  
Least deprived (n = 50) 
8 
(16.0) 
0.86 
(0.30 - 2.47) 
0.81 
(0.24 - 2.71) 
Abbreviations: OR, Odds ratio; CI, Confidence Interval; CCG, Clinical Commissioning Group; IMD, Index of Multiple 
deprivation 
1Adjusted ORs and 95% CIs are adjusted for all other covariates in the table. 
aReference group 
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7.4.3 Reminder process evaluation 
Self-referral method: The majority of people self-referred for an appointment (n = 28, 93.3%) by 
returning an appointment request slip in the Freepost envelope provided. The remainder (n = 2, 
6.7%) did so by calling the screening centre directly on the Freephone telephone number provided 
in the letter / leaflet.  
Follow-up reminder: The majority of people who self-referred for an appointment (n = 21, 70%) 
did so within four weeks of being sent a self-referral reminder. The remainder (n = 9, 30%) self-
referred after being sent the follow-up reminder. No responses were received beyond the 12 week 
cut-off period. 
Preferences for the day and time of the appointment: Of the thirty men and women who self-
referred for a BSS appointment, 24 (80%) expressed a preference for the day and / or time of the 
appointment. It was not possible to accommodate preferences for 12 people (50%). Only one 
cancelled because they could not schedule an appointment that suited them.  
Preferences for the gender of practitioner performing the test: Of those who self-referred for a 
BSS appointment, 27 (90%) indicated a preference for a same-sex practitioner, none indicated a 
preference for a practitioner of the opposite sex, and three (10%) gave no preference. It was not 
possible to accommodate the preference of eight (30%) individuals. No-one asked to be 
rescheduled or cancelled because of this.  
When examined by gender, women were significantly more likely to express a preference for a 
same-sex practitioner, with 100% of women who self-referred for an appointment expressing a 
preference for a same-sex practitioner, compared with only two-thirds of men (100% vs 67%; 
2=7.78, P < 0.05; Table 7-5).  
Table 7-5. Patient preferences for a same-sex practitioner by gender  
 
Female 
(n = 21) 
Male 
(n = 9) 
Difference 
2 
Indicated preference, n (%) 
Requested same-sex 
practitioner 
21 
(100) 
6 
(66.7) 
 
 
7.78* 
No preference 
0 
(0) 
3 
(33.3) 
*P < 0.05. 
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7.5 Discussion 
This study was initiated to test the feasibility and potential efficacy of incorporating a mailed self-
referral reminder into the current BSS invitation process at St Mark’s Hospital. The results show 
that, when sent with the theory-based leaflet developed in Chapter 6, the self-referral reminder 
resulted in self-referral and uptake in 16% of individuals, and thereby exceeded the threshold for 
further investigation in a formal RCT (n = 25 vs. n = 3). In addition, the results show that the 
additional appointments were easy to facilitate, with most people receiving their preferred 
practitioner gender and time and day of appointment (only one person cancelled as a result of not 
being able to book a convenient appointment). 
The finding that the interventions examined in this study met and exceeded the required level of 
efficacy is highly important. If the findings were replicated in a definitive RCT, then this simple 
intervention could have a considerable impact on BSS participation at St Mark’s Hospital. Indeed, 
a 16% increase in self-referral and attendance among previous non-responders would equate to 
an overall increase in uptake of approximately eight percentage points12, which would increase 
the overall uptake of BSS at St Mark’s Hospital from 40.5%, to almost 50% (five percentage points 
higher than the national average; McGregor et al., 2015a). It is important now not only to test the 
self-referral reminder against usual care in a RCT, but to examine the ADR among individuals 
who are screened in response to the reminder. If similar to the rate observed among those who 
attend the initial appointment (i.e. 9.8%; Bevan et al., 2014), the introduction of a self-referral 
reminder at St Mark’s Hospital might not only increase uptake, but have a considerable impact 
on the incidence and mortality of CRC in the local population as well (Geurts et al., 2015).  
In contrast to previous research (Senore et al., 1996; Sutton et al., 2000; McGregor et al., 2015a), 
the present study found that more women attended an appointment in response to the self-referral 
reminder than men (20% of women attended an appointment, compared with only 10% of men). 
One possible explanation for this is that the gender of the practitioner performing the test is a 
more important barrier for women than men (Varadarajulu et al., 2002; Farraye et al., 2004; 
Menees et al., 2005; Schneider et al., 2009), one which was directly and explicitly addressed by 
allowing individuals to communicate a preference for the gender of the practitioner performing the 
test (women were more likely to express a preference for a same-sex practitioner than men). This 
effect may have been exacerbated by the ethnic diversity of the area in which this study was 
conducted. Previous research has shown that the gender of the practitioner performing the test 
is a more pertinent barrier to FS screening for Black and Minority Ethnic (BME) group women 
(Varadarajulu et al., 2002), and the women included in this study were invited from some of the 
most ethnically diverse parts of the country (see Chapter 5).  
                                                     
12 Estimated by multiplying the proportion of adults not responding to the initial invitation [0.5] by the proportion of adults 
attending screening in response to the 12-month reminder [0.16]. 
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7.5.1 Strengths 
This study had several strengths. First, it used objective measures of self-referral and uptake, 
both of which have previously been shown to be more reliable than self-reported measures (Baier 
et al., 2000; Rauscher et al., 2008; Lo et al., 2016). Second, the data were analysed on an 
intention-to-treat basis, which is ecologically superior to the per-protocol method of analysis 
(Newell., 1992; Detry and Lewis., 2014; Abraha et al., 2015). Lastly, the study was conducted 
within an organised screening programme, as opposed to a trial setting. As such, the data were 
not vulnerable to demand characteristics or social desirability bias, both of which have previously 
been shown to affect the ecological validity of quantitative research studies (Podsakoff et al., 
2003). 
7.5.2 Limitations 
As well as several strengths, this study had a number of important limitations. First, it was 
performed at a single centre in London, and as such, it remains to be seen whether these 
reminders can be implemented at other centres outside of the study setting. Second, the study 
was limited to previous non-responders, and as such, the differential impact of the self-referral 
reminder on other subgroups of non-participants (e.g. previous non-attenders) could not be 
assessed. In addition, only a small proportion of the previously non-responding population were 
included in this study, and it remains to be seen whether self-referral reminders can be offered to 
the entire eligible population of non-responding adults. Lastly, the self-referral reminder used in 
this study contained multiple components, including the theory-based leaflet, and the effects of 
each component could not be assessed due to a lack of controls. The next step would be to 
perform a multi-arm RCT testing the impact of the self-referral reminder, with and without the 
theory-based leaflet, against usual care. Doing so would determine not only whether the self-
referral reminder is effective, but whether the theory-based leaflet contributes to uptake. If the 
self-referral reminder and theory-based leaflet are confirmed to be more effective than usual care, 
the method examined in this study could provide a potential strategy to improve uptake and 
possibly even reduce inequalities in participation, with the materials being easily adapted for other 
low uptake areas.  
7.6 Conclusion 
This study found that sending previous non-responders a theory-based leaflet and self-referral 
reminder letter with options for the day and time of the appointment and the gender of the 
practitioner performing the test was feasible and exceeded the minimum level of efficacy required 
to merit further investigation in a RCT.   
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Chapter 8. Assessing the impact of the self-referral reminder and 
theory-based leaflet on uptake (Study 3)13 
8.1 My contributions to the work presented in this chapter 
I conceived the idea for the study, wrote the trial protocol and submitted the ethics application 
with input from my supervisors. Sarah Marshall and Lorraine Gorman also contributed to the 
study’s design, providing pragmatic advice regarding the delivery of the reminder. I calculated the 
sample size for the study after receiving statistical advice confirming the appropriateness of my 
proposed calculation plans from Nick Counsell. Tark Elouihrani was responsible for identifying 
eligible adults on the BCSS. Ms Cherese Bennett (Health Improvement Specialist, St Mark’s 
BCSC) was responsible for maintaining the study database, randomising adults to study groups, 
mailing the reminders and anonymising and transferring the data at the end of the study. I coded 
the data and derived the values for area-level deprivation that were later matched to individuals 
within the dataset (by Cherese Bennett) using participant study IDs. I analysed the data after 
receiving statistical advice on the appropriateness of my proposed analysis plans from Nick 
Counsell. I also interpreted the results with input from my supervisors and led on the publication 
of the manuscript (Kerrison et al., 2017). All of the co-authors contributed to the interpretation of 
the results.  
  
                                                     
13 A version of this Chapter, entitled: ‘Improving uptake of flexible sigmoidoscopy screening: a randomized controlled trial 
of nonparticipant reminders in the English Screening Programme’ has been published in Endoscopy (see Appendix 8-1 
for the published manuscript). 
 
Reference: Kerrison RS, McGregor LM, Marshall S, Isitt J, Counsell N, Rees CJ, von Wagner C (2017) Improving uptake 
of flexible sigmoidoscopy screening: a randomized trial of nonparticipant reminders in the English Screening Programme. 
Endoscopy. 49(1): 35-43 
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8.2 Introduction 
In the previous chapter, I assessed the feasibility of sending previous BSS non-responders a self-
referral reminder 12 months after their initial invitation. I found that, when sent with the theory-
based leaflet developed in Chapter 6, the self-referral reminder resulted in self-referral and uptake 
in 16% of previous non-responders, and thereby exceeded the minimum level of efficacy of a 
‘good’ intervention (see 7.3.9 Power calculation).  
While the results were highly promising, the study described in the previous chapter lacked a 
control group against which the effectiveness of the self-referral reminder could be compared. 
The effectiveness of the intervention and some of its key components, therefore, still require 
formal evaluation in multi-arm RCTs. One such component requiring further investigation is the 
theory-based leaflet developed as part of this thesis. Tailoring information materials for the whole 
programme would incur considerable financial and logistical costs, which would need to be 
justified. 
Another component of the self-referral reminder that also requires further investigation is its 
differential impact on specific groups of non-participants. So far, the interventions have been 
tested exclusively on former non-responders (individuals who did not confirm the initial 
appointment offered), and their potential to improve uptake among other groups of non-
participants (e.g. non-attenders) has not yet been explored.  
Other aspects of the self-referral reminder and theory-based leaflet which have not yet been 
assessed include: 1) the cost of the interventions per additional attendee; 2) the ADR among 
individuals who self-refer for screening and; 3) individual preferences for a same-sex practitioner 
by factors other than gender.  
The present study set out to extend the evaluation of the self-referral reminder and theory-based 
leaflet to increase uptake by: 1) comparing uptake between individuals receiving the self-referral 
reminder against usual care (i.e. no reminder); 2) testing the relative impact of including the 
theory-based leaflet against a third group receiving a self-referral reminder with the standard 
information booklet used by the NHS BSSP and; 3) subdividing non-participants into ‘previous 
non-responders’ and ‘previous non-attenders’. 
8.2.1 Aims 
The specific aims of this study were to: 1) establish the effectiveness of the self-referral reminder 
to improve uptake among previous non-participants; 2) assess the benefit of using the theory-
based leaflet over the standard information booklet used by the NHS BSSP and; 3) explore the 
differential impact of the intervention materials to facilitate uptake among different groups of non-
participants.  
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The secondary aims were to: 1) examine the ADR among screened adults; 2) explore individual 
preferences for a same-sex practitioner by baseline characteristics and ethnicity, and; 3) estimate 
the cost of the intervention materials per additional person attending screening. 
8.3 Methods 
8.3.1 Study design 
This study was a single-centre RCT with three parallel arms.  
8.3.2 Study population and setting 
Eligible adults were men and women registered with a general practice within the London 
Boroughs of Brent and Harrow, who had not attended a BSS appointment within 12 months of 
being sent their initial invitation. Individuals included both those who previously did not respond 
to the initial invitation (non-responders), as well as those who did respond, but did not attend (non-
attenders). 
8.3.3 Identification  
Eligible adults were identified on the BCSS by a member of the direct care team at the Hub. The 
data were extracted one week prior to the beginning of the study (February, 2015) following a 
formal data request from the clinical programme manager at St Mark’s BCSC, who asked the Hub 
to identify individuals invited for BSS at the centre between February and August 2014 (i.e. 12 
months before the study start date). The request specified that individuals be excluded if they: 1) 
were no longer registered with a general practice within the London Boroughs of Brent and 
Harrow, 2) currently had an appointment booked at the screening centre, 3) were registered on 
the BCSS as ‘deceased’, or 4) had attended a BSS appointment since they were first invited one 
year ago. An overview of the data requested is presented in Table 8-1. 
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Table 8-1. Data specification from St Mark’s BCSC to the Hub 
Variable Reason for request 
NHS Number Required for mail out 
Title Required for mail out 
First Name Required for mail out 
Middle Name(s) Required for mail out 
Last Name Required for mail out 
Address Required for mail out 
Postcode Required for mail out 
Initial invite date Required for mail out 
Gender Important baseline characteristic 
CCG Important baseline characteristic 
Initial episode status Important baseline characteristic 
Current episode status Important exclusion criteria 
Date of initial appointment  Important exclusion criteria 
 
8.3.4 Enrolment 
Eligible adults were enrolled into the study over a 20 week period spanning February to August 
2015. On the basis that there was capacity to facilitate an additional five appointments each week, 
and that approximately 5% of all individuals across the three study groups would book and attend 
an appointment (see: 8.3.11.1 Expected uptake), the clinical programme manager at St Mark’s 
BCSC limited the number of eligible adults who could be enrolled into the study each week. As a 
result, not all eligible adults (i.e. previous non-participants) were included in the study, and 
individuals were randomly selected for inclusion in the study from a variable weekly total of 
previous non-participants based on their initial invitation date. This was done using blocked 
pseudo-random selection methods, with non-participants blocked according to the week they 
received their initial invitation, and a subset (n = 69) randomly selected for inclusion in the study 
(Efird., 2010). 
8.3.5 Randomisation and group allocation 
Individuals randomly selected for inclusion in the study were randomly assigned in a 1:1:1 ratio 
(using simple pseudo-random allocation methods; Babbie., 2011) to receive either: no reminder 
(control), a 12-month self-referral reminder with the standard information booklet used by the NHS 
BSSP, or a 12-month self-referral reminder with the theory-based leaflet (TMR-TBL) developed 
in Chapter 6. 
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8.3.6 Blinding 
As participants were randomised to receive no reminder, or a 12-month self-referral reminder with 
one of two leaflets (see 8.3.5 Randomisation and group allocation), it was not possible to blind 
them to the treatment they received. The health improvement specialist responsible for 
maintaining the study database was also aware of the treatment that individuals were allocated, 
as she had access to the data before it was pseudonymised. My supervisors and I, however, were 
blinded to the treatment participants received until the end of the study, when all of the data had 
been collected and any patient identifiable data removed. 
8.3.7 Procedures 
Individuals allocated to the control group received no reminder, as per usual care. They were able 
to self-refer for an appointment by calling the Freephone telephone number for St Mark’s BCSC. 
The standard process of self-referring for an appointment was outlined to them in the cancellation 
letter, which is sent to all individuals who do not attend a BSS appointment (see Appendix 2-6). 
Individuals allocated to the reminder groups were sent a 12-month self-referral reminder with one 
of two leaflets (depending on their group allocation), an ‘appointment-request-slip’ and a Freepost 
return envelope (addressed to St Mark’s BCSC) 12 months after their initial invitation. Individuals 
in both reminder groups were able to book an appointment either by returning the appointment-
request-slip to the centre (thereby initiating a call from a member of the administrative team), or 
by calling the centre directly on the Freephone telephone number provided. Individuals in both 
reminder groups were also able to indicate a preference for the gender of the practitioner 
performing the test, as well as the day and time of the appointment, either by selecting options 
on the appointment-request-slip, or when prompted during their call (administrative staff were 
given instruction to do this by the clinical programme manager).  
Anyone not responding to the self-referral reminder within four weeks was sent the follow-up 
reminder, which also included an appointment-request-slip, the allocated information leaflet and 
a Freepost return envelope. Individuals were then given another eight weeks to respond. At this 
time, their attendance status was assessed by the health improvement specialist (using routine 
data stored on the BCSS) and added to the study database. Any self-referrals made after this 
time were not included in the study results, but were still fulfilled by St Mark’s BCSC. 
Individuals who self-referred for an appointment (in all study groups) also received a pre-
appointment text-message reminder and telephone call, as per routine practice at St Mark’s 
BCSC. The procedures for the telephone call and text-message reminder are described in the 
previous chapter (see 7.3.7 5 Procedures). 
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8.3.8 Intervention details 
Detailed descriptions of the self-referral reminder, follow-up reminder and theory-based leaflet 
and their development are provided in Chapter 6. A copy of the standard information booklet is 
provided in the appendix (see Appendix 2-3). The following section provides a brief overview of 
the changes made to the intervention materials following the results of the feasibility study.  
12-month self-referral reminder: Two small changes were made to the 12-month self-referral 
reminder letter. One of these changes was made to the self-referral reminder letter for TMR-SIB 
group specifically. Namely, a line indicating that the leaflet ‘included stories from people who had 
previously had the test’ was omitted (see Appendix 8-2). The other change, which affected the 
self-referral reminder for both groups (i.e. TMR-SIB and TMR-TBL), was that some of the options 
for the day and time of the appointment were removed (see appendices 8-2 and 8-3 for the 
amended 12-month self-referral reminder letter used for the TMR-SIB group and the TMR-TBL 
group respectively). This change was made to the reminder on the basis that those appointments 
were not available at St Mark’s BCSC and were responsible for some of the difficulty in offering 
people their preferred appointment in the feasibility study (Chapter 7). 
Follow-up reminder: The same changes made to the self-referral reminder were also made to 
the follow-up reminder (see appendices 8-4 and 8-5 for amended versions of the follow-up 
reminder for the TMR-SIB group and TMR-TBL group respectively). 
8.3.9 Consent procedures 
Detailed descriptions of the consent procedures for self-referred appointments are provided in the 
previous chapter (see: 7.3.7 Consent procedures).  
8.3.10 Measures  
8.3.10.1 Gender, CCG and initial episode status 
Data on the gender, CCG and initial episode status (i.e. non-responder / non-attender status) of 
each person were extracted from the BCSS as part of the initial extraction performed by the Hub 
(see Table 8-1). 
8.3.10.2 Area-level deprivation  
The postcode of each person’s home address was converted into a score on the 2010 IMD using 
the same methods described in the previous chapter (see 7.3.8.2 for detailed descriptions). 
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8.3.10.3 Ethnicity 
The ethnicity of each person who attended screening was extracted from the BCSS and added 
to the study database by the health improvement specialist four and 12 weeks after the delivery 
of the self-referral reminder (i.e. when checking the self-referral and attendance status of each 
person; see 8.3.10.8 Self-referral and attendance). 
8.3.10.4 Clinical outcome 
As with ethnicity, the clinical outcome (i.e. test result) for each person was extracted from the 
BCSS and added to the study database by the health improvement specialist four and 12 weeks 
after the delivery of the self-referral reminder (see 8.3.10.3 Ethnicity).  
8.3.10.5 Method of referral 
The method of self-referral for each person was added to the study database using the same 
methods described in the previous chapter (see 7.3.8.3 for detailed descriptions).  
8.3.10.6 Preferred gender of the practitioner  
The preferred gender of the practitioner for each person who self-referred for an appointment was 
added to the study database using the same methods described in the previous chapter (see 
8.3.8.4 for detailed descriptions). 
8.3.10.7 Receipt of a pre-appointment reminder 
Receipt of a pre-appointment reminder (i.e. by text or by telephone) was added to the study 
database as the study progressed. Members of the administrative team at St Mark’s BCSC were 
informed of the study and were given specific instructions by the clinical programme manager to 
keep a record of any individuals they contacted, either by text or over the phone, on the BCSS. 
As there was no entry field for ‘receipt of a pre-appointment reminder’ on the BCSS, receipt of a 
pre-appointment reminder was recorded in each person’s ‘episode notes’ (on the BCSS). These 
data were then extracted from the BCSS by the health improvement specialist responsible for 
maintaining the study database. This was done on a weekly basis, four and 12 weeks after each 
person was sent their self-referral reminder (again, when checking the self-referral and 
attendance status of each person; see 8.3.10.8 Self-referral and attendance). 
8.3.10.8 Self-referral and attendance  
As with the previous study (Study 2), self-referral and attendance were verified by the health 
improvement specialist at St Mark’s BCSC four weeks following the delivery of the self-referral 
reminder and eight weeks following the delivery of the follow-up reminder.  
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The first assessment was carried out to establish which individuals had already self-referred / 
attended screening, and therefore did not need to receive the follow-up reminder. The second 
assessment was carried out to determine the ‘end of study’ uptake for each group.  
8.3.11 Sample size  
The sample size (n = 1383) was calculated using a standard test of difference between two 
proportions. As the study included three trial arms, the calculation was repeated for each pairwise 
comparison comprising a primary research question in the planned analysis (see Table 8-2). The 
final calculation gave a sample size requirement of 461 adults per trial arm to test for a 5% 
difference in uptake between any two of the three study groups, with expected values of 0%, 5% 
and 10% for the control, TMR-SIB and TMR-TBL groups respectively (see 8.3.11.1 Expected 
uptake, below). The study was designed to detect differences at the two-sided 5% alpha level 
with a 20% margin for type II error. The sample size was calculated using PASS (version 15). 
Table 8-2. Sample size calculation overview 
Comparison P1 P2 Alpha Beta 
n 
(per arm) 
n  
(Total) 
Control vs. TMR-SIB 0.004 0.049 0.05 0.2 194 582 
Control vs. TMR-TBL 0.004 0.099 0.05 0.2 84 252 
TMR-SIB vs. TMR-TBL 0.049 0.099 0.05 0.2 461 1383 
P1 = expected uptake for comparison group 1 
P2 = expected uptake for comparison group 2 
 
8.3.11.1 Expected uptake 
Control: the expected uptake of the control group was based on the self-referral rate of non-
participants at St Mark’s Hospital during the same time period of the previous year (i.e. 0.4%; 
personal communication). 
12-month reminder and standard information booklet: the expected uptake of the TMR-SIB group 
was based on a five percentage point difference in uptake between the TMR-SIB and TMR-TBL 
groups, with the TMR-TBL group achieving uptake five percentage points higher than the TMR-
SIB group (a recent review of interventions to improve organised screening uptake demonstrated 
that theory-based modifications improved median uptake on average by five percentage points; 
Duffy et al., 2016).  
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12-month reminder and theory-based leaflet: the expected uptake of the TMR-TBL group was 
estimated by calculating the two-sided 95% CIs for uptake among non-responders in the previous 
chapter (using exact methods) and then selecting the value associated with the lower 95% CI on 
the basis that a 9.9% uptake rate among previous non-participants would be considered 
operationally significant by the clinical programme manager at St Mark’s BCSC. 
8.3.12 Analysis 
Descriptive statistics were used to describe the trial population and report the number of 
adenomas detected. Univariable and multivariable binary logistic regression were used to 
investigate possible associations between treatment groups, self-referral and uptake (Engel., 
1988). To adjust for multiple comparisons, Bonferroni corrections were applied (0.05 / 3 = 0.017) 
and outcomes compared to an adjusted significance level of 0.015 (Bonferroni., 1936). Subgroup 
analyses were carried out on individuals who self-referred for an appointment. These analyses 
set out to: 1) explore possible associations between uptake and baseline characteristics, self-
referral method, and receipt of a pre-appointment reminder and; 2) assess variation in people’s 
preference for a same-sex practitioner by baseline characteristics and ethnicity. Both sets of 
subgroup analyses were performed using univariable and multivariable logistic regression 
(Engel., 1988). The latter used a step-wise model to determine the change in variance after 
accounting for ethnicity. The change in variance was reported using the Nagelkerke R square 
statistic (Nagelkerke., 1991). The data were assessed on an intention-to-treat basis using SPSS 
(version 24). 
8.3.13 Cost-analysis 
I calculated the cost per additional attendee by dividing the cost of the self-referral reminder and 
follow-up reminder (with the standard information booklet and theory-based leaflet separately) by 
the number of people who attended screening. I also performed a sensitivity analysis by 
calculating the range of variation of the cost estimates within the confidence intervals of the 
participation rates (calculated using exact methods based on the binomial distribution). 
8.3.14 Ethical approval, research governance and trial sponsorship 
The study was approved by the UCL JRO (reference: 14/0863) on the 17th of December 2014 
(Appendices 8-6 and 8-7), the North East Tyne & Wear South Research Ethics Service (Ref: 
15/NE/0043) on the 30th of January 2015 (Appendix 8-8), and the Northwest London Hospitals’ R 
and D group (Ref: RD15/011) on the 9th of February 2015 (Appendix 8-9). In accordance with the 
Consolidated Standards of Reporting Trial’s (CONSORT’s) guidelines (Moher et al., 2001), the 
study was registered with the International Standard Randomised Controlled Trial’s Number 
(ISRCTN’s) Registry for transparency (trial ID: ISRCTN44293755). 
Chapter 8. Assessing the impact of the self-referral reminder and theory-based leaflet on uptake (Study 3) 
 
134 
 
8.4 Results 
8.4.1 Sample characteristics 
This study took place between February and August 2015, with follow-up until October 2015. A 
total of 1383 adults were randomised and analysed as allocated. The majority of individuals were 
registered with a general practice located within the London Borough of Brent (n = 928, 67.1%), 
did not respond to the initial invitation (n = 1255, 90.7%) and were female (n = 727, 52.6%). Table 
8-3 describes the basic attributes of the study participants by trial arm. Figure 8-1 provides an 
overview of the flow of participants through the study.  
Table 8-3. Description of the trial population 
 
Control 
(n = 461) 
TMR-SIB 
(n = 461) 
TMR-TBL 
(n = 461) 
Total 
(n = 1383) 
Gender, n (%) 
    Female 
261  
(56.6) 
238  
(51.6) 
228  
(49.5) 
727  
(52.6) 
    Male 
200  
(43.4) 
223  
(48.4) 
233  
(50.5) 
656  
(47.4) 
CCG, n (%) 
    Brent 
304  
(65.9) 
302  
(65.5) 
322  
(69.8) 
928  
(67.1) 
    Harrow 
157  
(34.1) 
159  
(34.5) 
139  
(30.2) 
455  
(32.9) 
Tertile of deprivation (IMD Score), n (%) 
    Tertile 1 (Most deprived) 
    (0.00 – 17.68) 
152  
(33.0) 
144  
(31.2) 
133  
(28.9) 
429  
(31.0) 
    Tertile 2 (Median deprived) 
    (17.69 – 27.50) 
164  
(35.5) 
162  
(35.1) 
179  
(38.8) 
505  
(36.5) 
    Tertile 3 (Least deprived) 
    (27.51 – 80) 
140  
(30.4) 
151  
(32.8) 
144  
(31.2) 
435  
(31.5) 
    Missing 
5  
(1.1) 
4  
(0.9) 
5  
(1.1) 
14  
(1.0) 
Initial episode status, n (%) 
Non-responder 
411  
(89.2) 
408  
(88.5) 
436  
(94.6) 
1255  
(90.7) 
Non-attender 
50  
(10.8) 
53  
(11.5) 
25  
(6.4) 
128  
(9.3) 
Abbreviations: TMR, 12-Month Reminder; SIB, Standard Information Booklet; TBL, Theory-Based Leaflet; CCG, 
Clinical Commissioning Group; IMD, Index of Multiple deprivation 
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8.4.2 Uptake 
In total, 119 (8.6%) people attended a BSS appointment across all three study groups (Table 8-
4). A further 41 (3.0%) self-referred, but either did not attend (n = 21) or cancelled (n = 20), leaving 
1223 (88.4%) adult men and women who did not self-refer or attend.  
In the univariable analysis, there was strong evidence of differences in self-referral and uptake 
between individuals in the reminder groups and the control (Table 8-4). A total of 48 individuals 
(10.4%) in the TMR-SIB group and 70 (15.2%) in the TMR-TBL group attended an appointment, 
compared to only one (0.2%) in the control group (OR = 53.5, 95% CI = 7.4 – 389.1, P < 0.001; 
OR = 82.4, 95% CI = 11.4 – 595.6, P < 0.001 for the TMR-SIB and TMR-TBL groups respectively). 
There was also a strong trend toward differences in uptake between the reminder groups, with 
individuals in the TMR-TBL group being more likely to attend an appointment than individuals in 
the TMR-SIB group (OR = 1.5, 95% CI = 1.1 – 2.3, P = 0.03). 
Results were similar after adjusting for baseline characteristics in the multivariable analysis (Table 
8-4), with strong evidence of significant differences between the reminder groups and control 
(TMR-SIB vs. control: OR = 53.7, 95% CI = 7.4 – 391.4, P < 0.001; TMR-TBL vs. control: OR = 
89.0, 95% CI = 12.3 – 645.4, P < 0.001). After adjusting for baseline characteristics, there was 
also strong evidence for a difference in uptake between reminder groups, with individuals in the 
TMR-TBL group being more likely to self-refer and attend an appointment than individuals in the 
TMR-SIB group (OR = 1.7, 95% CI = 1.1 – 2.5, P = 0.01). There was also strong evidence of a 
difference in uptake by initial episode status after adjusting for study group and baseline 
characteristics (Table 8-5), with previous non-attenders being nearly twice as likely to self-refer 
and attend an appointment as previous non-responders (OR = 2.5, 95% CI = 1.4 – 4.4, P < 0.01). 
There was no evidence of an association between screening uptake and gender, regional IMD 
tertile or CCG (all Ps > 0.05).  
  
Chapter 8. Assessing the impact of the self-referral reminder and theory-based leaflet on uptake (Study 3) 
 
137 
 
 
  
Table 8-4. Self-referral and uptake by trial arm (univariable and multivariable regression 
outcomes) 
 
Mean  
n (%) 
Unadjusted OR 
(95% CI) 
Adjusted OR1 
(95% CI) 
Self-referred for an appointment comparisons 
Control vs. TMR-SIB 
1 vs. 64 
(0.2 vs. 13.9) 
74.16*** 
(10.24 - 536.97) 
73.27*** 
(10.11 - 531.11) 
    Control vs. TMR-TBL 
1 vs. 95 
(0.2 vs. 20.6) 
119.40*** 
(16.57 - 860.49) 
130.36*** 
(18.05 - 941.54) 
    TMR-SIB vs. TMR-TBL 
64 vs. 95 
(13.9 vs. 20.6) 
1.61 (1.14 - 2.28) 
1.78** 
(1.25 - 2.54) 
Attended an appointment comparisons 
    Control vs. TMR-SIB 
1 vs. 48 
(0.2 vs. 10.4) 
53.46*** 
(7.35 - 389.05) 
53.73*** 
(7.38 - 391.39) 
    Control vs. TMR-TBL 
1 vs. 70 
(0.2 vs. 15.2) 
82.35*** 
(11.39 - 595.58) 
89.01*** 
(12.28 - 645.40) 
    TMR-SIB vs. TMR-TBL 
48 vs. 70 
(10.4 vs 15.2) 
1.54* 
(1.04 - 2.28) 
1.69** 
(1.13 - 2.52) 
n for all groups, 1381; n per trial arm, 461 
Abbreviations: OR, Odds Ratio; CI, Confidence Interval 
1Adjusted OR and 95% CI are adjusted for gender, CCG, area-level deprivation and initial episode status 
* P < 0.015; ** P < 0.01; ***P < 0.001 
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Table 8-5. Self-referral and uptake by baseline characteristics (univariable & multivariable 
regression outcomes) 
 
Self-
referred  
n (%) 
Unadjusted 
OR  
(95% CI) 
Adjusted 
OR1 
(95% CI) 
Attended  
n (%) 
Unadjusted 
OR 
(95% CI) 
Adjusted  
OR1 
(95% CI) 
     Overall 
     (n = 1383) 
160 
(11.6) 
- - 
119 
(8.6) 
- - 
Gender 
Womena  
(n = 727) 
83 
(11.4) 
- - 
57  
(7.8) 
- - 
Men 
(n = 656) 
77 
(11.7) 
1.03 
(0.74-1.44) 
0.94 
(0.67-1.33) 
62  
(9.5) 
1.23 
(0.84-1.79) 
1.18 
(0.80-1.75) 
CCG 
Brenta 
(n = 926) 
101 
(10.9) 
- - 
75  
(8.1) 
- - 
Harrow 
(n = 457) 
59 
(12.9) 
1.21 
(0.86-1.71) 
1.39 
(0.89-2.18) 
44  
(9.6) 
1.21 
(0.82-1.79) 
1.34 
(0.80-2.22) 
Tertile of deprivation 
Tertile 1a  
     (n = 429) 
49 
(11.4) 
- - 
38  
(8.9) 
- - 
Tertile 2 
(n = 505) 
59 
(11.7) 
1.03 
(0.69-1.54) 
1.20 
(0.74-1.95) 
41  
(8.1) 
0.91 
(0.57-1.44) 
1.05 
(0.61-1.81) 
Tertile 3 
(n = 435) 
51 
(11.7) 
1.03 
(0.68-1.56) 
1.29 
(0.76-2.21) 
40  
(9.2) 
1.04 
(0.65-1.66) 
1.28 
(0.71-2.33) 
Initial episode status 
Non-
respondera 
(n = 1256) 
138 
(11.0) 
- - 
101 
(8.0) 
- - 
Non-
attender 
(n = 127) 
22 
(17.3) 
1.70 
(1.04-2.78) 
2.24** 
(1.30-3.85) 
18 
(14.2) 
1.89 
(1.10-3.24) 
2.45** 
(1.36-4.40) 
Abbreviations: OR, Odds Ratio; CI, Confidence Interval; CCG, Clinical Commissioning Group 
1Adjusted OR and 95% CI are adjusted for group allocation (trial arm) and all other co-variates in the table 
aReference category  
*P < 0.015; ** P < 0.01; ***P < 0.001 
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8.4.3 Confirmed appointments 
A total of 41 individuals booked an appointment but did not attend. Attendance was higher among 
previous non-attenders than non-responders (81.8% vs. 73.0%); however, the results of the 
regression revealed that there was no significant difference between these two groups (OR = 2.2, 
95% CI = 1.0 – 4.7, P > 0.05). A significant difference in attendance was observed between men 
and women (80.5% vs. 68.3%), however, with men being more likely to attend an appointment 
than their female counterparts (OR = 2.2, 95% CI = 1.0 – 4.7, P = 0.05; Appendix 8-10). There 
were no significant differences in non-attendance for any other variables included in the analysis, 
including receipt of a pre-appointment reminder and the method of referral (all Ps > 0.05).  
8.4.4 Clinical findings 
Of the 119 men and women who self-referred and attended an appointment, 114 (95.8%) were 
screened (i.e. had the scope inserted), four (3.4%) did not meet the clinical eligibility criteria, and 
one (0.8%) refused consent (Appendix 8-11). Of those who attended an appointment and were 
screened (n = 114), 54 (47.4%) had no abnormalities detected, 29 (25.4%) had polyps and 31 
(27.2%) had other pathology (Appendix 8-11). Nine (31.0%) of those who had polyps had 
adenomatous polyps, six (66.7%) of whom had pathology that met the clinical criteria for 
colonoscopy (see Chapter 2) and were subsequently referred for further examination. No-one 
was diagnosed with cancer. 
8.4.4.1 Adenoma detection rate 
The ADR among those who attended an appointment was 7.6% (n = 9). After exclusions (see 
8.4.4 Clinical findings), this increased to 7.9%.  
8.4.5 Preferences for the gender of practitioner performing the test by baseline 
characteristics 
Of the 159 men and women in the reminder groups who self-referred for a BSS appointment, 116 
(73.0%) expressed a preference for the gender of the practitioner performing the test. Of those 
indicating a preference (n = 116), the majority (n = 109, 94.0%) expressed a preference for a 
same-sex practitioner. When examined by baseline characteristics (Appendix 8-12), there were 
significant differences in the proportion of people expressing a preference for a same-sex 
practitioner between men and women, with men being significantly less likely to request a same-
sex practitioner (57.1% of men compared with 79.3% of women; adjusted OR = 0.30, 95% CI = 
0.14 to 0.64, P = 0.002). There was no evidence of an association for any other baseline 
characteristic (all Ps > 0.05). The variables included in the model accounted for 15.1% of the 
variance (Nagelkerke R Square = 0.151; Appendix 8-12).  
Chapter 8. Assessing the impact of the self-referral reminder and theory-based leaflet on uptake (Study 3) 
 
140 
 
8.4.6 Preferences for the gender of practitioner performing the test by ethnicity 
Of the 118 people in the reminder groups who attended an appointment, 112 (94.8%) provided 
their ethnicity (Appendix 8-13). Asian men and women were the most likely to express a 
preference for a same-sex practitioner, with 71.2% (37 / 52) of Asian men and women expressing 
a preference for a same-sex practitioner, compared with 65.6% (21 / 32) of Black and minority 
ethnic (BME) group men and women and only 60.7% (17 / 28) of White men and women 
(Appendix 8-14). In the univariable analysis, men and women from a BME group background or 
an Asian ethic background were no more likely to express a preference for a same-sex 
practitioner than those from a White ethnic background (both Ps > 0.05), and the same was true 
in the multivariable analysis after adjusting for group allocation and baseline characteristics (both 
Ps > 0.05). After adjusting for ethnicity, the total amount of variance explained by the model 
increased to 23.4% (Nagelkerke R Square = 0.234; Appendix 8-14). 
8.4.7 Costs 
The estimated cost of the interventions per additional person attending screening were £8.37 
(range: £6.38 – £11.17) in the TMR-SIB group and £8.75 (range: £7.05 – £11.14) in the TMR-
TBL group (see Appendices 8-15 and 8-16 for a breakdown of the intervention costs for each 
group respectively). 
8.5 Discussion 
The results of this study support the use of a ‘12-month’ self-referral reminder letter at St Mark’s 
Hospital and highlight an additional benefit to using the theory-based leaflet over the standard 
information booklet (uptake was 0.2%, 10.4% and 15.2% in the control, TMR-SIB & TMR-TBL 
groups respectively). In addition, the results indicate that the cost of the intervention per additional 
person attending screening was relatively low (similar to that an advance notification letter; 
Senore et al., 2015a), suggesting that they may be cost-effective, as well as clinically effective. 
At the current rate of attendance (40.5%; Chapter 5), the inclusion of a self-referral reminder to 
the invitation process would increase uptake at St Mark’s BCSC by between six and nine 
percentage points14, depending on which of the two leaflets were adopted (see Appendix 8-17 for 
projections). Irrespective of the method used, the inclusion of a self-referral reminder would 
increase overall uptake and the absolute number of adenomas detected by the centre.  
 
 
                                                     
14 Estimated by multiplying the proportion of adults not attending an initial appointment (0.59) by the proportion of adults 
attending in response to the 12-month reminder either with the SIB (0.10) or the TBL (0.15) 
Chapter 8. Assessing the impact of the self-referral reminder and theory-based leaflet on uptake (Study 3) 
 
141 
 
Given that attendance was consistent between tertiles of area-level deprivation, it seems unlikely 
that implementing a 12-month self-referral reminder with either leaflet would exacerbate existing 
inequalities in participation at St Mark’s Hospital (see Chapter 5). Through a process of 
elimination, these reminders might even reduce inequalities in participation at the centre. This will 
be explored further in the next study (Chapter 9). 
While uptake did not vary by gender, CCG or area-level deprivation, it did vary by initial episode 
status, with previous non-attenders being more likely to self-refer and attend an appointment than 
previous non-responders (uptake was 14.2% and 8.0%, respectively). One possible explanation 
for this is that, previous non-attenders perceive fewer barriers and more benefits to screening 
than non-responders, and are qualitatively similar to screened adults, but have difficulty 
translating their intentions into actions due to circumstantial aspects such as poor health (Power 
et al., 2008). Previous research by Ferrer and colleagues (2011) has shown that participation in 
CRC screening is a behavioural process comprised of several qualitatively distinct stages through 
which individuals transition based on their readiness to be screened (see Chapter 3). Each stage 
is strongly associated with a specific set of attitudes and beliefs towards the test, and it may be 
that the interventions used in this study were more effective at facilitating forward-stage transitions 
in previous non-attenders by addressing issues which are specific to those who have already 
engaged with the programme by confirming an appointment. It is also possible that it may simply 
be easier to facilitate forward stage transitions in individuals who have previously responded to 
the initial invitation than in individuals who have not, and so a higher response in previous non-
attenders may have been observed for this reason. 
This study also found that, among those who self-referred and subsequently made an 
appointment, women were less likely to attend screening than men (68.3% vs. 80.5%). This was 
consistent with previous research examining factors associated with non-attendance, in which 
women who stated that they ‘probably would’ or ‘definitely would’ attend screening were less likely 
to attend than their male counterparts (Power et al., 2008). One possible explanation as to why 
women were less likely to attend a confirmed screening appointment is that they perceive more 
barriers to FS screening (e.g. they are more likely to indicate that they think the test would be 
uncomfortable, embarrassing, make them feel anxious, etc. Wardle et al., 2005), which may make 
it more difficult for them to translate their intentions into behaviour (Sutton et al., 2000). In 
particular, women have been found to view the preparation for endoscopic procedures to be a 
major barrier (more so than men), which might explain why women confirm an appointment, but 
then do not attend (Friedemann‐Sánchez., 2007; Jones et al., 2010b). 
It is possible that a telephone reminder would have been more effective (Stone et al., 2002; Power 
et al., 2009; Senore et al., 2015b; Duffy et al., 2016). However, telephone reminders are not 
considered cost-effective for CRC screening and subsequently are not recommended by the 
European Union Quality Assurance Guidelines for Colorectal Cancer Screening (von Karsa et al., 
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2013). In addition, screening centres do not have access to people’s telephone numbers unless 
they confirm an appointment and provide it at this stage. It is also possible that additional 
reminders, delivered 24, 36 and 48 months after the initial invitation might improve uptake even 
further, just as repeated rounds of invitation do for gFOBt screening (Steele et al., 2010; Lo et al., 
2014). However, further research assessing the effects of such reminders is required to test this 
hypothesis. 
8.5.1 Strengths 
This study had several strengths. First, this study used a randomised design, which is considered 
the gold standard approach for testing public health interventions (Sackett et al., 1996). Second, 
it used parallel groups (i.e. randomisation of individuals), which are considered less vulnerable to 
sample bias than clustered designs (i.e. randomisation of clusters of individuals, such GP 
practices; Donner and Klar., 2004). Lastly, both previous non-responders and non-attenders were 
included, which meant that it was possible to explore the differential impact of self-referral 
reminders by non-participant subgroup, and thereby directly address a limitation of the previous 
study (see 7.5.2 Limitations).  
8.5.2 Limitations 
In addition to several strengths, this study had a number of important limitations. First, it was 
performed at a single centre in London, and as such, it remains to be seen whether the 
interventions would be as effective at other centres. Second, in order to ensure endoscopy 
capacity, only a proportion of previous non-participants eligible to receive a self-referral reminder 
were selected for inclusion in the trial, and as such, it cannot be said whether or not St Mark’s 
BCSC would be able to deliver these reminders to the entire eligible population of previously non-
participating adults. Lastly, this study did not examine demographic variation in uptake within 
study groups, and as such, it is not known whether specific subgroups of individuals (e.g. men) 
were more likely to respond in one group (e.g. the TMR-TBL group) than another (e.g. the TMR-
SIB group). The next study will attempt to address this by providing a breakdown of uptake within 
each study group while also evaluating the impact of sending non-participants a second self-
referral reminder 24 months after their initial invitation. 
8.6 Conclusion 
Sending previous non-participants a self-referral reminder 12 months after their initial invitation 
was effective at improving uptake. The Inclusion of a theory-based leaflet added significantly to 
this strategy, increasing uptake even further.   
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Chapter 9. Assessing the impact of sending a second self-
referral reminder on uptake (Study 4)15 
9.1 My contributions to the work presented in this chapter 
I conceived the idea for the study, wrote the trial protocol and submitted the ethics application 
with input from my supervisors. Sarah Marshall and Lorraine Gorman also contributed to the 
study’s design, providing pragmatic advice regarding the delivery of the reminder. I calculated the 
power of the study to detect differences between study groups after receiving statistical advice 
confirming the appropriateness of my proposed calculation plans from Nick Counsell. Mr Andrew 
Prentice (Health Improvement Specialist, St Mark’s BCSC) was responsible for checking the 
eligibility of study participants and for updating and maintaining the study database, delivering the 
reminders, and anonymising and transferring the data at the end of the study. I analysed the data, 
after receiving statistical advice on the appropriateness of my proposed analysis plans from Nick 
Counsell. I also interpreted the results with input from my supervisors and led on the submission 
of the manuscript (Kerrison et al., under review), writing the first draft and then submitting for 
publication. All of the co-authors contributed to the interpretation of the results.  
  
                                                     
15 A version of this chapter, entitled: ‘Use of two self-referral reminders and a theory-based leaflet to increase the uptake 
of flexible sigmoidoscopy in the English Bowel Scope Screening Programme: results from a randomised controlled trial in 
London’ has been published in Annals of Behavioural Medicine (see Appendix 9-1 for the published manuscript). 
 
Reference: Kerrison RS, McGregor LM, Counsell N, Marshall S, Prentice A, Isitt J, Rees CJ, von Wagner C (2018) Use 
of Two Self-referral Reminders and a Theory-Based Leaflet to Increase the Uptake of Flexible Sigmoidoscopy in the 
English Bowel Scope Screening Program: Results From a Randomized Controlled Trial in London. Ann Behav Med. doi: 
10.1093/abm/kax068   
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9.2 Introduction 
In the previous chapter, I examined the effectiveness of sending previous BSS non-participants 
a self-referral reminder 12 months after their initial invitation. I found that, when sent with the 
theory-based leaflet developed in Chapter 6, the self-referral reminder resulted in self-referral and 
uptake in 15% of individuals, which was significantly more than when sent with the standard 
information booklet sent with the initial invitation (uptake was 10%). I also found that the self-
referral reminder and theory-based leaflet were both relatively inexpensive (i.e. compared with 
other interventions described in the previous literature), indicating that they might be cost-effective 
(for the NHS), as well as clinically effective (the ADR among screened adults coming forward in 
response to the reminder was approximately 8%, which is similar to the rate among initial 
attenders; Bevan et al., 2014).  
At the end of the previous chapter, I proposed that additional self-referral reminders sent 24 and 
36 months after the initial invitation might also be effective, just as repeated invitations are for 
gFOBt screening (Steele et al., 2010; Lo et al., 2014). In the present Chapter, I set out to test the 
first part of this hypothesis by sending participants from the RCT a second self-referral reminder 
24 months after their initial invitation (i.e. 12 months after the first reminder was sent) if they were 
allocated to either of the reminder groups, or no reminder if they were allocated to the control 
group. I also set out to extend the evaluation of sending self-referral reminders to previous non-
participants by addressing limitations highlighted in the previous chapter. For example, by 
assessing demographic variation in uptake within study groups. 
9.2.1 Aims 
The specific aims of this study were to: 1) examine whether a second self-referral reminder 
increased uptake among non-participants who had previously received the self-referral reminder 
as part of the RCT (i.e. ‘additional uptake’); 2) assess the cumulative effect of two self-referral 
reminders on the overall uptake of BSS among individuals included in the previous RCT and 
present extension (i.e. ‘overall uptake’); 3) test whether the effect of the theory-based leaflet on 
participation observed following the delivery of the first reminder was sustained after the delivery 
of a second reminder and; 4) examine demographic variation in uptake within groups to assess 
whether there are subgroup differences between reminder arms.  
As with the previous chapter, the secondary aims were to: 1) examine the ADR among screened 
adults; 2) examine people’s preferences for a same-sex practitioner by baseline characteristics 
and; 3) estimate the cost of the intervention materials per additional person attending screening. 
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9.3 Methods 
9.3.1 Study design 
This study was an extension of the RCT described in the previous chapter (see 8.3.1 Study design 
for an overview). 
9.3.2 Study population and setting 
Eligible adults were men and women included in the RCT who had not attended a BSS 
appointment at St Mark’s Hospital within 24 months of being sent their initial invitation. 
9.3.3 Identification  
The eligibility of each person included in the RCT was assessed for inclusion in the extension by 
the health improvement specialist at St Mark’s BCSC using routine data stored on the BCSS. 
Individuals were excluded from the extension if they: (1) were no longer registered with a general 
practice in the London Boroughs of Brent and Harrow, (2) currently had an appointment booked 
at the screening centre, (3) were registered on the BCSS as ‘deceased’, or (4) had attended a 
BSS appointment since the study was initiated one year ago. 
9.3.4 Procedures 
Eligible adults retained their group allocation from the RCT. Individuals allocated to the control 
group received no reminder, as per usual care. They were able to self-refer for an appointment 
by calling the Freephone telephone for St Mark’s BCSC. The process of self-referring for an 
appointment was outlined to them in the cancellation letter, which is sent to all individuals who do 
not attend a BSS appointment (see Appendix 2-6). 
Individuals allocated to either of the reminder groups received a further self-referral reminder 
(hereafter referred to as a ’24-month’ self-referral reminder), plus the corresponding information 
leaflet (i.e. the standard information booklet used by the NHS, or the theory-based leaflet 
described in Chapter 6), an appointment request slip and Freepost return envelope 24 months 
after their initial invitation. As with the 12-month self-referral reminder, individuals sent a 24-month 
reminder were able to book an appointment either by returning an appointment request slip to the 
centre (thereby initiating a call from a member of the administrative team), or by calling the centre 
directly on the Freephone telephone number provided. Again, as with the 12-month self-referral 
reminder, individuals sent a 24-month reminder were able to indicate a preference for the gender 
of the practitioner performing the test, as well as the time and day of the appointment, either by 
selecting options on the appointment request-slip, or when prompted during their call 
(administrative staff were given instructions to do this by the clinical programme manager). 
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Following a similar format to the 12-month self-referral reminder, anyone not responding to the 
24-month self-referral reminder within four weeks was sent a follow-up reminder, which also 
included an appointment-request-slip, the allocated information leaflet, and a Freepost return 
envelope. Individuals were then given another eight weeks to respond. At this time, their 
attendance status was assessed by the health improvement specialist (using routine data stored 
on the BCSS) and added to the study database. Any self-referrals made after this time were not 
included in the study results, but were still fulfilled by St Mark’s BCSC. 
Individuals who self-referred for the test received a pre-appointment text-message reminder and 
telephone call, as per routine practice at St Mark’s BCSC. Detailed descriptions of the text-
message reminder and telephone call are reported in the Chapter 7 (see: 7.3.7 Procedures).  
9.3.5 Intervention details 
Detailed descriptions of the self-referral reminder, follow-up reminder and theory-based leaflet 
and their development are provided in Chapter 6. An overview of the changes made to the self-
referral reminder and follow-up reminder following the results of the feasibility study are described 
in Chapter 8 (see 8.3.8 Intervention details). A copy of the standard information booklet is 
provided in the appendix (see Appendix 2-3).  
9.3.6 Consent procedures 
Detailed descriptions of the consent procedures for BSS appointments are provided in Chapter 7 
(see: 7.3.7 Consent procedures).  
9.3.7 Measures 
9.3.7.1 Gender, CCG and initial episode status 
Data on the gender, CCG and initial episode status of each person were extracted from the BCSS 
as part of the initial extraction performed by the Hub (see Chapter 8, Table 8-1). 
9.3.7.2 Area-level deprivation 
The postcode of each person’s home address was converted into a score on the 2010 IMD as 
part of the RCT (see 8.3.10.2 Area-level deprivation for detailed descriptions). 
9.3.7.3 Ethnicity 
The ethnicity of each person who attended screening was extracted from the BCSS and added 
to the study database by the health improvement specialist four and 12 weeks after the delivery 
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of the self-referral reminder (i.e. when checking the self-referral and attendance status of each 
person; see 9.3.7.8 Self-referral and attendance below). 
9.3.7.4 Clinical outcome 
As with ethnicity, the clinical outcome for each person was extracted from the BCSS and added 
to the study database by the health improvement specialist four and 12 weeks after the delivery 
of the self-referral reminder (again, when checking the self-referral and attendance status of each 
person; see 9.3.10.8 Self-referral and attendance).  
9.3.7.5 Method of referral 
The method of self-referral for each person was added to the study database using the same 
methods described in Chapter 7 (see 7.3.8.3 Method of referral).  
9.3.7.6 Preferred gender of the practitioner 
The preferred gender of the practitioner for each person who self-referred for an appointment and 
expressed a preference was added to the study database using the same methods described in 
Chapter 7 (see 7.3.8.4 Preferred gender of the practitioner for detailed descriptions). 
9.3.7.7 Receipt of a pre-appointment reminder 
Receipt of a pre-appointment reminder (i.e. by text or by telephone) was added to the study 
database using the same methods described in the previous chapter (see 8.3.10.7 Receipt of a 
pre-appointment reminder for detailed descriptions).   
9.3.7.8 Self-referral and attendance 
Self-referral and attendance were verified by the health improvement specialist (using objective 
data stored on the BCSS) at St Mark’s BCSC four weeks following the delivery of the 24-month 
reminder and eight weeks following the delivery of the follow-up reminder. The first assessment 
was carried out to establish which individuals had self-referred / attended screening, and therefore 
did not need to receive the follow-up reminder. The second assessment was carried out to 
determine the ‘end of study’ uptake for each group.  
9.3.8 Power calculation 
Power was calculated using a standard test of difference between two proportions. As the study 
included three trial arms, the calculation was repeated for each pairwise comparison comprising 
a primary research question in the planned analysis (see Table 9-1). All three calculations 
demonstrated that the sample size (n = 461 per trial arm) provided sufficient levels of power (i.e. 
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beta <0.2) to detect a 7.5 percentage point difference in uptake at the two-sided 5% alpha level, 
with expected values of 0.4% for the control group, 15.2% for the TMR-SIB group, and 21.7% for 
the TMR-TBL group (see 10.3.8.1 Expected uptake below). The power calculations were 
performed using PASS (version 15). 
Table 9-1. Power calculation overview 
Comparison P1 P2 Alpha Beta 
n 
(per arm) 
n  
(Total) 
Control vs. TMR-SIB <0.01 0.15 0.05 1.0 461 1383 
Control vs. TMR-TBL <0.01 0.22 0.05 1.0 461 1383 
TMR-SIB vs. TMR-TBL 0.15 0.22 0.05 0.8 461 1383 
P1 = expected uptake for comparison group 1 
P2 = expected uptake for comparison group 2 
 
9.3.8.1 Expected uptake 
The expected overall uptake for the reminder groups was estimated by multiplying the uptake of 
each group following the 12-month reminder by 1.5. This value was selected on the basis that 
similar studies examining the use of non-participant interventions (e.g. repeated invitations) to 
promote the uptake of gFOBt screening have shown that the second round of intervention tends 
to yield approximately 50% of the return of the first, so that the overall impact of the two rounds 
combined is 150% of that of the first round alone (Steele et al., 2010; Lo et al., 2014). For example, 
Steele and colleagues (2010) found that the first round of repeated invitation increased the overall 
uptake of gFOBt screening in the English BCSP by six percentage points (i.e. from 54% to 60%), 
whereas the second only increased uptake by an additional three percentage points (i.e. from 
60% to 63%; Steele et al., 2010).  
9.3.9 Analysis 
Descriptive statistics were used to describe the trial population after exclusions (see 9.3.3 
Identification). Additional attendance (i.e. attendance in response to the delivery of the 24-month 
reminder) was assessed by calculating the two-sided 95% CI for each group using exact methods 
based on the binomial distribution. Univariable and multivariable binary logistic regression were 
used to investigate possible associations between treatment groups and self-referral and overall 
uptake (i.e. attendance for the 12 and 24-month reminders combined), before and after adjusting 
for baseline characteristics (Engel., 1988). To adjust for multiple comparisons, Bonferroni 
corrections were applied (0.05 / 3 = 0.017), and outcomes compared to an adjusted significance 
level of 0.015 (Bonferroni., 1936). 
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Several subgroup analyses were carried out on individuals who self-referred for an appointment. 
The purpose of these analyses was to: 1) explore possible associations between uptake and 
baseline characteristics, self-referral method, and receipt of a pre-appointment reminder and; 2) 
assess variation in people’s preference for a same-sex practitioner by baseline characteristics 
and ethnicity. Both sets of subgroup analyses were performed using univariable and multivariable 
binary logistic regression (Engel., 1988). The latter used a step-wise model to determine the 
change in variance after accounting for ethnicity. The change in variance was reported using the 
Nagelkerke R square statistic (Nagelkerke., 1991).  
A subgroup analysis was also carried out on individuals who attended an appointment and were 
screened (i.e. individuals who attended an appointment, provided consent, were clinically eligible 
to take part and had the scope inserted). This analysis was performed to explore possible 
variations in the ADR between demographic subgroups of individuals (e.g. between men and 
women). As with the aforementioned subgroup analyses, univariable and multivariable binary 
logistic regression were used to test for differences (Engel., 1988). A subgroup analysis was also 
performed on the subgroup of individuals who were allocated to the reminder groups. This 
analysis compared uptake within demographic subgroups of individuals, between trial arms, to 
assess whether specific groups of individuals (e.g. men) were more responsive to one leaflet over 
the other. The data were assessed on an intention-to-treat basis using SPSS (version 24). 
9.3.10 Cost-analysis 
I calculated the cost per additional attendee by dividing the cost of the self-referral reminder and 
follow-up reminder (with the standard information booklet and theory-based leaflet separately) by 
the number of people who attended screening. I also performed a sensitivity analysis by 
calculating the range of variation of these cost estimates within the confidence intervals of the 
participation rates (calculated using exact methods based on the binomial distribution). 
9.3.11 Ethical approval, research governance and trial sponsorship 
Details of the ethical approvals, research governance and trial sponsorship for this study are 
described in the previous chapter (see 8.3.14 Ethical approval, research governance and trial 
sponsorship for details). 
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9.4 Results 
9.4.1 Sample characteristics 
This study took place between February and August 2016, with follow-up until October 2016. A 
total of 1264 (91.4%) of 1383 men and women from the initial sample were assessed for inclusion 
in the extension (Figure 9-1). One-hundred and nineteen (8.6%) were known to have taken part 
in screening and were not assessed for this reason. Of the 1264 adults who were assessed, eight 
(0.6%) had died and 38 (2.8%) were no longer registered with a general practice within the 
London Boroughs of Brent and Harrow, leaving a total sample size of 1218 men and women who 
were eligible for inclusion across all three study groups (control, n = 453; TMR-SIB, n = 399; TMR-
TBL, n = 366; Table 9-2). The majority of individuals were registered with a general practice in 
the London Borough of Brent (n = 816, 67.0%), did not respond to the initial invitation (n = 1072, 
88.0%) and were female (n = 650, 53.4%). Table 9-2 describes the basic attributes of the study 
population by trial arm. Figure 9-1 provides an overview of the flow of individuals through the 
study. 
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Table 9-2. Description of the trial population 
 Control 
(n = 453) 
TMR-SIB 
(n = 399) 
TMR-TBL 
(n = 366) 
Total 
(n = 1218) 
Gender, n (%) 
    Female 255  
(56.3) 
213  
(53.4) 
182  
(49.7) 
650  
(53.4) 
    Male 198  
(43.7) 
186  
(46.6) 
184  
(50.3) 
568 
(46.6) 
CCG, n (%) 
    Brent 300  
(66.2) 
259  
(64.9) 
257  
(70.2) 
816  
(67.0) 
    Harrow 153  
(33.8) 
140  
(35.1) 
109  
(29.8) 
402  
(33.0) 
Tertile of deprivation (IMD score), n (%) 
Tertile 1 
(0.00 - 17.68) 
148  
(32.7) 
128  
(32.1) 
104  
(28.4) 
380  
(31.2) 
Tertile 2 
(17.69 - 27.50) 
164  
(36.2) 
141  
(35.3) 
142  
(38.8) 
447  
(36.7) 
Tertile 3 
(27.51 – 80) 
137  
(30.2) 
126  
(31.6) 
115  
(31.4) 
378  
(31.0) 
    Missing 4  
(0.9) 
4  
(1.0) 
5  
(1.4) 
14  
(1.1) 
Initial episode status, n (%) 
Non-responder 
404  
(89.2) 
342  
(85.7) 
326  
(89.1) 
1072  
(88.0) 
Non-attender 
49  
(10.8) 
57  
(14.3) 
40  
(10.9) 
146  
(12.0) 
Abbreviations: CCG, Clinical Commissioning Group; IMD, Index of Multiple Deprivation 
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Figure 9-1. Trial flowchart/CONSORT diagram. 
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9.4.2 Uptake (additional uptake; 24-month reminder) 
In total, 50 (4.1%) people included in the extension attended a BSS appointment across all three 
study groups (Table 9-3). A further seven (0.6%) self-referred, but either did not attend (n = 4) or 
cancelled (n = 3), leaving 1161 (95.3%) adult men and women who did not self-refer or attend. 
The percentage of people who self-referred and attended an appointment within each group was 
0.4% (n = 2; 95% CI = 0.0 – 1.6), 4.8% (n = 19; 95% CI = 2.9 - 7.3) and 7.9% (n = 29; 95% CI = 
5.4 – 11.2) in the control, TMR-SIB and TMR-TBL groups respectively (Table 9-3). Sending a 
second self-referral reminder 24 months after the initial invitation, therefore, further increased 
screening uptake and was significantly more effective than usual care (i.e. the 95% CI between 
the reminder groups and the control did not overlap), but was not enhanced by the inclusion of a 
theory-based leaflet (i.e. the 95% CI between the two reminder groups did overlap; Table 9-3).  
9.4.3 Uptake (overall uptake; 12 and 24-month reminder combined) 
In total, 169 (12.2%) people included in the RCT and extension (n = 1383) attended an 
appointment across all three study groups (Table 9-4). A further 43 (3.1%) self-referred, but either 
did not attend (n = 25) or cancelled (n = 18), leaving 1171 (84.7%) who did not self-refer or attend. 
In the univariable analysis, there was strong evidence of differences in self-referral and uptake 
between the reminder groups and the control (Table 9-4). A total of 67 individuals (14.5%) in the 
TMR-SIB group and 99 individuals (21.5%) in the TMR-TBL group attended an appointment, 
compared with only three (0.7%) in the control (OR = 26.0, 95% CI = 8.1 – 83.2, P < 0.001 and 
OR = 41.8, 95% CI = 13.1 – 132.8, P < 0.001 for the TMR-SIB and TMR-TBL groups respectively). 
There was also strong evidence of a difference in uptake between the reminder groups, with 
individuals in the TMR-TBL group being significantly more likely to attend an appointment than 
individuals in the TMR-SIB group (OR = 1.6, 95% CI = 1.1 – 2.3, P = 0.006).  
Results were similar after adjusting for baseline characteristics in the multivariable analysis (Table 
9-4), with strong evidence of differences in uptake between the reminder groups and the control 
(TMR-SIB vs. control: aOR = 26.1, 95% CI = 8.1 – 84.0, P < 0.001; TMR-TBL vs. control: aOR = 
46.91, 95% CI = 14.7 – 149.9, P < 0.001). After adjusting for baseline characteristics, there 
remained a significant difference in participation between intervention groups, with individuals in 
the TMR-TBL group being more likely to book and attend an appointment than individuals in the 
TMR-SIB group (aOR = 1.8, 95% CI = 1.3 – 2.6, P < 0.001). There was also strong evidence of 
a difference in uptake by initial episode status after adjusting for study group and other baseline 
characteristics, with initial non-attenders being more likely to book and attend an appointment 
than initial non-responders); uptake was 11.4% and 20.3% respectively (aOR = 2.6, 95% CI = 1.6 
– 4.4, P < 0.001; Table 9-5). There was no evidence of an association between screening uptake 
and gender, regional IMD tertile, or CCG (all Ps > 0.05). 
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Table 9-3. Uptake at 12 and 12 and 24 months combined by trial arm 
 12 months 
Uptake % (95% CI) 
12 & 24 months 
Uptake %  (95% CI) 
Usual care 
(n = 461) 
0.2 
(0.0 - 1.2) 
0.7 
(0.2 - 2.0) 
TMR-SIB 
(n = 461) 
10.4 
(7.8 - 13.6) 
14.5 
(11.4 - 18.1) 
TMR-TBL 
(n = 461) 
15.2 
(12.1 - 18.8) 
21.5 
(17.8 - 25.5) 
 
Table 9-4. Self-referral and uptake by trial arm (12 & 24 months combined)  
 n (%) Unadjusted OR 
(95% CI) 
Adjusted OR1 
(95% CI) 
Self-referred for an appointment comparisons 
    Control vs. TMR-SIB 
3 vs. 83 
(0.7 vs. 18.0) 
33.52*** 
(10.51 - 106.92) 
33.90*** 
(10.60 - 108.36) 
    Control vs. TMR-TBL 
3 vs. 126 
(0.7 vs. 27.3) 
57.42*** 
(18.12 - 182.00) 
65.25*** 
(20.48 - 207.90) 
    TMR-SIB vs. TMR-TBL 
83 vs. 126 
(18.0 vs. 27.3) 
1.71*** 
(1.25 - 2.34) 
1.93*** 
(1.39 - 2.66) 
Attended an appointment comparisons 
    Control vs. TMR-SIB 
3 vs. 67 
(0.7 vs. 14.5) 
25.96*** 
(8.10 - 83.18) 
26.14*** 
(8.14 - 83.95) 
    Control vs. TMR-TBL 
3 vs. 99 
(0.7 vs. 21.5) 
41.75*** 
(13.13 - 132.76) 
46.91*** 
(14.68 - 149.93) 
    TMR-SIB vs. TMR-TBL 
67 vs. 99 
(14.5 vs. 21.5) 
1.61** 
(1.14 - 2.26) 
1.80*** 
(1.26 - 2.55) 
n for all groups, 1381; n per trial arm, 461 
Abbreviations: OR, Odds Ratio; CI, Confidence Intervals 
1Adjusted OR and 95% CI are adjusted for gender, area, deprivation and initial episode status 
aReference group 
* P < 0.015; ** P < 0.01; ***P < 0.001 
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Table 9-5. Self-referral and uptake by baseline characteristics – (12 & 24 months combined) 
 
Self-
referred 
n (%) 
Unadjusted 
OR 
(95% CI) 
Adjusted  
OR1 
(95% CI) 
Attended  
n (%) 
Unadjusted 
OR 
(95% CI) 
Adjusted  
OR1 
(95% CI) 
     Overall 
     (n = 1383) 
212 
(15.3) 
- - 
169 
(12.2) 
- - 
Gender 
Womena  
(n = 727) 
109 
(15.0) 
- - 
82 
(11.3) 
- - 
Men  
(n = 656) 
103 
(15.7) 
1.06 
(0.79-1.42) 
0.96 
(0.71-1.32) 
87 
(13.3) 
1.20 
(0.87-1.66) 
1.14 
(0.81-1.60) 
CCG 
Brenta 
(n = 926) 
134 
(14.5) 
- - 
103 
(11.1) 
- - 
Harrow 
(n = 457) 
78 
(17.1) 
1.22 
(0.90-1.65) 
1.26 
(0.84-1.89) 
66 
(14.4) 
1.35 
(0.97-1.88) 
1.44 
(0.93-2.24) 
Deprivation 
Tertile 1a  
     (n = 429) 
70 
(16.3) 
- - 
58 
(13.5) 
- - 
Tertile 2 
(n = 505) 
74 
(14.7) 
0.88 
(0.62-1.26) 
0.97 
(0.63-1.49) 
55 
(10.9) 
0.78 
(0.53-1.16) 
0.92 
(0.58-1.48) 
Tertile 3 
(n = 435) 
67 
(15.4) 
0.93 
(0.65-1.35) 
1.09 
(0.68-1.76) 
56 
(12.9) 
0.95 
(0.64-1.40) 
1.22 
(0.73-2.04) 
Initial episode status 
Non-
respondera 
(n = 1255) 
181 
(14.4) 
- - 
143 
(11.4) 
- - 
Non-attender 
(n = 128) 
31 
(24.2) 
1.90** 
(1.23-2.93) 
2.67*** 
(1.63-4.37) 
26 
(20.3) 
1.98** 
(1.25-3.15) 
2.60*** 
(1.55-4.36) 
Abbreviations: OR, Odds ratio; CI, Confidence Interval; CCG, Clinical Commissioning Group 
1Adjusted ORs and 95% CIs are adjusted all other covariates in the table 
aReference category  
Adjusted OR and 95% CI are adjusted for group allocation (trial arm) and all other covariates in the table  
*P < 0.015; **P < 0.01; ***P < 0.001 
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9.4.4 Confirmed appointments (12 and 24-month data combined) 
A total of 43 individuals booked an appointment but did not attend. A significant difference in 
attendance among people who self-referred was observed between men and women (84.4% vs. 
74.5%), with men being more likely to attend their appointment (aOR = 2.1, 95% CI = 1.0 – 4.2, 
P = 0.05). A similar difference in uptake was observed between people who received a pre-
appointment reminder and people who did not (83.6% vs. 73.6%); although this did not reach 
statistical significance in the multivariable analysis (aOR = 1.7, 95% CI = 0.8 – 3.4, P = 0.14; 
Appendix 9-2). There was no evidence of differences in non-attendance for any of the other 
variables included in the analysis, including initial episode status, and the method of referral (all 
Ps > 0.05). 
9.4.5 Clinical findings (12 and 24-month data combined) 
Of the 166 adult men and women in the reminder groups who self-referred and attended an 
appointment, 158 (95.2%) were screened, seven (4.2%) did not meet the clinical eligibility criteria, 
and one (0.6%) refused consent (Appendix 9-3). Of those who attended an appointment and were 
screened (n = 158), 74 (46.8%) had no abnormalities detected, 42 (26.6%) had polyps, 42 (26.6%) 
had other pathology and one (0.6%) had cancer. Fourteen (33.3%) of those who had polyps had 
adenomatous polyps, seven (50%) of whom had pathology that met the clinical criteria for 
colonoscopy (see Chapter 2) and were subsequently referred for further examination.  
9.4.6 Adenoma detection rate (12 and 24-month data combined) 
The ADR among those who attended an appointment was 8.4% (n = 14). After exclusions (i.e. 
removal of those not adequately screened: see 9.4.5 Clinical findings), this increased to 8.9%. 
There was no evidence of differences in the ADR between demographic subgroups (see 
Appendices 9-4 and 9-5), including gender, ethnicity, and initial episode status (all Ps > 0.05). 
9.4.7 Preferences for the gender of practitioner performing the test by baseline 
characteristics (12 and 24 month reminder data combined) 
Of the 209 men and women in the reminder groups who self-referred for BSS, 144 (68.9%) 
expressed a preference for the gender of the practitioner. Of those indicating a preference (n = 
144), the majority (n = 131, 90.3%) expressed a preference for a same-sex practitioner. When 
examined by baseline characteristics (Appendix 9-6), there were significant differences between 
the proportion of men and women expressing a preference for a same-sex practitioner, with men 
being significantly less likely to request a same-sex practitioner (61.2% of men compared with 
76.4% of women; aOR = 0.4, 95% CI = 0.2 – 0.6, P < 0.001). There was no evidence of an 
association for any other characteristic included in the analysis (all Ps > 0.05). The variables 
accounted for 12.4% of the variance (Nagelkerke R Square = 0.124; Appendix 9-6).  
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9.4.8 Preferences for the gender of practitioner performing the test by ethnic group (12 
and 24-month reminder combined) 
Of the 166 people in the reminder groups who attended an appointment, 152 (91.6%) provided 
their ethnicity (Appendix 9-7). Asian men and women were the most likely to express a preference 
for a same-sex practitioner, with 69.4% (50 out of 72) of Asian men and women expressing a 
preference for a same-sex practitioner, compared with 59.0% (23 out of 39) of BME group men 
and women and only 51.2% (21 out of 31) of White men and women (Appendix 9-8). In the 
univariable analysis, men and women from a BME group background or an Asian ethnic 
background were not significantly more likely to express a preference for a same-sex practitioner 
than those from a White ethnic group background (both Ps > 0.05) and the same was true in the 
multivariable analysis after adjusting for the group allocation and baseline characteristics (both 
Ps > 0.05). After adjusting for ethnicity, the total amount of variance explained by the model 
increased from, 12.4%, to 14.6% (Nagelkerke R Square = 0.146; Appendix 9-8). 
9.4.9 Demographic variation in uptake by trial arm (12 and 24-month reminder combined) 
Appendix 9-9 shows the results of the subgroup analysis comparing uptake between 
demographic subgroups of individuals (e.g. men) within the two reminder arms. Unadjusted and 
adjusted ORs and 95% CIs are reported for each subgroup. After adjusting for baseline 
characteristics, the only group who were not significantly more likely to attend a BSS appointment 
in the TMR-TBL group were people living in the most deprived tertile of areas (Appendix 9-9).  
9.4.10 Costs (24-month reminder) 
The estimated cost of the interventions per additional person attending screening were £18.31 
(range: £12.00 – £29.00) in the TMR-SIB group and £16.93 (range: £11.97 – £24.55) in the TMR-
TBL group (see Appendices 9-10 and 9-11 for a breakdown of the intervention costs for each 
group respectively). 
9.5 Discussion 
The results of this study support the use of a second self-referral reminder at St Mark’s Hospital 
and highlight an additional benefit to using the theory-based leaflet over the standard information 
booklet (the combined uptake was 0.7%, 14.5% and 21.5% in the control, TMR-SIB and TMR-
TBL groups respectively). In addition, the results indicate that the cost of the intervention per 
additional person attending screening was relatively low (similar to that an advance notification 
letter; Senore et al., 2015a), suggesting they might be cost-effective, as well as clinically effective. 
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At the current rate of attendance (40.5%; Chapter 5), the inclusion of two self-referral reminders 
in the NHS BSSP would increase uptake at St Mark’s Hospital by between nine and 13 
percentage points16, depending on which of the two leaflets were adopted (see Appendix 9-12 for 
projections). Irrespective of the leaflet used, the inclusion of two ‘annual’ self-referral reminders 
would increase overall uptake and the number of adenomas detected by the centre. Given that 
uptake was consistent between tertiles of area-level deprivation, it seems unlikely that 
implementing self-referral reminders with either leaflet would exacerbate existing inequalities in 
uptake at St Mark’s Hospital (see Appendices 9-13 and 9-14 for projections on the impact of the 
12 and 24 month self-referral reminder on social inequalities in uptake at St Mark’s Hospital).  
While the uptake of BSS following the 12 and 24-month reminder was high, the present study 
suggests that it could have been higher still. A total of 18% of people in the TMR-SIB group and 
28% of people in the TMR-TBL group self-referred for an appointment, but only 14.5% and 21.5% 
(respectively) attended. If the entire self-referring population had attended an appointment, an 
additional 1.8% to 3.5% of people initially invited for BSS at St Mark’s Hospital would attend an 
appointment17, taking the total combined uptake at 24 months with the standard information 
booklet to 50.8%, and with the theory-based leaflet to 56.5%. Understanding the reasons for non-
participation in these individuals would be useful in terms of developing strategies to prevent non-
attendance. This should be a focal point of future research. 
9.5.1 Strengths 
This study had several strengths. First, the sample size was quite large, making it possible to 
conduct several subgroup analyses that would have been underpowered to detect differences 
had a smaller sample been used. Second, the study is the first to examine whether self-referral 
reminders can increase the uptake of BSS, and as such, it is the first to show that these are 
effective without being vulnerable to bias (e.g. confirmation bias) and confounding data present 
in other studies (Kaptchuk., 2003). Lastly, the study setting, St Mark’s Hospital, is one that serves 
an ethnically diverse population from a range of socioeconomic areas and, as with the rest of 
London, the bowel screening programme has found it difficult to encourage attendance here (Hirst 
et al., 2016). The results of this study are likely to be generalisable to other London boroughs and 
national and international urban settings struggling to reach the European target for acceptable 
participation (von Karsa et al., 2013).  
                                                     
16 Estimated by multiplying the proportion of adults not attending the initial appointment (0.59) by the proportion attending 
in response to the 12 and 24-month reminders (combined) on an intention-to-treat basis (i.e. 0.15 (67/461) & 0.22 (99/461) 
for the SIB and TBL groups respectively). 
 
17 Estimated by multiplying the proportion of adults not attending the initial appointment (0.59) by the proportion who self-
refer for an appointment in response to the 12 and 24-month reminders (combined) on an intention to treat basis (i.e. 0.18 
(83/461) and 0.27 (126/461)). 
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9.5.2 Limitations 
In addition to several strengths, this study had a number of important limitations. First, it did not 
include a group that only received a 24-month reminder, and as such, it is not possible to say 
whether uptake would have been the same or higher had a single reminder been delivered at this 
time point (i.e. as opposed to two reminders sent 12 and 24 months after the initial invitation). 
Second, the 12 and 24-month reminders were examined in isolation of one another (i.e. 12 
months apart), and as such, it cannot be said whether the reminders could be delivered 
concurrently (i.e. whether St Mark’s Hospital could manage all the self-referred appointments 
arising from these reminders if they were sent to both individuals who did not participate 12 and 
24 months after their initial invitation). Lastly, ethnicity data were not available for all individuals 
included in the study, and as a result, it was not possible to assess the differential impact of the 
self-referral reminders and theory-based leaflet on different ethnic groups. 
9.6 Conclusion 
Sending non-participants a self-referral reminder 12 and 24 months after their initial invitation was 
effective at improving uptake. The Inclusion of a theory-based leaflet added significantly to this 
strategy, increasing uptake even further. Future studies should focus on the feasibility of 
implementing these interventions across multiple centres and the wider population of eligible 
adults.  
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Chapter 10.  DISCUSSION 
10.1 Summary of the literature  
CRC is a leading cause of morbidity and mortality throughout the world (Ferlay et al., 2015). 
Several large RCTs have shown that a single FS between the ages of 55 and 64 can significantly 
reduce the incidence and mortality of the disease among those who complete the test (Elmunzer 
et al., 2012). As a result, several countries have begun piloting FS-based screening programmes 
for the prevention of CRC (Screuders et al., 2015), with England currently rolling out a national 
programme (the NHS BSSP) set to reach full population coverage in 2018 (Geurts et al., 2015). 
Although offered automatically and for free, the uptake of BSS has been low and 
socioeconomically graded (McGregor et al., 2015a). The most recent examination of uptake 
demonstrated that only 43% of men and women invited for BSS attended their appointment, and 
that uptake was lowest among individuals living in the most deprived quintile of areas (uptake 
ranged from 32% in the most deprived quintile, to 52% in the least deprived; McGregor et al., 
2015a). These observations, alongside the finding that there has been little previous research 
examining the use of intervention strategies to improve participation in FS screening, formed the 
basis of this thesis. 
10.2 Summary of findings 
10.2.1 Chapter 5 – Study 1 
The first study in this thesis used routine data collected by the NHS BSSP to examine uptake at 
St Mark’s Hospital during the first fourteen months of the programmes initial implementation. The 
aim was to examine whether national variations in uptake were observed at the centre, with a 
wider aim of developing interventions to promote uptake based on the study findings. Uptake data 
were received for almost 5000 individuals, the majority of whom were registered with an address 
within the most ethnically diverse quintile of areas in England, which was reflective of the higher 
overall ethnic diversity of the area. 
Data analysis revealed that approximately half of invitees confirmed their appointment, and that 
the remainder either did not respond or cancelled (data on the individual proportions of these 
were not obtained). Invitees were more likely to confirm their appointment if they were from the 
least deprived quintile of areas, compared with the most deprived quintile of areas. Further 
analysis demonstrated that most people (81%) who confirmed an appointment went on to attend. 
It was established, therefore, that the greatest opportunities to improve uptake resided in targeting 
non-responders, who comprised the largest group (50%) of people examined in the study.  
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10.2.2 Chapter 6 – Intervention development 
I developed a self-referral reminder letter and theory-based leaflet to promote uptake among non-
responders at St Mark’s Hospital. The strategy was informed by the BCW, which was used to 
identify: 1) the putative targets for change and; 2) the specific BCTs likely to be effective in 
affecting those targets. Initial designs of the interventions were informed by a review of the 
previous literature on the perceived benefits and barriers to FS screening and telephone 
interviews with previously screened adults. These designs were then tested in a co-design 
workshop and revised iterations further tested in a series of focus groups and face-to-face 
interviews with members of the public. The final versions of the interventions were then assessed 
in several studies guided by the MRC framework for developing and evaluating complex 
interventions (Studies 2, 3 and 4). 
10.2.3 Chapter 7 – Study 2 
Study 2 was a single-arm trial that assessed the feasibility and potential efficacy of sending 
previous BSS non-responders the self-referral reminder and theory-based leaflet 12 months after 
their original invitation. A total of 160 men and women who did not respond to the initial invitation 
within one year were randomly selected for inclusion in the study and were mailed a self-referral 
reminder. Twenty-five self-referred and attended an appointment, which exceeded the threshold 
for further investigation in a RCT. 
A number of additional observations were made within this study. First, it was documented that 
women who self-referred for an appointment were more likely to express a preference for a same-
sex practitioner than men who self-referred for an appointment. Second, although half of all 
people who self-referred for screening expressed a preference for the day and time of the 
appointment, the inability to accommodate this preference only deterred one person from 
continuing to arrange an appointment, suggesting that it is not necessarily receiving the preferred 
appointment that is the important factor for people who self-refer, but the option to arrange one’s 
own appointment over the phone. 
10.2.4 Chapter 8 – Study 3 
Study 3 was a single-centre RCT with three parallel arms. The study design enabled me to 
compare uptake among groups of individuals receiving either: no reminder (control), a self-referral 
reminder with the standard information booklet, or a self-referral reminder with the theory-based 
leaflet, and thereby test the effects of the reminder and leaflet separately. The study design also 
enabled me to test the differential impact of the self-referral reminder on different groups of non-
participants (both non-responders and non-attenders were included in the study). 
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The results of the trial demonstrated that sending non-participants a self-referral reminder with 
either leaflet was more effective than usual care (uptake in the control, TMR-SIB and TMR-TBL 
groups was 0.2%, 10.4% and 15.2% respectively). In addition, the study showed that sending the 
self-referral reminder with the theory-based leaflet was more effective than sending it with the 
standard information booklet. The results also revealed that, contrary to previous research 
suggesting that non-attenders might never translate their intentions into actions (Power et al., 
2008), previous non-attenders were more likely to self-refer and attend an appointment than 
previous non-responders (uptake was 8.0% and 14.2%, respectively), and that these individuals 
represent a willing group who should not be excluded. The cost of the interventions was consistent 
with others currently used by the BSSP.  
10.2.5 Chapter 9 – Study 4 
Study 4 was an extension of the RCT described in Chapter 9. It examined the impact of sending 
non-responders and non-attenders a second self-referral reminder, twenty-four months after their 
initial invitation. The results of the study were similar to those observed in the RCT. Additional 
uptake (i.e. uptake for the extension only) was higher among non-participants allocated to the 
reminder groups (additional uptake in the control, TMR-SIB and TMR-TBL groups was 0.4%, 
4.8% and 7.9% respectively). However, there was no significant difference between groups in 
terms of the information used.  
Overall uptake (i.e. uptake reported for the RCT and extension combined) was higher among non-
participants allocated to the reminder groups (overall uptake in the control, TMR-SIB and TMR-
TBL groups was 0.7%, 14.5% and 21.5%, respectively). The cost of the sending a second 
reminder was slightly higher than the first, but was still similar to other interventions used to 
promote the uptake of FS screening. The ADR among screened adults was comparable to that 
of initial attenders. Preferences for a same-sex practitioner were confirmed to be higher among 
women, but did not vary by any other baseline characteristics. 
10.3 Strengths 
10.3.1 St Mark’s Hospital 
Conducting the studies at St Mark’s Hospital was a major strength of the research. The centre 
funded the development of the interventions, and was therefore highly motivated to deliver them. 
In addition, the centre had previous experience organising self-referred appointments as part of 
the UK FS trial (Atkin et al., 2010), and it seems likely that this experience benefitted the research 
in terms of the centre’s ability and willingness to incorporate the self-referral reminder.  
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10.3.2 Measurement of uptake 
All of the studies reported in this thesis used objective measures of self-referral and uptake, as 
opposed to self-reported measures, which have previously been shown to be less reliable (Baier 
et al., 2000; Rauscher et al., 2008; Lo et al., 2016). 
10.3.3 Randomised designs 
Studies 3 and 4 used randomised designs. Such designs add validity to the conclusions of studies 
and are considered the gold standard approach for testing public health interventions (Sackett et 
al., 1996).  
10.3.4 Parallel groups 
In addition to using randomised designs, Studies 3 and 4 used parallel groups (i.e. randomisation 
was performed at the level of the individual). Parallel groups are less vulnerable to sample bias 
than clustered groups (i.e. randomisation of clusters of individuals, e.g. patients registered with a 
GP practice; Donner and Klar., 2004). They are also more efficient, requiring fewer participants 
to achieve statistical power (Campbell and Donner., 2007; Wardle et al., 2016). Four recent RCTs 
conducted within the English BCSP illustrate this point very clearly (McGregor et al., 2016b; Raine 
et al., 2016a; Raine et al., 2016b; Smith et al., 2017). They each had sample size requirements 
in excess of 40,000 participants per trial arm after factoring in the use of small clusters; nearly 
twice their estimated sample size with parallel groups (Wardle et al., 2016). 
10.3.5 Demand characteristics and social desirability 
Individuals included in Studies 2, 3 and 4 were not informed they were participants in a research 
study. As such, the data were not vulnerable to demand characteristics or social desirability bias 
(Podsakoff et al., 2003), both of which have been shown to affect CRC screening research (Van 
de Mortel., 2008).  
10.3.6 Intention-to-treat method 
The data from Studies 2, 3 and 4 were assessed on an intention-to-treat basis. This method of 
analysis assesses uptake between individuals as they were originally allocated and is considered 
to be ecologically superior to the per-protocol method of analysis (Newell., 1992; Detry and 
Lewis., 2014; Abraha et al., 2015), which incurs bias through the removal of individuals who do 
not complete the treatment regimen (Montori and Guyatt., 2001).  
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10.3.7 Study setting 
The setting of the studies described in this thesis is one that contains an ethnically diverse 
population from a range of socioeconomic areas. As such, the results are likely to be 
generalisable to other London boroughs and national and international urban settings struggling 
to reach the European target for acceptable participation in CRC screening (i.e. 45%; von Karsa 
et al., 2013; Klabunde et al., 2015). 
10.3.8 Non-participant subgroups 
Studies 3 and 4 included both non-responders and non-attenders, meaning that it was possible 
to explore the differential impact of the interventions on subgroups of non-participants, and 
thereby address a limitation of Study 2.  
10.4 Limitations 
10.4.1 St Mark’s Hospital 
Conducting the research at a single centre (which initiated and funded this research) limited my 
ability to assess how easily the interventions could be implemented at other centres. It is possible 
that centres which were not involved in the funding or development of the interventions would be 
less willing to implement them, as they do not have the same vested interests. Centres that were 
not involved in the UK FS trial might be particularly reluctant to implement them, as they have 
less experience facilitating self-referral appointments. They may also find them difficult to 
incorporate alongside usual care because of this.  
10.4.2 Proportion of eligible adults 
None of the studies used the entire population of individuals eligible for self-referral reminders. It 
remains to be seen, therefore, whether self-referral reminders could be offered to the all non-
participants. The issue is compounded by the fact that the 12 and 24-month reminders were not 
sent out at the same time. Both reminders facilitated uptake in a considerable proportion of 
individuals, irrespective of whether they were sent with the theory-based leaflet or standard 
information booklet.  
10.4.3 Measurement of area-level deprivation 
The measurement of area-level deprivation was an important aspect of this thesis. Across all four 
studies, area-level deprivation was measured using the IMD, which is the government’s official 
measure of relative deprivation for small areas in England (Department for Communities and 
Local Government., 2011). The studies reported in this thesis used data from the 2010 index, as 
this was the latest version available at the time. Given that the studies were conducted between 
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2014 and 2016, and the 2010 IMD census data collected in 2001, the measure used may be 
outdated, especially for London, which has a transient and changing population. It may also be a 
less reliable measure in London because of the diversity of the population, even within a single 
postcode sector. 
10.4.4 Lack of controls 
While Studies 3 and 4 did include a control group receiving no reminders (i.e. 12 or 24 months 
after the initial invitation), Study 4 did not include a group that only received the 24-month 
reminder, and as such, it is not possible to say whether uptake would have been the same or 
higher had a single reminder been delivered at this time point (i.e. as opposed to one 12 months 
after the initial invitation and then a second 24 months after the initial invitation).  
10.4.5 Missing ethnicity data 
Ethnicity data were not available for all individuals included in Studies 3 and 4. Previous research 
has found that some ethnicities are more likely to report the gender of the practitioner performing 
the test as a potential barrier to screening (Zapatier et al., 2011). The same ethnicities have also 
been shown to be less likely to take part in screening (Robb et al., 2008a). It would have been 
interesting, therefore, to see whether the offer of a same-sex practitioner improved uptake in these 
individuals. Future research may address this through a RCT using ethnicity data available on the 
GP clinical system. 
10.4.6 Multi-factorial behavioural interventions  
The interventions used a number of BCTs, including prompts / cues, information about health 
consequences and feedback on the outcomes of the behaviour. As such, it is not possible to say 
whether the effects of the interventions were due to a single BCT, or a combination of some or all 
of the BCTs. Running a trial with multiple versions of the interventions, each including combination 
of one or more of the BCTs would enable the effect of each BCT to be teased apart from the 
overall effect. A factorial RCT would be the most statistically efficient approach (Winer et al., 
1971). 
10.4.7 Complex interventions 
Differences between the standard information booklet and theory-based leaflet were not limited 
to the use of theory. The theory-based leaflet was shorter and more readable (i.e. had a lower 
readability score) than the standard information booklet used by the NHS, and so may have been 
more effective for these reasons, as well as the use of BCTs. The theory-based leaflet also 
contained photos, which the standard information booklet does not (it uses cartoons instead; see 
Appendix 2-3), and was tailored to the local population. Any of these differences may have 
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contributed towards the effectiveness of the interventions. Disentangling their effects from those 
of the BCTs would add an additional layer of complexity to evaluating the theory-based leaflet. It 
may be more feasible and less costly, therefore, to interview people who attend an appointment 
after receiving the self-referral reminder and theory-based leaflet. Such studies might provide 
valuable insights into the reasons why people are more likely to change their screening behaviour 
in one condition over the other (see 10.6 Further research).  
10.4.8 Study setting 
As discussed in Chapter 5, the London Boroughs of Brent and Harrow are among the most 
ethnically diverse, with over half of all residents living in these boroughs being of a non-White 
ethnic background. While the setting of the studies enabled me to generalise the findings to other 
London boroughs and national international urban settings, I am not able to generalise the 
findings to non-urban settings. 
10.5 Implications for policy and practice 
10.5.1 St Mark’s Hospital 
Since publishing the results of the feasibility study (Kerrison et al., 2016) and RCT (Kerrison et 
al., 2017), NHS England (London region) have commissioned St Mark’s BCSC to send all non-
responders and non-attenders a self-referral reminder 12 months after their initial invitation (see 
Appendix 10-1). The finding that NHS England (London region) have commissioned this work is 
highly encouraging. It can take years for research to be implemented into practice (Morris et al., 
2011), but the decision to implement self-referral reminders at St Mark’s Hospital has taken place 
within months of the results of the RCT being published and presented at conferences. It is 
possible that, with the results of the extension now published (Kerrison et al., 2018), PHE will 
commission St Mark’s Hospital to send previous non-responders and non-attenders a second 
self-referral reminder (i.e. 24-months after the initial invitation) as part of a future initiative. The 
results from this thesis suggest that doing so would be effective and would improve the overall 
uptake of BSS at St Mark’s Hospital even further. 
10.5.2 Other centres 
With regards to other centres, there is no reason to believe that self-referral reminders would not 
be as effective, although it would be important to perform multicentre studies before rolling-out 
these reminders too widely. Perhaps the biggest consideration is whether some centres are willing 
and able to facilitate the additional appointments brought about by the self-referral reminder. 
Another important consideration would be the offer of a same-sex practitioner. Not every 
screening centre in England has both male and female screening practitioners, and so, for some 
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centres, providing a same-sex practitioner to the patient is not an option. These aspects, among 
others, would need to be investigated in future studies.  
The English Programme should consider implementing a 12-month reminder to improve uptake. 
Doing so would most likely bring uptake up to the European benchmark of acceptable participation 
(i.e. 45%). Other countries looking to employ FS screening should also consider including a 
routine 12-month reminder for the non-responding population when setting up the programme. 
Findings from this thesis suggest that delivering such reminders with materials designed using 
theory are likely to have additional benefits on uptake (Michie and West., 2013).  
10.6 Further research 
The findings and limitations for the work reported in this thesis point towards several different 
avenues for further research.  
10.6.1 Monitoring self-referral at St Mark’s Hospital 
Now that self-referral reminders have been implemented at St Mark’s Hospital, it will be important 
to monitor their roll-out to the entire eligible population. As discussed in the Limitations section 
(see 11.4), only a proportion of adults eligible to receive a self-referral reminder were included in 
the studies reported in this thesis, and so it remains to be seen whether the centre is able to 
facilitate roll-out to all eligible adults without increasing their endoscopy capacity.  
10.6.2 Health economic analysis 
A full health economic analysis is now required to assess the cost-effectiveness of the self-referral 
reminder. The results of such an analysis would enable policy and decision makers to decide 
whether to implement these reminders at St Mark’s BCSC and other centres in the future.  
10.6.3 Evaluating additional reminders 
During the timeframe of this thesis, it was not possible to test the effectiveness of sending 
additional ‘annual’ self-referral reminders 36 and 48 months after the initial invitation. It may be 
worth investigating reminders delivered at these time points in future studies. The present findings 
suggest that they are likely to yield diminishing returns, but that they may still yield clinically 
meaningful results nonetheless.  
It is also possible that the reminders would have been more effective had they been delivered at 
different times (e.g. three and six months after the reminder, as opposed to 12 and 24 months 
after the reminder). For some individuals, there may be seasonal reasons why they are unable to 
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attend BSS (e.g. going on holiday, looking after children during the school holidays, etc.). Varying 
the timing of the reminder may benefit these individuals specifically. 
10.6.4 Enhancing the self-referral reminder 
Additional components, such as GP endorsement (Wardle et al., 2016), offering an endoscopist 
of the same ethnicity (Zapatier et al., 2011), having the enema administered at the hospital 
(Friedemann‐Sánchez., 2007) and offering a timed appointment (Hudson et al., 2016) might 
augment the observed effect of the self-referral reminder. Two recent studies found that offering 
breast screening non-participants a second timed appointment was more effective than a 
reminder with instructions on how to book an appointment (Hudson et al., 2016; Allgood et al., 
2017). It is possible that they may also be more effective than reminders for BSS. Future studies 
looking to improve participation using self-referral reminders should consider this potential 
augmentation a priority.  
10.6.5 Alternative strategies to improve uptake 
This thesis examined interventions to improve uptake by targeting non-participants; however, it 
did not examine interventions to improve uptake prior to or during the initial invitation. Studies 
examining interventions to promote uptake at both of these stages of the screening pathway 
indicate that such interventions can be implemented and have potential to improve uptake (Duffy 
et al., 2016). Future studies could also aim to promote uptake, therefore, by enhancing the pre-
invitation and invitation stages to minimise the number of non-participants. It is likely that there 
will remain a place for interventions focusing on non-participants, however. The NHS Breast 
Screening Programme has been in operation now for over 25 years and still there is scope for 
improvement and recent studies have shown that offering non-participants a second timed 
appointment can improve uptake above and beyond current participation (Hudson et al., 2016; 
Allgood et al., 2017). 
10.7 Concluding remarks 
The interventions described in this thesis constitute the first to be examined in the context of an 
organised national FS-based screening programme for CRC. Countries looking to employ FS 
screening with an aim of achieving high uptake should consider using self-referral reminders for 
the non-responding population; delivering such reminders with a theory-based leaflet might 
improve uptake further. Future research should consider the programme costs of implementing a 
self-referral reminder nationally.  
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Appendices 
Appendix 1-1. UK National Screening Committee Criteria for Screening (Public Health 
England, 2013b). 
The condition 
 The condition should be an important health problem. 
 The epidemiology and natural history of the condition, including development from 
latent to declared disease, should be adequately understood and there should be a 
detectable risk factor, disease marker, latent period or early symptomatic stage. 
 All the cost-effective primary prevention interventions should have been implemented 
as far as practicable. 
 If the carriers of a mutation are identified as a result of screening, the natural history of 
people with this status should be understood, including the psychological implications. 
The test 
 There should be a simple, safe, precise and validated screening test. 
 The distribution of test values in the target population should be known and a suitable 
cut-off level defined and agreed. 
 The test should be acceptable to the population. 
 There should be an agreed policy on the further diagnostic investigation of individuals 
with a positive test result and on the choices available to those individuals. 
 If the test is for mutations, the criteria used to select the subset of mutations to be 
covered by screening, if all possible mutations are not being tested, should be clearly 
set out. 
The treatment 
 There should be an effective treatment or intervention for patients identified through early 
detection, with evidence of early treatment leading to better outcomes than late treatment. 
 There should be agreed evidence-based policies covering which individuals should be 
offered treatment and the appropriate treatment to be offered. 
 Clinical management of the condition and patient outcomes should be optimised in all 
healthcare providers prior to participation in a screening programme. 
Cost considerations 
 There should be evidence from high-quality randomised controlled trials that the 
screening programme is effective in reducing mortality or morbidity. Where screening is 
aimed solely at providing information to allow the person being screened to make an 
informed choice (eg, Down's syndrome, cystic fibrosis carrier screening), there must be 
evidence from high-quality trials that the test accurately measures risk. The information 
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that is provided about the test and its outcome must be of value and readily understood 
by the individual being screened.  
 There should be evidence that the complete screening programme (test, diagnostic 
procedures, treatment/intervention) is clinically, socially and ethically acceptable to 
health professionals and the public. 
 The benefit from the screening programme should outweigh the physical and 
psychological harm (caused by the test, diagnostic procedures and treatment). 
 The opportunity cost of the screening programme (including testing, diagnosis and 
treatment, administration, training and quality assurance) should be economically 
balanced in relation to expenditure on medical care as a whole (ie value for money). 
Assessment against this criteria should have regard to evidence from cost benefit 
and/or cost-effectiveness analyses and have regard to the effective use of available 
resource. 
 All other options for managing the condition should have been considered (eg, 
improving treatment, providing other services), to ensure that no more cost-effective 
intervention could be introduced or current interventions increased within the resources 
available. 
 There should be a plan for managing and monitoring the screening programme and an 
agreed set of quality assurance standards. 
 Adequate staffing and facilities for testing, diagnosis, treatment and programme 
management should be available prior to the commencement of the screening 
programme. 
 Evidence-based information, explaining the consequences of testing, investigation and 
treatment, should be made available to potential participants to assist them in making 
an informed choice. 
 Public pressure for widening the eligibility criteria for reducing the screening interval, 
and for increasing the sensitivity of the testing process, should be anticipated. 
Decisions about these parameters should be scientifically justifiable to the public. 
 If screening is for a mutation, the programme should be acceptable to people identified 
as carriers and to other family members. 
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Appendix 2-1. Preinvitation letter for the national screening programme.  
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Appendix 2-2. Invitation and appointment letter for the national screening programme. 
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Appendix 2-3. Information booklet for the NHS Bowel Scope Screening Programme.  
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Appendix 2-4. Reminder letter for the NHS Bowel Scope Screening Programme. 
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Appendix 2-5. Cancellation letter for the NHS BSS Programme.  
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Appendix 2-6. Cancellation letter to the invitees General Practice for the national screening 
programme.  
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Appendix 2-7. Appointment confirmation letter for the national screening programme.  
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Appendix 2-8. Enema letter for the national screening programme.  
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Appendix 2-9. Enema leaflet for the national screening programme.  
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Appendix 2-10. Consent form for the national screening programme.  
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Appendix 5-2. Distribution of the population by demographic factors (Office for National 
Statistics, 2011). 
 Brent Harrow London England 
No. of people 311,215 239,056 8,173,941 53,012,456 
Diversitya 
   White (%) 36.4 42.3 59.8 85.5 
   Asian (%) 34.0 42.7 18.4 7.7 
   Black (%) 18.8 8.2 13.4 3.5 
   Chinese/other (%) 10.8 6.8 8.4 3.3 
Economic activitya 
Economically Active; Employee; Full-Time 35.8 37.5 39.8 38.6 
Economically Active; Employee; Part-
Time 
11 12.3 10.9 13.7 
Economically Active; Self-Employed 12.8 12.7 11.7 9.8 
Economically Active; Unemployed 5.8 4.5 5.2 4.4 
Economically Active; Full-Time Student 4.7 3.7 4.1 3.4 
Economically Inactive; Retired 8 10.3 8.4 13.7 
Economically Inactive; Student (Including 
Full-Time Students) 
8.5 7.7 7.8 5.8 
Economically Inactive; Looking After 
Home or Family 
5.6 5.5 5.2 4.4 
Economically Inactive; Long-Term Sick or 
Disabled 
3.9 2.9 3.7 4 
Economically Inactive; Other 3.9 2.9 3.2 2.2 
Car or van availabilitya 
No Cars or Vans in Household 43 23.5 41.6 25.8 
1 Car or Van in Household 39.5 43.9 40.5 42.2 
2 Cars or Vans in Household 13.5 24.9 14 24.7 
3 Cars or Vans in Household 3.1 5.9 2.9 5.5 
4 or More Cars or Vans in Household 0.9 1.8 1.0 1.8 
Marital and civil partnership statusa 
Single (never married or registered a civil 
partnership) 
42.1 32.3 44.1 34.6 
Married 43.2 53.7 39.8 46.6 
In a registered same-sex civil partnership 0.3 0.2 0.4 0.2 
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Separated (but still legally married or in a 
civil partnership) 
3.4 2.3 3.2 2.7 
Divorced or formerly in a civil partnership 
now legally dissolved 
6.2 5.4 7.5 9 
Widowed or surviving partner from a 
same-sex civil partnership 
4.8 6.1 5 6.9 
Religiona 
Christian 41.5 37.3 48.4 59.4 
Buddhist 1.4 1.1 1 0.5 
Hindu 17.8 25.3 5 1.5 
Jewish 1.4 4.4 1.8 0.5 
Muslim 18.6 12.5 12.4 5 
Sikh 0.5 1.1 1.5 0.8 
Other religion 1.2 2.5 0.7 0.4 
No religion 10.6 9.6 20.7 24.7 
Religion not stated 7.0 6.2 8.5 7.2 
Education (Highest Qualification)b 
No qualifications 19.2 16.8 17.6 22.5 
Level 1 qualification 10.4 10.9 10.7 13.3 
Level 2 qualifications 10.9 12.8 11.8 15.2 
Level 3 qualifications 9.7 10.4 10.5 12.4 
Level 4 qualifications and above 33.3 36.8 37.7 27.4 
Other qualifications 15.4 10.6 10.1 5.6 
Apprenticeship 1.1 1.7 1.6 3.6 
Housing tenurec 
Owned; owned outright 20.3 31.1 21.1 30.6 
Owned; owned with a mortgage or loan 22.6 34.1 27.1 32.8 
Shared Ownership (part owned and part 
rented) 
1.5 1 1.3 0.8 
Social Rented; rented from council (local 
authority) 
9.7 6.1 13.5 9.4 
Social rented; other 14.4 4.5 10.6 8.3 
Private rented; private landlord or letting 
agency 
28.8 20.4 23.7 15.4 
Private rented; other 1.3 1.4 1.3 1.4 
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Living rent free 1.4 1.4 1.4 1.3 
Household languagec 
All people aged 16+ in household have 
English as a main language 
57 67 74 90.9 
At least one person aged 16+ in 
household have English as a main 
language  
16.3 13.5 10.5 3.9 
No one aged 16+ in household but at 
Least one Person aged 3-15 has English 
as a main language  
4.3 3.6 2.6 0.8 
No one in household has English as a 
Main Language 
22.4 15.9 12.9 4.4 
aAll usual residents aged over 16. 
bAll usual residents aged over 16 not in education. 
cAll households. 
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Appendix 5-3. Flow of data through study 1.  
  
Data transferred to St Mark’s Hospital 
via a secure NHS.Net connection 
Master copy containing study IDs 
retained by St Mark’s Hospital 
List of pseudonymised postcodes 
transferred to UCL 
Data merged with study database and 
transferred to UCL for analysis 
Data extracted from BCSS by Eastern 
Bowel Cancer Screening Hub 
Postcodes converted into area-level 
measures of deprivation and diversity 
Data received and pseudonymised by 
St Mark’s Hospital 
Data returned to St Mark’s and 
merged with study database for 
Data request submitted by St Mark’s 
Hospital 
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Appendix 6-1. Worksheet 1 - Define the problem in behavioural terms.  
Question Answer 
What behaviour? Uptake of bowel scope screening. 
Where? St Mark’s Hospital. 
Who? Eligible men and women aged 55-59. 
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Appendix 6-2.  Worksheet 2 - Select target behaviour. 
Task 1. Generate a list of candidate target behaviours that could bring about the desired outcome 
Intervention aim: Improve uptake of Bowel Scope Screening among eligible adults at St Mark’s Hospital. 
Candidate target behaviours:  
1) Confirmation of initial appointment offered 
2) Attendance of confirmed appointment 
3) Self-referral  
Task 2. Prioritise candidate target behaviours 
Potential target 
behaviours relevant to 
improving uptake of BSS 
at St Mark’s Hospital 
How much of an impact will 
changing the behaviour have 
on desired outcome? 
How likely it is that 
behaviour can be 
changed? 
How likely is it that the behaviour 
will have an impact on other related 
behaviours? 
How easy will it be 
to measure the 
behaviour? 
1) Confirmation of initial 
appointment 
A big impact, 80% of people who 
confirm their initial appointment 
attend 
Not very likely, can’t 
change invitation 
materials 
Not likely to change attendance of 
confirmed appointments or self-referral 
Very easy – data 
available on the 
BCSS 
2) Attendance of confirmed 
appointment 
A moderate impact, if everyone 
who confirmed their appointment 
attended uptake would increase 
by 10% 
Not very likely, can’t 
change existing 
reminder materials 
Not likely to change self-referral or 
acceptance of initial appointment 
offered 
Very easy – data 
available on the 
BCSS 
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3) Self-referral  A big impact, half of non-
participants interviewed in a 
recent study indicated they would 
consider screening in the future 
Very likely, can 
introduce non-
participant interventions 
Not likely to change acceptance of 
initial appointment offered or 
attendance of confirmed appointments 
Very easy – data 
available on the 
BCSS 
Selected target behaviour: Self-referral  
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Appendix 6-3. Worksheet 3 – Specify the target behaviour.  
Task 1. Describe the target behaviour according to who needs to do what, when, where, how 
often and with whom 
Question Answer 
What is the target behaviour? Self-referral  
Who needs to perform the behaviour? BSS non-participants 
What do they need to do to achieve the 
desired change? 
Book an appointment 
Where do they need to do it? They can do it from anywhere 
How often do they need to do it? Once, before the age of 60 
With whom do they need to do it? A member of staff at St Mark’s Hospital 
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Appendix 6-4. Worksheet 4 – Identify what needs to change. 
Task 1. Describe the target behaviour according to who needs to do what, when, where, how often and with whom 
COM-B components TDF domains linking to COM-B components What needs to happen for the target 
behaviour to occur? 
Is there a need for change? 
Physical capability Physical skills The appointment needs to be 
convenient  
No, people who self-refer for 
screening are able to choose the 
day and time of their appointment 
Psychological capability Knowledge The person needs to know the harms 
and benefits of screening 
Yes, 63% of CRC screening non-
participants report that they did 
not read the information leaflet 
(Koboyashi et al., 2016), and 
86% of all age-appropriate adults 
do not know that BSS helps 
prevent bowel cancer (Chorley et 
al., 2017) 
Cognitive and interpersonal skills The person needs to be able to read 
and understand the information 
provided to them 
Yes, 63% of non-participants do 
not read the information currently 
used by the programme 
(Kobayashi et al., 2016) 
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 Memory attention and decision processes Not relevant - 
Behavioural regulation Not relevant - 
Physical opportunity Environmental context and resources Non-participants need to be reminded 
of the procedures for self-referral 
Yes, there are currently no cues 
reminding non-participants of the 
procedures for self-referral 
Social opportunity Social influences The behavioural needs to be 
normalised 
Yes, BSS is still very novel, and 
therefore not yet normalised 
Reflective motivation Social professional role and identity Person needs to perceive themselves 
as someone who looks after their 
health 
Yes, person needs to be made 
aware that they are at risk of 
developing bowel cancer 
Beliefs about capabilities Not relevant Not relevant 
Optimism Not relevant Not relevant 
Intentions Person has to intend to go for BSS  Yes, person needs to translate 
their intentions into actions by 
self-referring for BSS 
Goals Not relevant Not relevant 
Beliefs about consequences Person needs to believe in the 
effectiveness of screening 
Yes, 86% of all age-appropriate 
adults do not know that BSS 
helps prevent bowel cancer 
(Chorley et al., 2017) 
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Automatic motivation  Reinforcement Not relevant Not relevant 
Emotion Not relevant Not relevant 
Behavioural diagnosis of 
the relevant COM-B 
components: 
Psychological capability, physical opportunity, social opportunity and reflective motivation need to change in order for the 
behaviour to occur. 
2
4
6
 
A
p
p
e
n
d
ic
e
s
 
 
0. Appendices 
 
247 
 
Appendix 6-5. Worksheet 5 – Identify intervention functions.  
Candidate intervention functions Does the intervention function meet the 
APEASE criteria (affordability, 
practicability, effectiveness/cost-
effectiveness, acceptability, side-
effects/safety, equity) in the context of 
self-referring for an appointment after the 
initial invitation? 
Modelling Yes 
Environmental restructuring Yes 
Persuasion Yes 
Incentivisation  No, unethical/not acceptable 
Coercion  No, unethical/not acceptable 
Education Yes 
Training Not relevant in context of self-referral 
Enablement Yes 
Restriction Not relevant in context of self-referral 
Selected Intervention functions: Modelling, environmental restructuring, 
persuasion, education and enablement 
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Appendix 6-6. Worksheet 6 – Identify policy categories.  
Intervention function COM-B component Potentially useful policy 
categories 
Does the policy category meet 
the APEASE criteria in the 
context of self-referring for an 
appointment after the initial 
invitation? 
Modelling Social opportunity 
Automatic motivation 
Communication/marketing  Yes 
Service provision Not relevant in self-referral context 
Environmental restructuring 
Physical opportunity 
Social opportunity 
Automatic motivation 
Guidelines Possible in the long term, but not 
present 
Fiscal measures No, not acceptable. 
Regulation Not relevant in the self-referral 
context 
Legislation Not relevant in the self-referral 
context 
Environmental/social planning Not relevant in the self-referral 
context 
Persuasion 
Automatic motivation 
Reflective motivation 
Communication/marketing As above 
Guidelines As above 
Regulation As above 
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  Legislation As above 
Service provision As above 
Education  
Psychological capability 
Reflective motivation 
Communication/marketing As above 
Guidelines As above 
Regulation As above 
Legislation As above 
Service provision As above 
Enablement Physical capability 
Psychological capability 
Physical opportunity 
Social opportunity 
Automatic motivation 
Guidelines As above 
Fiscal measures As above 
Regulation As above 
Legislation As above 
Environmental/social planning As above 
Service provision As above 
Policy category selected: Communication/marketing 
 
 
  
2
4
9
 
A
p
p
e
n
d
ic
e
s
 
 
0. Appendices 
 
250 
 
Appendix 6-7. Worksheet 7 – Identify behaviour change techniques.  
Intervention function COM-B component Most frequently used BCTs Does the BCT meet the APEASE 
criteria in the context of self-
referring for an appointment after 
the initial invitation? 
Modelling Social opportunity 
Automatic motivation 
Demonstration of the behaviour Yes 
Environmental restructuring Physical opportunity 
Social opportunity 
Automatic motivation 
Adding objects to the environment Yes 
Prompts/cues Yes 
Restructuring the physical 
environment 
Not relevant in the self-referral 
context 
Persuasion Automatic motivation 
Reflective motivation 
Credible source Yes 
Information about social and 
environmental consequences 
Not relevant in self-referral context 
Information about health 
consequences 
Yes 
Feedback on behaviour No, not practicable 
Feedback on outcome(s) of the 
behaviour 
Yes 
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Education. Psychological capability 
Reflective motivation 
Information about social and 
environmental consequences 
As above 
Information about health 
consequences 
As above 
Feedback on behaviour As above 
Feedback on outcomes of the 
behaviour 
As above 
Prompts/cues As above 
Self-monitoring of behaviour Not applicable 
Enablement Physical capability 
Psychological capability 
Physical opportunity 
Social opportunity 
Automatic motivation 
  
BCTs selected: Demonstration of the behaviour, adding objects to the environment, prompts/cues, credible source, information about health 
consequences and feedback on outcome(s) of the behaviour 
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Appendix 6-8. Worksheet 8 –  Identify mode of delivery.  
Mode of delivery Does the mode of delivery 
meet the APEASE criteria 
in the context of self-
referring for an 
appointment after the 
initial invitation? 
Face-to-face Individual No, not likely to be 
affordable, practicable or 
cost-effective 
Group No, not likely to be 
affordable, practicable or 
cost-effective 
Distance Population-level Broadcast media TV No, not likely to be 
affordable or practicable 
Radio No, not likely to be 
affordable or practicable 
Outdoor media Billboard No, not likely to be 
practicable or equitable 
Poster No, not likely to be equitable 
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  Print media Newspaper No, not likely to be equitable 
Leaflets  Yes 
Digital media Internet No, not likely to be equitable 
Mobile phone app No, not likely to be equitable 
Individual-level Phone Phone call No, not likely to be cost-
effective 
Mobile phone text No, not likely to be equitable 
or practicable (screening 
centre does not have access 
to telephone numbers) 
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Appendix 6-9. Overview of perceived barriers and benefits to BSS reported in the 
previous literature 
Barriers 
Vernon., 1997 
Absence of current health problems 
Practical reasons (e.g. conflicts with work or family, 
inconvenience, being too busy, being out of town, 
lack of interest and cost) 
Worried about pain, discomfort, or injury associated 
with the examination 
Not wanting to know about health problems 
McCaffery et al., 2001 
Avoidant attitudes 
Forgetting to make a decision 
Test not necessary 
Embarrassment 
Fear of pain / discomfort associated with test 
Practical barriers 
James et al., 2002 
Doctor never recommended test 
Test would be painful 
Tests are too expensive 
Tests would be too embarrassing 
Preparation is too hard  
Janz et al., 2003 
No need / problems 
Embarrassing 
Pain 
Anxious about procedure 
Cost 
Farraye et al., 2004 
Enema difficult 
FS exam inconvenient 
Believe FS unimportant 
Lack of symptoms 
Concerns about infection from unsterile equipment 
Do not need FS as too old 
Friedemann‐Sánchez., 2007 
 
Test invasive 
Concerned about being exposed 
Concerned about pain 
Concerns about the enema 
Embarrassed 
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Austin et al., 2009 
Invasive  
Lack of confidence in completing the enema 
Fear of cancer / results / the unknown 
Lack of symptoms 
Concerns about the gender of the practitioner 
performing the test 
Threat to masculinity 
Language difficulties 
Concerns about invite not coming from own GP 
Lack of awareness 
Having the test would take up too much time 
Jones et al., 2010a 
Not wanting to do the preparation and take laxatives 
Healthcare provider has never suggested the having 
test 
Worried that the test is uncomfortable of painful 
Not wanting a tube inserted into the rectum 
Not knowing whether they should have the test 
Lack of time, inconvenience, and lack of transportation 
Distasteful, prolonged bowel preparation 
Embarrassing / humiliating 
Invasive 
Painful / uncomfortable / discomfort 
Cost (e.g. unaffordable co-payment / deductible) / lack 
of insurance coverage 
Being awake during procedure 
Examines only distal colon 
Honein-AbouHaidar et al., 2016 
Lack of awareness of CRC screening 
Fear of cancer, screening results and treatment 
Cancer is fatal and no screening can stop it 
Negative attitudes towards CRC screening tests 
Embarrassment 
Questioning efficacy of the test 
Other health concerns  
Competing life demands deterred from seeking 
screening 
Transportation and finding an escort was a challenge 
Low health literacy 
Language barriers 
Scheduling challenges 
Ethnic foods protect from CRC 
Wellness visits are not part of the culture 
CRC screening tests are offensive to masculinity 
Females perceived CRC as a male disease 
Taking time off was not possible 
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Hall et al., 2016 
FS not felt to be required 
FS not wanted 
Concerns about FS investigation 
Competing priorities 
Unwilling or unable to administer enema 
Unable to attend provided appointment 
Not realised need to confirm appointment 
Unable to administer enema 
Unexpected events 
Fear of test / unable to proceed with FS 
Benefits 
Sutton et al., 2000 Peace of mind 
James et al., 2002 
Sets a good example for family 
Will take care of body as God’s Holy temple 
Will have better control over health 
Will be following doctor’s advice 
Will worry less 
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Appendix 6-10. Leaflet extract 1.  
 
 
Appendix 6-11. Leaflet extract 2. 
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Appendix 6-12. Promotional flyer for participant interview study.  
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Appendix 6-13. Interview schedule for participant interviews.  
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Appendix 6-14. Participant consent form for participant interviews.  
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Appendix 6-15. Leaflet extract 3.  
 
 
Appendix 6-16. Reminder letter extract 1. 
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Appendix 6-17. Letter extract 2.  
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Appendix 6-18. Leaflet extract 4.  
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Appendix 6-19. Leaflet extract 5.  
 
Appendix 6-20. Leaflet extract 6. 
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Appendix 6-21. Leaflet brief.  
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Appendix 6-22. Co-design workshop guide.  
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Appendix 6-23. Co-design workshop report. 
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Appendix 6-24. Interview schedule. 
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Appendix 6-25. UCL JRO Insurance confirmation letter.  
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Appendix 6-26. UCL JRO Insurance confirmation certificate. 
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Appendix 7-1. Publication of Study 2.  
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Appendix 7-2. UCL JRO Insurance confirmation letter. 
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Appendix 7-3. UCL Insurance certificate. 
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Appendix 7-4. Favourable opinion with conditions. 
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Appendix 7-5. Acknoweledgement of compliance with conditions. 
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Appendix 7-6. R and D approval letter. 
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Appendix 7-7. Power calculation overview. 
P0 P1 Alpha Beta R+1 n 
0.012 0.0535 0.015 0.01 5 160 
P0 = expected uptake for a poor intervention 
P1 = expected uptake for a good intervention 
R+1 = the minimum number of self-referred appointments required to merit further investigation in a RCT 
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Appendix 8-1. Publication of Study 3.  
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Appendix 8-2. 12-month self-referral reminder letter (TMR-TBL).  
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Appendix 8-3. 12-month self-referral reminder letter (TMR-SIB).  
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Appendix 8-4. Follow-up self-referral reminder letter (TMR-TBL). 
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Appendix 8-5. Follow-up self-referral reminder letter (TMR-SIB). 
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Appendix 8-6. UCL JRO Insurance confirmation letter. 
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Appendix 8-7. UCL Insurance certificate. 
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Appendix 8-8. REC approval for RCT.  
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Appendix 8-9. R and D approval for RCT. 
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Appendix 8-10. Uptake of self-referred appointment by baseline characteristics and 
trial arm (univariable and multivariable regression).  
 
Attended an 
appointment 
n (%) 
Unadjusted OR 
(95% CI) 
Adjusted OR1 
(95% CI) 
Group 
TMR-SIBa 
(n = 64) 
48 
(75.0) 
- - 
TMR-TBL 
(n = 95) 
70 
(73.7) 
0.93 
(0.45 - 1.93) 
0.88 
(0.41 - 1.90) 
Gender 
Womena  
(n = 82) 
56 
(68.3) 
- - 
Men  
(n = 77) 
 
62  
(80.5) 
1.92 
(0.92 - 3.99) 
2.18* 
(1.00 - 4.74) 
CCG 
Brenta 
(n = 100) 
74 
(74.0) 
- - 
Harrow 
(n = 59) 
44  
(74.6) 
1.03 
(0.49 - 2.15) 
1.14 
(0.44 - 2.94) 
Deprivation 
Tertile 1a  
     (n = 49) 
38 
(77.6) 
- - 
Tertile 2 
(n = 59) 
41  
(69.5) 
0.66 
(0.28 - 1.57) 
0.60 
(0.22 - 1.67) 
Tertile 3 
(n = 50) 
39  
(78.0) 
1.03 
(0.40 - 2.65) 
1.00 
(0.30 - 3.29) 
Initial episode status 
Non-respondera 
(n = 137) 
100 
(73.0) 
- - 
Non-attender 
(n = 22) 
18 
(81.8) 
1.67 
(0.53 - 5.24) 
1.38 
(0.42 - 4.55) 
Referral method 
Returned slip 
(n = 142) 
105 
(73.9) 
- - 
Telephoned 
(n = 17) 
13 
(76.5) 
1.15 
(0.35 - 3.73) 
1.04 
(0.30 - 3.61) 
Received a pre-appointment reminder by text and / or by phone 
No 
(n = 68) 
46 
(67.6) 
- - 
Yes 
(n = 91) 
72 
(79.1) 
1.81 
(0.89 - 3.71) 
1.67 
(0.79 - 3.52) 
Abbreviations: OR, Odds Ratio; CI, Confidence Interval; CCG, Clinical Commissioning Group 
1Adjusted ORs and 95% CIs are adjusted for all other co-variates in the table 
aReference category; *P < 0.05; **P < 0.01; ***P < 0.001 
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Appendix 8-11. Clinical findings.  
Clinical finding 12-month reminder  
n (%) 
Adults who attended screening 
No pathology 54 (45.4) 
Normal mucosal polyps 2 (1.6) 
Inflammatory polyps 2 (1.6) 
Hyperplastic polyps 16 (13.5) 
Adenomatous polyps 9 (7.6) 
Cancer 0 
Other pathology (.g. diverticulitis, hemorrhoids, etc.) 31 (26.1) 
Not screened – refused consent 1 (0.8) 
Not screened – did not meet clinical eligibility criteria 4 (3.4) 
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Appendix 8-12. Preference for a same-sex practitioner by trial baseline 
characteristics and trial arm (univariable & multivariable regression outcomes).  
 
Preferred same-sex 
practitioner 
n (%) 
Unadjusted OR 
(95% CI) 
Adjusted OR1 
(95% CI) 
Group 
TMR-SIBa 
(n = 64) 
38 
(59.4) 
- - 
TMR-TBL 
(n = 95) 
71 
(74.7) 
2.02* 
(1.03 - 4.00) 
1.96 
(0.96 - 4.03) 
Gender 
Womena  
(n = 82) 
65 
(79.3) 
- - 
Men  
(n = 77) 
44 
(57.1) 
0.35** 
(0.17 - 0.70) 
0.30** 
(0.14 - 0.64) 
CCG 
Brenta 
(n = 100) 
68 
(68.0) 
- - 
Harrow 
(n = 59) 
41 
(69.5) 
1.07 
(0.54 - 2.15) 
0.94 
(0.37 - 2.38) 
Deprivation 
Tertile 1a  
     (n = 49) 
34 
(69.4) 
- - 
Tertile 2 
(n = 59) 
44 
(74.6) 
1.29 
(0.56 - 3.01) 
1.46 
(0.54 - 3.92) 
Tertile 3 
(n = 50) 
30 
(60.0) 
0.66 
(0.29 - 1.52) 
0.56 
(0.19 - 1.69) 
Initial episode status 
Non-
respondera 
(n = 137) 
96 
(70.1) 
- - 
Non-attender 
(n = 22) 
13 
(59.1) 
0.62 
(0.25 - 1.56) 
0.38 
(0.30 - 2.33) 
Abbreviations: OR, Odds Ratio; CI, Confidence Interval; CCG, Clinical Commissioning Group 
1Adjusted ORs and 95% CIs are adjusted for all other co-variates in the table 
aReference category  
*P < 0.05; **P < 0.01; ***P < 0.001 
Nagelkerke R square = 0.151 
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Appendix 8-13. Ethnicity of adults attending an appointment.  
 Screened adults  
  n (%) 
Asian – Any (n = 52; 44.0%) 
Asian or Asian British – Bangladeshi 1 (0.8) 
Asian or Asian British – Indian 42 (35.6) 
Asian or Asian British – Pakistani 5 (4.2) 
Asian or Asia British – Any other Asian background 4 (3.4) 
White – Any (n = 28; 23.8%) 
White or White British – British 18 (15.3) 
White or White British – Irish 4 (3.4) 
White or White British – Any other White background 6 (5.1) 
Black & Minority Ethnic groups – Any (n = 32; 27.0%) 
Black or Black British – African 6 (5.1) 
Black or Black British – Caribbean  8 (6.8) 
Black or Black British – Any other Black background 3 (2.5) 
Mixed – White and Asian 1 (0.8) 
Mixed – White and Black Caribbean 5 (4.2) 
Mixed – Any other Mixed Background 3 (2.5) 
Other Ethnic Groups – Chinese 2 (1.7) 
Other Ethnic Groups – Any other Ethnicity 4 (3.4) 
Missing (n = 6; 5.2%) 
Ethnicity not recorded 6 (5.2) 
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Appendix 8-14. Preference for a same-sex practitioner by ethnic group (univariable 
& multivariable regression outcomes).  
 
Preferred same-sex 
practitioner 
n (%) 
Unadjusted OR 
(95% CI) 
Adjusted OR1 
(95% CI) 
      Ethnicity 
Whitea 
(n = 28) 
38 
(60.7) 
- - 
Asian 
(n = 52) 
71 
(71.2) 
2.16 
(0.80 - 5.84) 
1.97 
(0.65 - 5.98) 
BME 
(n = 32) 
21 
(65.6) 
1.94 
(0.65 - 5.85) 
1.97 
(0.54 - 7.18) 
Abbreviations: OR, Odds Ratio; CI, Confidence Interval; BME, Black and Minority Ethnic groups 
1Adjusted ORs and 95% CIs are adjusted for group allocation (trial arm), gender, CCG, deprivation and initial 
episode status 
aReference category  
1Nagelkerke R square = 0.234 
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Appendix 8-15. Associated costs of the reminder and standard information booklet.  
Cost analysis 
  12-month reminder Follow-up reminder 
Item 
Quantity 
Ordered 
Cost  
(per order) 
Cost  
(per unit) 
Units  
(per person) 
Units 
(totals) 
Cost 
(totals) 
Units 
(totals) 
Cost 
(totals) 
Headed Paper 15000 £440.26 £0.03 (2) 922 £27.66 848 £25.44 
A5 Envelopes 500 £10.08 £0.02 (1) 461 £9.22 424 £8.48 
Pre-paid envelopes  3000 £224.33 £0.075 (1) 461 £34.58 424 £31.80 
Business Reply Plus - - £0.27 N/A 37 £9.99 27 £7.29 
Toner Cartridge 1 £194.20 £0.00492 (2) 922 £4.54 848 £4.17 
Postage (2nd Class) - - £0.27 (1) 461 £124.47 424 £114.48 
Standard information 
booklet 
- - £0.00 (1) 461 £0.00 424 £0.00 
Box of staples 5,000 £0.36 £0.000072 (1) 461 £0.03 424 £0.03 
Total direct costs of 
each reminder 
- - - - - £210.49 - £191.69 
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Total direct costs of 
both reminders 
    £402.18 
Cost per person sent 
an intervention 
    
£0.87 
(£402.18 / 461) 
Cost per additional 
screening attendee 
    
£8.38 
(£402.18 / 48) 
Sensitivity analysis 
Cost per additional 
screening attendee 
(Lower 95% CI) 
    
£11.17 
(£402.18 / 36) 
Cost per additional 
screening attendee 
(Upper 95% CI) 
    
£6.38 
(£402.18 / 63) 
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Appendix 8-16. Associated costs of the reminder and theory based leaflet.  
Direct costs 
  12-month reminder Follow-up reminder 
Item 
Quantity 
Ordered 
Cost  
(per order) 
Cost  
(per unit) 
Units  
(per person) 
Units 
(totals) 
Cost 
(totals) 
Units 
(totals) 
Cost 
(totals) 
Headed Paper 15000 £440.26 £0.03 (2) 922 £27.66 826 £24.78 
A5 Envelopes 500 £10.08 £0.02 (1) 461 £9.22 413 £8.26 
Pre-paid envelopes  3000 £224.33 £0.075 (1) 461 £34.58 413 £30.98 
Business Reply Plus - - £0.27 N/A 48 £12.96 47 £12.70 
Toner Cartridge 1 £194.20 £0.00492 (2) 922 £4.54 826 £4.06 
Postage (2nd Class)   £0.27 (1) 461 £124.47 413 £111.51 
Theory-based leaflet 3000 £711.36 £0.237 (1) 461 £109.26 413 £97.88 
Box of staples 5,000 £0.36 £0.000072 (1) 461 £0.03 413 £0.03 
Total direct costs of 
each reminder 
- - - - - £322.72 - £290.20 
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Total direct costs of 
both reminders 
    £612.92 
Cost per person sent 
an intervention 
    
£1.33 
(£612.92 / 461) 
Cost per additional 
screening attendee 
    
£8.75 
(£612.92 / 70) 
Sensitivity analysis 
Cost per additional 
screening attendee 
(Lower 95% CI) 
    
£11.14 
(£612.92 / 55) 
Cost per additional 
screening attendee 
(Upper 95% CI)  
    
£7.05 
(£612.92 / 87) 
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Appendix 8-17. Uptake in the different study groups and the absolute impact on uptake.  
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Appendix 9-1. Publication of Study 4.  
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Appendix 9-2. Uptake of self-referred appointment by baseline characteristics and trial 
arm (univariate and multivariate regression).  
 
Attended an 
appointment/ 
self-referred 
n (%) 
Unadjusted OR 
(95% CI) 
Adjusted OR1 
(95% CI) 
Group 
TMR-SIBa 
(n = 83) 
67 
(80.7) 
- - 
TMR-TBL 
(n = 126) 
99 
(78.6) 
0.88 
(0.44 - 1.75) 
0.85 
(0.41 - 1.77) 
Gender 
Womena  
(n = 106) 
79 
(74.5%) 
- - 
Men  
(n = 103) 
87 
(84.5)            
1.86 
(0.93 - 3.70) 
2.06* 
(1.01 - 4.23) 
CCG 
Brenta 
(n = 132) 
101 
(76.5) 
- - 
Harrow 
(n = 77) 
65 
(84.4) 
1.66 
(0.80 - 3.47) 
1.74 
(0.68 - 4.40) 
Deprivation 
Tertile 1a  
     (n = 69) 
57 
(82.6) 
- - 
Tertile 2 
(n = 74) 
55 
(74.3) 
0.61 
(0.27 - 1.37) 
0.83 
(0.32 - 2.17) 
Tertile 3 
(n = 65) 
54 
(83.1) 
1.03 
(0.42 - 2.54) 
1.56 
(0.51 - 4.74) 
Initial episode status 
Non-respondera 
(n = 180) 
142 
(78.9) 
- - 
Non-attender 
(n = 29) 
24 
(82.8) 
1.29 
(0.46 - 3.59) 
1.08 
(0.36 - 3.18) 
Referral method  
Returned slip 
(n = 175) 
138 
(78.9%) 
- - 
Telephoned 
(n = 34) 
28 
(82.4) 
1.25 
(0.48 - 3.25) 
1.70 
(0.84 - 3.44) 
Received a pre-appointment reminder by text and/ or by phone 
No 
(n = 87) 
64 
(73.6) 
- - 
Yes 
(n = 122) 
102 
(83.6) 
1.83 
(0.93 - 3.60) 
0.79 
(0.29 - 2.18) 
Abbreviations: OR, Odds Ratio; CI, Confidence Interval; CCG, Clinical Commissioning Group 
1Adjusted ORs and 95% CIs are adjusted for all other co-variates in the table 
aReference category  
*P < 0.05; **P < 0.01; ***P < 0.001 
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Appendix 9-3. Clinical findings.  
Clinical finding 12 and 24 month reminders  
n (%) 
Adults who attended screening 
No pathology 74 (44.0) 
Normal mucosal polyps 4 (2.4) 
Inflammatory polyps 4 (2.4) 
Hyperplastic polyps 20 (12.0) 
Adenomatous polyps 14 (8.4) 
Cancer 1 (0.6) 
Other pathology (.g. diverticulitis, hemorrhoids, etc.) 42 (25.3) 
Not screened – refused consent 1 (0.6) 
Not screened – did not meet clinical eligibility criteria 7 (4.2) 
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Appendix 9-4. Adenomas detected by trial arm and baseline characteristics - 12 & 24 
month reminder data combined (univariate and multivariate regression).  
 
Adenomas detected 
n (%) 
Unadjusted OR 
(95% CI) 
Adjusted OR1 
(95% CI) 
Group 
TMR-SIBa 
(n = 65) 
3 
(4.6) 
- - 
TMR-TBL 
(n = 93) 
11 
(11.8) 
2.77 
(0.74 - 10.36) 
2.75 
(0.70 - 10.78) 
Gender 
Womena (n = 
76) 
 
7 
(9.2) 
- - 
Men  
(n = 82) 
 
7  
(8.5) 
0.92 
(0.31 - 2.76) 
0.87 
(0.27 - 2.76) 
CCG 
Brenta 
(n = 96) 
10 
(10.4) 
- - 
Harrow 
(n = 62) 
4  
(6.5) 
0.59 
(0.18 - 1.98) 
0.82 
(0.19 - 3.53) 
Deprivation 
Tertile 1a  
     (n = 53) 
2 
(3.8) 
- - 
Tertile 2 
(n = 54) 
8  
(14.8) 
4.44 
(0.90 - 21.96) 
4.48 
(0.74  - 25.98) 
Tertile 3 
(n = 51) 
4  
(7.8) 
2.17 
(0.38 - 12.40) 
2.29 
(0.31 - 16.95) 
Initial episode status 
Non-respondera 
(n = 136) 
11 
(8.1) 
- - 
Non-attender 
(n = 22) 
3 
(13.6) 
1.79 
(0.46 - 7.02) 
2.67 
(0.60 - 11.79) 
Abbreviations: OR, Odds Ratio; CI, Confidence Interval; CCG, Clinical Commissioning Group 
1Adjusted ORs and 95% CIs are adjusted for all other co-variates in the table 
aReference category  
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Appendix 9-5. Adenomas detected by ethnic group - 12 & 24 month reminder data 
combined (univariable and multivariable regression).  
 
Adenomas detected 
n (%) 
Unadjusted OR 
(95% CI) 
Adjusted OR1 
(95% CI) 
Ethnic group 
Whitea 
(n = 41) 
5 
(12.2) 
- - 
Asian 
(n = 72) 
6 
(8.3) 
0.66 
(0.19 - 2.30) 
0.49 
(0.12 - 1.92) 
BME 
(n = 39) 
2 
(5.1) 
0.39 
(0.07 - 2.14) 
0.29 
(0.05 - 1.84) 
Abbreviations: OR, Odds Ratio; CI, Confidence Interval; BME, Black and Minority Ethnic groups 
1Adjusted ORs and 95% CIs are adjusted for group allocation (trial arm), gender, CCG, deprivation and initial 
episode status 
aReference category  
Table excludes data from the control arm, where no adenomas were detected in screened adults 
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Appendix 9-6. Preference for a same-sex practitioner by trial baseline characteristics 
and trial arm 12 & 24 month reminder data combined (univariate & multivariate 
regression outcomes). 
 
Preferred same-sex 
practitioner 
n (%) 
Unadjusted OR 
(95% CI) 
Adjusted OR1 
(95% CI) 
Group 
TMR-SIBa 
(n = 83) 
55 
(66.3) 
- - 
TMR-TBL 
(n = 126) 
89 
(70.6) 
1.53 
(0.87 - 2.71) 
1.52 
(0.83 - 2.78) 
Gender 
Womena  
(n = 106) 
81 
(76.4) 
- - 
Men  
(n = 103) 
63 
(61.2) 
0.38*** 
(0.21 - 0.68) 
0.35*** 
(0.19 - 0.63) 
CCG 
Brenta 
(n = 132) 
89 
(67.4) 
- - 
Harrow 
(n = 77) 
55 
(71.4) 
1.12 
(0.62 - 1.99) 
1.22 
(0.57 - 2.60) 
Deprivation 
Tertile 1a  
     (n = 69) 
51 
(73.9) 
- - 
Tertile 2 
(n = 74) 
53 
(71.5) 
0.75 
(0.47 - 1.49) 
0.81 
(0.36 - 1.83) 
Tertile 3 
(n = 65) 
39 
(60.0) 
1.33 
(0.67 - 2.66) 
1.68 
(0.69 - 4.11) 
Initial episode status 
Non-
respondera 
(n = 180) 
127 
(76.0) 
- - 
Initial  
non-attender 
(n = 29) 
17 
(58.6) 
1.99 
(0.90 - 4.39) 
1.76 
(0.76 - 4.08) 
Abbreviations: OR, Odds Ratio; CI, Confidence Interval; CCG, Clinical Commissioning Group;  
1Adjusted ORs and 95% CIs are adjusted for all other co-variates in the table 
aReference category  
*P < 0.05; **P < 0.01; ***P < 0.001 
Nagelkerke R square = 0.124 
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Appendix 9-7. Ethnicity of adults attending an appointment - 12 & 24 month reminder 
data combined. 
 Screened adults 
 n (%) 
Asian – Any (n = 72; 43.4%) 
Asian or Asian British – Bangladeshi 1 (0.6%) 
Asian or Asian British – Indian 54 (32.5%) 
Asian or Asian British – Pakistani 8 (4.8%) 
Asian or Asia British – Any other Asian background 9 (5.4%) 
White – Any (n = 41; 24.7%) 
White or White British – British 28 (16.9%) 
White or White British – Irish 5 (3.0%) 
White or White British – Any other White background 8 (4.8%) 
Black & Minority Ethnic groups – Any (n = 39; 23.5%) 
Black or Black British – African 8 (4.8%) 
Black or Black British – Caribbean  11 (6.6%) 
Black or Black British – Any other Black background 3 (1.8%) 
Mixed – White and Asian 1 (0.6%) 
Mixed – White and Black Caribbean 6 (3.6%) 
Mixed – Any other Mixed Background 3 (1.8%) 
Other Ethnic Groups – Chinese 2 (1.2%) 
Other Ethnic Groups – Any other Ethnicity 5 (3.0%) 
Missing (n = 14; 8.4%) 
Ethnicity not recorded 14 (8.4%) 
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Appendix 9-8. Preferences by ethnicity.  
 Preferred same-sex 
practitioner 
n (%) 
Unadjusted OR 
(95% CI) 
Adjusted OR1 
(95% CI) 
Ethnicity 
Whitea 
(n = 41) 
21 
(51.2) 
- - 
Asian 
(n = 72) 
50 
(69.4) 
2.57 
(0.47 - 14.11) 
3.43 
(0.55 - 21.58) 
BME 
(n = 39) 
23 
(59.0) 
1.68 
(0.32 - 8.76) 
1.68 
(0.27 - 10.32) 
Abbreviations: OR, Odds Ratio; CI, Confidence Interval; BME, Black and Minority Ethnic groups 
1Adjusted ORs and 95% CIs are adjusted for group allocation (trial arm), CCG, deprivation and initial episode 
status 
aReference category  
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Appendix 9-9. Subgroup analysis – uptake for baseline characteristics by reminder 
group - 12 & 24 month reminder data combined.  
 
SIBa 
(n = 461) 
TBL 
(n = 461) 
Unadjusted OR 
(95% CI) 
Adjusted OR1 
(95% CI) 
Gender 
Female 
32/238 
(13.4) 
47/228 
(20.6) 
1.67* 
(1.02 - 2.73) 
1.82* 
(1.10 - 3.00) 
Male 
35/223 
(15.7) 
52/233 
(22.3) 
1.54 
(0.96 - 2.48) 
1.88* 
(1.14 - 3.11) 
CCG 
Brent 
39/301 
(13.0) 
62/321 
(19.3) 
1.61* 
(1.04 - 2.49) 
1.70* 
(1.09 - 2.65) 
Harrow 
28/160 
(17.5) 
37/140 
(26.4) 
1.69 
(0.97 - 2.95) 
2.00* 
(1.10 - 3.49) 
Tertile of deprivation (IMD Score) 
Tertile 1 
(0.00 - 17.68) 
23/144 
(16.0) 
34/133 
(25.6) 
1.81* 
(1.00 - 3.27) 
2.08* 
(1.12 - 3.84) 
Tertile 2 
(17.69 - 27.50) 
18/162 
(11.1) 
37/179 
(20.7) 
2.10* 
(1.13 - 3.83) 
2.16* 
(1.17 - 4.00) 
Tertile 3 
(27.51 – 80) 
26/151 
(17.2) 
28/144 
(19.4) 
1.16 
(0.64 - 2.10) 
1.43 
(0.77 - 2.69) 
Initial episode status 
Non-responder 
55/408 
(13.5) 
87/436 
(20.0) 
1.60* 
(1.11 - 2.31) 
1.63** 
(1.12 - 2.36) 
Non-attender  
12/53 
(22.6) 
12/25 
(48.0) 
3.15* 
(1.14 - 8.67) 
5.76** 
(1.67 - 19.84) 
Abbreviations: OR, Odds Ratio; CI, Confidence Interval; CCG, Clinical Commissioning Group; IMD, Index of 
Multiple Deprivation 
1Adjusted ORs and 95% CIs are adjusted for all other co-variates in the table 
aReference category  
*P < 0.05; **P < 0.01; ***P < 0.001 
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Appendix 9-10. Associated costs of the 24 month reminder intervention and standard information booklet. 
Direct costs 
     24-month reminder Follow-up reminder 
Item 
Quantity 
Ordered 
Cost  
(per order) 
Cost  
(per unit) 
Units  
(per person) 
Units 
(totals) 
Cost 
(totals) 
Units 
(totals) 
Cost 
(totals) 
Headed Paper 15000 £440.26 £0.03 (2) 798 £23.94 776 £23.28 
A5 Envelopes 500 £10.08 £0.02 (1) 399 £7.98 388 £7.76 
Pre-paid envelopes  3000 £224.33 £0.075 (1) 399 £29..93 388 £29.10 
Business Reply Plus - - £0.27 N/A 11 £2.97 10 £2.70 
Toner Cartridge 1 £194.20 £0.00492 (2) 798 £3.93 776 £3.82 
Postage (2nd Class) - - £0.27 (1) 399 £107.73 388 £104.76 
Standard information 
booklet 
- - £0.00 (1) 399 £0.00 388 £0.00 
Box of staples 5,000 £0.36 £0.000072 (1) 399 £0.03 388 £0.03 
Total direct costs of 
each reminder 
- - - - - £176.51 - £171.45 
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Total direct costs of 
both reminders 
    £347.96 
Costs per person 
sent an intervention 
    
£0.87 
(£347.96 / 399) 
Cost per additional 
screening attendee 
    
£18.31 
(£347.96 / 19) 
Sensitivity analysis 
Cost per additional 
screening attendee 
(Lower 95% CI) 
    
£29.00 
(£347.96 / 12) 
Cost per additional 
screening attendee 
(Upper 95% CI) 
    
£12.00 
(£347.96 / 29) 
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Appendix 9-11. Associated costs of the 24-month reminder intervention and theory-based leaflet.  
Direct costs 
     24-month reminder Follow-up reminder 
Item 
Quantity 
Ordered 
Cost  
(per order) 
Cost  
(per unit) 
Units  
(per person) 
Units 
(totals) 
Cost 
(totals) 
Units 
(totals) 
Cost 
(totals) 
Headed Paper 15000 £440.26 £0.03 (2) 732 £21.96 702 £21.06 
A5 Envelopes 500 £10.08 £0.02 (1) 366 £7.32 351 £7.02 
Pre-paid envelopes  3000 £224.33 £0.075 (1) 366 £27.45 351 £26.33 
Business Reply Plus - - £0.27 N/A 15 £4.05 19 £5.13 
Toner Cartridge 1 £194.20 £0.00492 (2) 732 £3.60 702 £3.45 
Postage (2nd Class)   £0.27 (1) 366 £98.82 351 £94.77 
Theory-based leaflet 3000 £711.36 £0.237 (1) 366 £86.74 351 £83.19 
Box of staples 5,000 £0.36 £0.000072 (1) 366 £0.03 351 £0.03 
Total direct costs of 
each reminder 
- - - - - £249.97 - £240.98 
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Total direct costs of 
both reminders 
    £490.95 
Costs per person 
sent an intervention 
    
£1.34 
(£490.95 / 366) 
Cost per additional 
screening attendee 
    
£16.93 
(£490.95 / 29) 
Sensitivity analysis 
Cost per additional 
screening attendee 
(Lower 95% CI) 
    
£24.55 
(£490.95 / 20) 
Cost per additional 
screening attendee 
(Upper 95% CI) 
    
£11.97 
(£490.95 / 41) 
3
6
5
 
A
p
p
e
n
d
ic
e
s
 
 
0. Appendices 
 
361 
 
Appendix 9-12. Uptake in the different study groups and the absolute impact on uptake. 
 
 
Appendix 9-13. Socioeconomic variation in uptake in response to the reminders and 
their absolute effects on the socioeconomic gradient. 
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Appendix 9-14. Socioeconomic variation in uptake in response to the reminders and 
their absolute effects on the socioeconomic gradient.  
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Appendix 10-1. 2017-18 CQUIN for St Mark’s BCSC.  
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